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Abstract 
Athletes commonly consume caffeine as an ergogenic aid. The effect of caffeine 
ingestion on the immune response in humans, and in particular following exercise, has 
received little scientific attention. Caffeine may affect immune responses via 
adenosine receptor antagonism or adrenaline-mediated mechanisms. Following the 
relatively recent removal of caffeine from the WADA list of prohibited substances, its 
use is expected to increase further, therefore any influence of caffeine on immune 
function is of particular relevance. The aim of this thesis was to investigate the 
influence of caffeine ingestion on immunoendocrine responses following prolonged 
and intensive cycling in humans. 
Initially, caffeine (6 mg. kg4 body mass) did not affect neutrophil functional responses 
when participants rested for 3.5 h following ingestion (Chapter 4). Caffeine ingestion 
attenuated the post-exercise decline in neutrophil oxidative burst response when 
stimulated by f-MLP (Chapter 6) but not PMA (Chapter 5). An in vitro study 
suggested that this most likely occurs as a result of adenosine-receptor antagonism by 
caffeine (Chapter 8). Although caffeine ingestion improved pre-loaded TT 
performance by 4%, there was no attenuating effect of caffeine on post-exercise f- 
MLP-stimulated neutrophil oxidative burst responses (Chapter 7) nor was there any 
benefit of co-ingesting caffeine with CHO on oxidative responses, compared with 
either supplement alone (Chapter 9). Caffeine supplementation did not affect total 
circulating leukocyte or neutrophil count at rest or following exercise, but increased 
circulating lymphocyte count both at rest and during exercise following ingestion. 
Caffeine ingestion was consistently associated with an increased plasma adrenaline 
concentration but not noradrenaline concentration at rest and following exercise. 
Caffeine generally had no effect on plasma cortisol concentration, though it was 
consistently associated with an increased plasma IL-6 concentration following 
exercise of various duration and intensity. 
In conclusion, the attenuating/positive effects of caffeine ingestion on post-exercise 
neutrophil oxidative burst responses appear to be stimulant-dependent. None of the 
experimental studies,, - however, indicated that caffeine ingestion was more detrimental 
than placebo on the f-MLP-stimulated neutrophil oxidative burst response to exercise. 
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Introduction 
Anecdotal, survey and epidemiological data suggest that athletes who perform 
prolonged and intensive exercise are at an increased risk for upper respiratory tract 
infection (URTI) (Nieman, 2000). This may be detrimental to an athletic performer, 
causing them to miss training and competition days through illness or compromise the 
intensity of their training schedules. A direct link between immune function in vivo 
and actual infection has not been established, primarily due to an ethical concern 
about inoculating participants with a virus before or after heavy-exertion exercise 
(Bishop, 2006). However, exercise is a useful model to determine immune responses 
as it is a reproducible and quantifiable stressor that can be manipulated to evoke 
defined hormonal, endocrine and nervous responses, depending upon its intensity and 
duration (Smith, 1997). Exercise of moderate duration and intensity is associated with 
few disturbances to immune function (Nieman, 1997); however, following prolonged 
and intensive exercise, many components of the immune system exhibit change. 
During this period of altered immunity, opportunistic viruses and bacteria may gain a 
foothold, increasing the susceptibility for infection. This has subsequently been 
termed the `open window for infection' (Nieman and Pedersen, 1999; Nieman, 2000). 
The impairment of immune function following exercise appears to be predominantly 
caused by elevated concentrations of stress hormones (Smith, 1997; Gleeson and 
Bishop, 1999; Gleeson et al., 2004a). Not surprisingly, therefore, nutritional 
interventions have attempted to reduce stress hormone responses in an attempt to 
reduce the magnitude of this immunosuppression and attempt to `close' this window. 
The consumption of carbohydrate (CHO) before and during exercise is associated 
with an attenuated rise of plasma adrenaline, cortisol, adrenocorticotrophic hormone 
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(ACTH), growth hormone and a number of cytokines (Nehlsen-Canarella et al., 1997; 
Nieman et al., 1998; Davison and Gleeson, 2005; Nieman et al., 2005). CHO 
ingestion has also been reported to attenuate the decline of formyl-methionyl-leucyl- 
phenylalanine (f-MLP)-stimulated neutrophil oxidative burst response (Scharhag et 
al., 2002), bacterially-stimulated neutrophil degranulation response (Bishop et al., 
2000; Davison and Gleeson, 2005), and cell-adjusted phytohaemagglutinin (PHA)- 
induced lymphocyte proliferation (Henson et al., 1998) following prolonged duration 
exercise. Nutritional anti-oxidants have also been extensively researched with regards 
to immune function and oxidative stress. Peters et al. (1993) reported that daily 
supplementation with large Vitamin C doses reduced incidence of URTI following an 
ultramarathon race. This has been associated with an attenuation of the post-race 
plasma cortisol and adrenaline concentrations following Vitamin C supplementation 
(Peters et al., 2001). Supplementation with Vitamins C and E significantly reduced 
cortisol and interleukin-6 (IL-6) responses following 3-h dynamic knee-extensor 
exercise (Fischer et al., 2004), but a 2-week supplementation with Vitamin C alone 
did not affect IL-6 or neutrophil functional responses following 2.5-h cycling 
(Davison and Gleeson, 2006). Furthermore, Vitamin C supplementation for 1-week 
did not affect any immune changes following a 10-h ultramarathon event (Nieman et 
al., 2002). Glutamine supplementation did not alter post-exercise leukocytosis or 
immune function following prolonged exercise (Walsh et al., 2000). Equivocal 
evidence has been reported with regards to the effects of a number of minerals, such 
as iron and zinc supplementation, upon immune responses following exercise and the 
incidence of URTI (Gleeson et al., 2004a). 
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Caffeine is contained in various foods, beverages and medications. It is the most 
widely consumed behaviourally active substance in the world (Fredholm et al., 1999), 
yet it is not a typical nutrient nor is it essential for health (Graham, 2001a). Athletes 
commonly consume caffeine as an ergogenic aid (Tarnopolsky, 1994) and its use is 
highly prevalent in the sport of amateur and professional cycling. Following the 
relatively recent removal of caffeine from the World Anti-Doping Agency (WADA) 
list of prohibited substances, its use is expected to increase considerably amongst 
athletes during periods of training and competition. The effect of caffeine ingestion on 
the immune response in humans, and in particular following exercise, has not been 
extensively researched (Section 2.10). Caffeine ingestion, however, is consistently 
associated with an increased secretion of adrenaline (Graham and Spriet, 1991,1995) 
and is also reported to increase plasma cortisol concentration (Laurent et at., 2000). 
Furthermore, the main action of caffeine at physiological concentrations is that of 
adenosine-receptor antagonism (Ongini & Fredhoim, 1996). Adenosine receptors are 
found in most tissues, including immune cells, therefore this thesis investigated the 
influence of caffeine ingestion on immunoendocrine responses following prolonged 
and intensive cycle ergometry exercise. 
Firstly, the effect of caffeine ingestion upon hormonal and immune responses was 
determined in participants at rest (Chapter 4). The effect of caffeine ingestion on post- 
exercise neutrophil oxidative burst responses to phorbol-12-myristate-13-acetate 
(PMA) and f-MLP stimulation was investigated in Chapters 5 and 6, respectively. As 
caffeine is consumed as an ergogenic aid, its effect on neutrophil oxidative burst, 
hormonal and cytokine responses was investigated following a pre-loaded time-trial 
performance test (Chapter 7). The potential mechanisms by which caffeine may affect 
4 
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neutrophil oxidative burst responses were investigated in vitro (Chapter 8). Caffeine is 
commonly consumed with CHO in commercially available soft drinks and energy 
drinks. The effect of caffeine co-ingested with CHO on hormonal, cytokine and 
neutrophil responses following endurance exercise was determined in Chapter 9. 
5 
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Chapter 2 
2.1. Are athletes more susceptible to infection? 
A common perception exists among elite performers and their coaches that athletes 
performing chronic exercise (i. e. prolonged and intensive exercise sessions) are at 
increased risk of URTI (e. g. common cold, cough, sore throat and middle ear 
infection) (Nieman et al., 1997; Nieman, 2000). Such respiratory infections could lead 
to an increased number of training or competition days missed through illness, or may 
reduce the intensity that an athlete is able to train or compete, therefore potentially 
having a substantial negative impact for the elite performer. This anecdotal evidence 
is supported by survey-based epidemiological data (Peters and Bateman, 1983; 
Nieman et at., 1990a). These studies reported that the risk of URTI is between 2 and 6 
times greater in the 2-week period following a prolonged endurance event 
(marathon/ultramarathon) and is correlated with race finishing time (Peters and 
Bateman, 1983) and pre-race training distance (Nieman et al., 1990a). The diagnosis 
of URTI in these studies was based upon responses to questionnaires, rather than 
clinical assessment and determination. This self-reported evidence may therefore be 
subject to response bias due to an increased body-awareness in highly trained athletes 
(Gleeson and Bishop, 1999). Furthermore, other practices may also contribute to an 
increased incidence of infection amongst athletes such as improper nutrition, lack of 
sleep, psychological stress, air pollution, travel and sharing of drinking bottles, which 
may confound this epidemiological evidence (Gleeson and Bishop, 1999). 
Although epidemiological evidence has supported the notion that strenuous exercise 
leads to increased infection risk, a direct link between immune function in vivo and 
actual infection has not been established. One reason for this is a serious ethical 
concern about inoculating participants with a virus prior to heavy-exertion exercise 
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(Bishop, 2006). A study conducted by Bruunsgaard et al. (1997) investigated whether 
in vivo impairment of immune response could be demonstrated following intense 
exercise of prolonged duration. In this study, a mixture of antigens was injected into 
the forearm skin of triathletes after they had completed a half-ironman race (3 km 
swim, 130 km cycle, 21 km run) and hypersensitivity response was measured. This is 
a complex immunological reaction involving several different cell types and 
mediators, resulting in swelling at the site of antigen administration which was 
measured at 48 h following injection. The response of the triathletes after exercise 
was significantly lower than both non-exercising triathletes and moderately trained 
controls, suggesting that cell-mediated immunity is depressed in the first days 
following prolonged high-intensity exercise. In trained swimmers, salivary 
immunoglobulin A (sIgA) concentration was inversely related to training volume over 
the course of a 7-month season (Gleeson et at., 1999b). Furthermore, the pre-season 
sIgA levels and the rate of decrease in pre-training sIgA levels were associated with 
an increase in the number of episodes of URTI as assessed by a clinician (Gleeson et 
al., 1999b). 
This general perception that athletes are at increased risk of URTI has contrasted with 
the belief of recreational exercisers or `keep-fit fanatics', that physical exercise 
provides protection or resistance to URTI (Mackinnon, 2000). For example, in a 
survey of 170 experienced non-elite marathon runners, 90% reported that they `rarely 
got sick' (Nieman, 2000). Moreover, a 15-week moderate exercise training 
programme (5 sessions of 45 min walking per week) was associated with significantly 
fewer days suffering from URTI symptoms in a group of mildly obese women when 
compared with a sedentary control group (Nieman et al., 1990b). In this study, natural 
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killer (NK) cell activity was significantly elevated in the exercising group during the 
initial 6-week period; however there was no difference at the end of the 15-week 
study. A J-shaped hypothesis has therefore been proposed, suggesting that intense 
exercise increases the risk, whereas moderate exercise may decrease the risk of 
contracting URTI (Nieman, 1994). After an acute bout of prolonged and intensive 
endurance exercise, many components of the immune system exhibit change. This 
period, which may last between 3 and 72 hours depending upon the immune 
parameter measured and the exercise protocol utilised, has been termed the `open 
window' for infection and during this time, opportunistic viruses and bacteria may 
gain a foothold, increasing the susceptibility of infection (Nieman and Pedersen, 
1999; Pedersen et al., 1999; Nieman, 2000). The major components of the immune 
system that exhibit change following exercise are described in Section 2.2. 
2.2. Exercise and immune responses 
Exercise exerts significant effects upon the immune system. In general, acute bouts of 
exercise that are of moderate duration (< 60 min) and intensity (< 60% V02 max) are 
associated with fewer perturbations to the immune system and may actually enhance 
immune responses (Nieman, 1997). The following changes have generally been 
reported to occur following prolonged (> 90 min) and intensive (>_ 70% V02 max) 
endurance exercise: - 
9 Circulating neutrophil concentration increases at post-exercise and recovery 
(McCarthy and Dale, 1988). Circulating lymphocyte count increases during 
exercise and falls below pre-exercise values following exercise (McCarthy and 
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Dale, 1988). Collectively, this leads to an increase of the 
neutrophil/lymphocyte ratio. 
" Increase in circulating neutrophil phagocytosis (Blannin et al., 1996) and 
decreased nasal neutrophil phagocytosis (Muns, 1994). 
. Increase in neutrophil degranulation response (Suzuki et at., 2003; Peake et 
al., 2004) but a decreased degranulation response to bacterial stimulation on a 
per-cell basis (Robson et al., 1999; Walsh et al., 2000). 
9 Decrease in bacterially-stimulated neutrophil oxidative burst response on a 
per-cell basis (Robson et al., 1999; Suzuki et al., 2003; Davison and Gleeson, 
2005). Occasionally an increase (Smith et al., 1990) or no change (Walsh et 
at., 2000) in the response has been observed. 
" Decrease in NK cell cytotoxic activity (Shek et at., 1995; Nieman, 1997). 
" Decrease in the ratio of helper T cells (CD4) to suppressor T cells (CD8+). A 
decrease of the CD4+: CD8+ ratio to below 1.5 is associated with an increased 
susceptibility to infection (Shephard et al., 1991). 
" Decrease in mitogen-induced T cell proliferative responses (Nieman et al., 
1995). 
" Either a decrease (Tvede et al., 1989) or no change (Mackinnon et al., 1989) in 
mitogen-stimulated B cell Ig synthesis in vitro. 
" Decreased cell-mediated delayed hypersensitivity response (Bruunsgaard et 
al., 1997). 
" Decreased toll like receptor expression on monocytes and decreased functional 
responses (Lancaster et al., 2005). 
9 Decreased major histocompatibility complex (MHC II) expression in 
macrophages (Woods et al., 1997). 
10 
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" Increase in a number of pro-inflammatory and anti-inflammatory cytokines 
such as tumour necrosis factor (TNF-a) and IL-Iß, IL-6, IL-10, IL-ira 
(Ostrowski et al., 1998). 
" Decrease in nasal IgA concentration (Nieman, 1997) and changes in salivary 
IgA concentration (Gleeson et al., 2004b). 
As detailed above, one aspect of the immune system that exhibits change following 
endurance exercise is that of neutrophil response, and it is these responses upon which 
this thesis will focus. 
2.3. Neutrophils and host defence 
Neutrophils constitute 50-60% of circulating leukocytes and act as the first-line of 
defence against agents that penetrate the body's physical barriers (Smith, 1997). Their 
targets include bacteria, fungi and viruses, yet they require signalling mediators 
within the immune system to direct their attack since they have the inability to 
differentiate between host and foreign agents. Without this, healthy host tissues may 
be damaged resulting in inflammation (Pyne, 1994). The neutrophil functional 
cascade begins when previously mobile neutrophils adhere to the vascular 
endothelium. Upon signalling from various chemoattractants, neutrophils penetrate 
the endothelial layer (diapedesis), move through connective tissues and are localised 
to the sites of infection (chemotaxis and migration). At the site of infection 
neutrophils bind to and ingest the foreign material by a process called phagocytosis, 
leading to the activation of the oxidative burst and secretory function of neutrophils 
(Smith and Pyne, 1997; Mackinnon, 1999). Activation of the secretory function of 
neutrophils results in the release of cytoplasmic granules (eg. Myeloperoxidase 
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(MPO), elastase, lysozyme and lactoferrin) into the phagolysosomal vacuole and often 
occurs simultaneously with the oxidative burst. The neutrophil oxidative burst 
consists of a complex series of events that can be divided into 3 distinct phases: 
stimulation and recognition, signal transduction and activation phase (Pyne, 1994). A 
detailed explanation of these phases is beyond the scope of this review: for further 
detail the reader is directed to Peake (2002). 
Neutrophils are stimulated via receptor-mediated and receptor-independent 
mechanisms. Receptor-mediated stimuli include the complement fragment C5a, 
various N-formylated methionyl peptides, bacterial endotoxins, bioactive lipids such 
as platelet activating factor (PAF) and leukotriene B4 (Pyne, 1994). Receptor- 
independent stimuli include long-chain unsaturated fatty acids and phorbol esters, 
that directly activate protein kinase C (Chanock et al., 1994). Receptor-dependent 
stimuli usually activate nicotinamide adenine dinucleotide phosphate (NADPH) 
oxidase for <5 min, while receptor-independent stimuli activate the enzyme for a 
much longer period (Chanock et al., 1994). When neutrophils become activated, a 50 
to 100-fold increased consumption of molecular oxygen (02) results in the formation 
of superoxide ions (02-") via the action of a plasma-membrane NADPH oxidase 
(Chanock et al., 1994; Hasegawa et at., 1997; Smith, 1997; Babior, 1999). The 
NADPH core enzyme consists of 5 components: 3 of these exist in the cytosol 
(pOPHOX p47PHOX p67PHOx) and 2 are located within the membranes of secretory 
vesicles and are collectively known as cytochrome b558 (p22pxox gp91PHOX) 
Following stimulation, the cytosolic p47PHOX component is heavily phosphorylated 
and the component migrates to the membrane where it associates with cytochrome 
b55s to assemble the active oxidase (Babior, 1999). It catalyzes the production of 02-" 
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by the one-electron reduction of 02. The 02-O may then initiate a cascade of reactions, 
involving hydrogen peroxide (11202), hydroxyl radicals (*OH-) and chloride ions (C1") 
resulting in the production of reactive oxygen species (ROS), or through a different 
mechanism, reactive nitrogen species (RNS) (Smith, 1997; Babior, 1999; Peake, 
2002). These act to eliminate micro-organisms and damaged tissue by damaging the 
cell membrane and/or rendering the cells inactive. This process is illustrated in Figure 
2.1. 
The importance of neutrophils in host defence cannot be underestimated and is 
illustrated by deficiencies in number and/or function (Smith, 1997). For example, the 
neutrophil oxidative burst is essential for killing a number of micro-organisms, as 
shown by the increased susceptibility to infections of individuals with chronic 
granulomatous disease (CGD). CGD is a genetic disease in which the NADPH 
oxidase is inactive, thus neutrophils do not undergo a burst when bacteria is ingested 
and do not produce oxidising radicals. Infections can occur anywhere within the body 
and may take many forms (Smith and Curnutte, 1991). It is therefore clear that 
neutrophils play an important role in the resistance against infection, thus their 
function during and following exercise is of importance. Neutrophils undergo several 
functional alterations during exercise, 'some of which are discussed below (for a 
comprehensive review refer to Smith and Pyne, 1997). 
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NADPH oxidase 02 
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H2O OZ-" 
102 "OIi 
Figure 2.1. The production of reactive oxidants by neutrophils (from Peake, 
2002). 
2.4. Exercise-induced neutrophilia 
The concept of exercise-induced neutrophilia is not a new phenomenon, with a large 
body of published literature demonstrating a marked increase in circulating neutrophil 
count during and after virtually all forms of exercise (reviewed by McCarthy and 
Dale, 1988). The magnitude of this increase, however, is related to the intensity, 
duration and mode of exercise performed (Hansen et al., 1991; Gabriel and 
Kindermann, 1997; Robson et al., 1999; Pyne et al., 2000; Peake, 2002, amongst 
others). 
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Data from brief exercise suggests that only a transient disturbance in circulating 
neutrophil count occurs as a result of short duration exercise. For example, Nieman et 
al. (1992) showed that numbers of circulating neutrophils increased by approximately 
40% following a 30 s maximal-effort cycle sprint, yet neutrophil counts returned to 
pre-exercise values after 1h recovery. However, in studies where multiple post- 
exercise blood samples were taken, Hansen et at. (1991) and Gabriel et al. (1992) 
reported that circulating neutrophil counts exhibit a biphasic response consisting of a 
modest increase immediately following brief and intensive exercise, returning to 
baseline levels within 30 min but exhibiting a delayed and prolonged neutrophilia at 2 
and 4h following exercise cessation. This was demonstrated following a maximal 60 
s cycling sprint (Gabriel et al., 1992) and in the recovery following short (1.7 km), 
medium (4.8 km) and long (10 km) duration running distances (Hansen et al., 1991). 
Immediately following exercise, neutrophil count had increased by approximately 
20%, yet the delayed neutrophilia occurring at 2h was 68%, 102% and 170% above 
pre-exercise values following the short, medium and long runs, respectively. The 
magnitude of the delayed response varied amongst subjects but was associated with 
the duration of the exercise performed. 
In relation to endurance exercise, many researchers have reported an immediate 
increase in circulating neutrophils during exercise that remains elevated for several 
hours after the cessation of exercise (review by Peake, 2002). For example, in 
endurance trained cyclists, 2h cycling at 75% VO2 max resulted in a 4-fold increase 
in circulating neutrophils immediately post-exercise with a further rise at 1h post- 
exercise (Bishop et al., 2003). A 4.5-fold increase was reported at post-exercise when 
recreationally active cyclists performed the same duration of exercise at 65% 
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V02 max (Bishop et al., 2004). In healthy untrained males, a 2.5-fold increase in 
circulating neurophil count was found following 1.5 h cycling at 70% 
VO2 max, 
rising to greater than 3-fold at 1h post-exercise (Suzuki et al., 1996a). Responses of a 
similar magnitude were reported by Walsh et al. (2000) and Scharhag et al. (2002, 
2006) using cycling protocols of 2h at 60% VO2 max and 4h at 70% individual 
anaerobic threshold, respectively. In addition to an increase in circulating neutrophil 
count during and after exercise, an increase in the number of neutrophils in the upper 
respiratory tract has also been demonstrated. A study conducted by Muns (1994) used 
a nasal lavage technique to assess neutrophil count following a 20 km road race. 
Immediately following the race, a 3-fold increase in respiratory tract neutrophils was 
found that remained elevated by 1.6-fold above pre-race values following a 24 h 
recovery period. 
The neutrophilia that occurs with exercise appears to be directly related to the 
duration rather than the intensity of the exercise performed. Circulating neutrophil 
count was increased by 2-fold at post-exercise when participants cycled for 1.5 h at 
60% VOZ max (Li and Gleeson, 2005). However, a 4-fold increase was reported 
when participants cycled for 2.5 h at the same relative exercise intensity (Davison and 
Gleeson, 2006). Furthermore, the delayed neutrophilia is also related to exercise 
duration rather than intensity. Robson et al. (1999) compared the effects of cycling at 
80% VO2 max (resulting in fatigue within I h) with cycling at 55% V02 max (up to 
3 h) and reported a significantly higher neutrophil count at 0 h, 1 h, 2.5 h and 5h post- 
exercise on the prolonged exercise trial. In slight contrast to the above results, the 
studies of Suzuki et al. (2003) and Hessel et al. (2000) observed the effects of 
marathon distance running on neutrophil cell counts. Both research groups found 
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increases of the same magnitude (approximately 4.5-fold) even though there was a 
marked difference in reported finishing times between the subjects in the 2 races 
(mean finishing time: 2.6 h vs. 3.5 h). 
The mode of exercise performed has also been documented as a reason for 
discrepancies between research findings. In a study conducted by Pizza et al. (1995) 
blood neutrophil counts were higher at 1.5 h and 12 h post-exercise following a 60 
min downhill treadmill run at 70% VO2 max compared with level running, 
suggesting that when eccentric exercise is performed, a larger mobilisation of 
neutrophils is elicited. In contrast, however, Nieman et at. (1998) reported little 
difference in circulating count between exercise modes following 2.5 h of running or 
cycling at 75% VO2 max . Pyne et al. (2000) assessed the effects of intensity and type 
on neutrophil count with a protocol employing 3 separate 40-min interval treadmill 
bouts (8 x5 min). Circulating neutrophil counts were higher in the uphill treadmill 
run compared to both the downhill or near-level run; however the intensity of the 
uphill run was 90% "02 max compared to 52% "02 max for the other 2 conditions. 
The neutrophil response to repeated exercise on the same day (Ronsen et at., 2001; 
Boyum et al., 2002) and on repeated days (Suzuki et al., 1996a) has been studied. The 
second of two exercise bouts separated by a3h recovery produced a significantly 
stronger neutrophilia than a single exercise bout (Ronsen et at., 2001) or two bouts 
separated by a6h recovery (Boyum et at., 2002). The exercise protocol of Suzuki and 
co-workers (1996a) consisted of 7 consecutive days of cycling for 90 min at 70% 
VO2 max with blood samples at 1,4 and 7 days. A single bout of endurance exercise 
induced a marked neutrophilia but the magnitude of the response to exercise on days 4 
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and 7 was attenuated. This may have reflected an adaptive response to repeated 
physiological stress, which may have confounded the results obtained at the end of the 
study. 
2.5. Mechanisms underlying neutrophil distribution during and after exercise 
The leukocytosis of exercise has been extensively studied (McCarthy and Dale, 
1988). Following a prolonged bout of exercise, the leukocytosis of exercise shows a 
biphasic response consisting of an immediate increase in lymphocytes and 
neutrophils, followed by a lymphocytopenia (decrease in lymphocyte number) and a 
neutrophilia towards or following the cessation of exercise. The mechanisms which 
underly neutrophil mobilisation during and following prolonged exercise have been 
well documented (Pyne, 1994). Changes in the number of circulating neutrophils 
during exercise were originally attributed to the mechanical effect of the increase in 
cardiac output with exercise (Foster et al., 1986). The shear forces associated with an 
increased pulmonary blood flow may mobilise neutrophils from marginated pools 
within the vascular endothelium and lungs, and possibly the liver and spleen into the 
systemic circulation (Muir et al., 1984; McCarthy and Dale, 1988). 
Although this appears the major mechanism for the increases in circulating neutrophil 
number during exercise, at high work rates the cardiac output begins to plateau while 
neutrophilia continues to increase (Blannin, 2006). Increased plasma catecholamine 
concentrations therefore make a significant contribution (Boxer et al., 1980, 
McCarthy and Dale, 1988, Tvede et al., 1994). The effects of catecholamines are 
mediated via adrenoreceptors, which are separated into 4 categories (al, a2, (3i, 02) 
based on their sensitivity to particular agonists (Benschop et at., 1996). Neutrophil 
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count has been reported to increase and neutrophil adherence to vascular endothelium 
is reported to decrease following adrenaline infusion (Boxer et al., 1980). When a 0- 
antagonist was infused prior to adrenaline infusion, there were no significant changes, 
suggesting that the response is mediated via ß-adrenoreceptors. It was proposed that 
ß-receptors on endothelial cells are stimulated by adrenaline to activate adenylate 
cyclase, which increases cAMP concentration and subsequently reduces neutrophil 
adherence (Boxer et al., 1980). Furthermore, adrenaline dose-dependently inhibited 
neutrophil adherence to endothelial cell monolayers (Bazzoni et al., 1991). In 
contrast, however, Benschop et al. (1996) reported that a-adrenoreceptors are 
involved in the effects of catecholamines on granulocyte trafficking. During exercise, 
there is a decrease in the expression of L-selectin (CD62L) on neutrophils (Van Eeden 
et al, 1999). L-selectin plays an important role in endothelial cell interaction, therefore 
an altered expression of cell-surface adhesion molecules may effect neutrophil 
mobilisation to and from the circulation. 
The delayed neutrophilia that occurs following exercise has been attributed to the 
effects of cortisol (Gabriel et at., 1992; McCarthy et al., 1992; Pyne, 1994; Brenner et 
al., 1998). Cortisol is a steroid hormone, synthesised and secreted by the adrenal 
cortex, with its secretion controlled by the anterior pituitary ACTH (Brenner et al., 
1998). Both psychological and physiological stressors are major stimuli for cortisol 
release. Cortisol concentrations increase in response to acute exercise with a critical 
level of approximately 60% V02 max (Davies and Few, 1973), but the effects of 
cortisol only appear after a lag-period that is in some cases maybe more than 1 hour 
(Viru and Viru, 2004). It is reported that cortisol typically stimulates the migration of 
neutrophils from the bone marrow into the circulation (Hetherington and Quie, 1985; 
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McCarthy et al., 1987). In rabbits, however, glucocorticoid infusion caused a 
significant granulocytosis primarily by the process of demargination with only a 
minor contribution from bone marrow release (Nakagawa et al., 1998). Plasma 
cortisol levels were found to directly correlate with granulocyte number (Moorthy and 
Zimmermann, 1978) and the neutrophil/lymphocyte ratio (Nieman, 1997) following 
endurance running. Furthermore, plasma cortisol was significantly higher at post- 
exercise following low-intensity, long duration exercise than high-intensity short 
duration exercise (Robson et al., 1999). Subsequently, circulating neutrophil counts 
were significantly higher throughout a5h recovery period following the prolonged 
duration exercise, yet others have reported no relationship between cortisol and post- 
exercise neutrophilia (Shinkai et al., 1996) or delayed neutrophilia (Hansen et al., 
1991). Growth hormone and IL-6 have also been reported to mediate the delayed- 
onset neutrophilia (Suzuki et al., 1996b; Peake, 2002). 
2.6. Exercise and neutrophil degranulation 
An analysis of the number of circulating cells does not provide the whole story, 
because the function of those cells is an equally important consideration (Rowbottom 
and Green, 2000). An important microbicidal process of neutrophils is degranulation, 
which corresponds to the release of contents of azurophilic (primary) and specific 
(secondary) granules into the phagocytic vesicle to form a phagolysosome (Smith, 
1997). A large body of evidence suggests that neutrophil degranulation increases after 
exercise of varied intensities and durations. For example, an increase in plasma MPO 
concentration has been reported following exercise to volitional exhaustion in both 
humans and rats (Suzuki et al., 1996b; Morozov et al., 2003), running for 1h at 85% 
VOz Max (Peake et at., 2004) and marathon running (Suzuki et al., 2003). This was 
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reflected in a decreased neutrophil intracellular MPO concentration following 
exercise (Peake et al., 2004). Similarly, an increased plasma elastase concentration is 
reported following medium and prolonged-duration cycle ergometry exercise 
(Blannin et al., 1997b; Robson et al., 1999; Walsh et al., 2000; Bishop et al., 2001a, 
2004). The authors concluded that exercise activates neutrophils; however Suzuki et 
al. (1999) reported that there was no difference in plasma elastase concentration 
following marathon running when adjusted on a per-cell basis, indicating that an 
increased plasma elastase concentration is not a useful parameter for neutrophil 
activation in vivo when accompanied by a similar neutrophilia. 
lt may be more clinically relevant to examine the effects of exercise on the changes in 
bacterially-stimulated elastase release per neutrophil, since the site of infection may 
only allow a limited number of cells to surround the infected tissue, regardless of the 
number of cells in the circulation (Bishop et al., 2001c). Bacterially-stimulated 
elastase release is widely reported to decrease on a per-cell basis following 
submaximal intensity exercise of prolonged duration (Robson et al., 1999; Walsh et 
al., 2000; Bishop et al., 2000; Bishop et al., 2003; Li and Gleeson, 2005). For 
example, research conducted by Bishop et al. (2000) and Walsh et al. (2000) using the 
same protocol (2 h cycling at 60 % 
VOz max) demonstrated post-exercise decreases 
in bacterially-stimulated elastase release on a per-cell basis of 40 and 33% 
respectively, compared with pre-exercise values. A protocol of the same duration at a 
higher relative exercise intensity (75% VO2 max) revealed a 47% fall in bacterially- 
stimulated elastase release at post-exercise that remained at 45% of the resting value 
following aIh recovery (Bishop et al., 2003). The findings of Robson et al. (1999) 
confirmed that the duration rather than the intensity of exercise induces a larger 
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suppression of in vitro neutrophil elastase release to bacterial stimulation. Neutrophil 
degranulation response was significantly lower at post and 2.5 h post-exercise after 
approximately 3h cycling at 55% "02 max compared to 80% VO2 max (resulting in 
fatigue within 1 h). At 24 h post-exercise, a significant reduction was still evident 
following the prolonged-duration trial, whereas neutrophil degranulation had returned 
to pre-exercise values on the high-intensity trial. Furthermore a 5-week endurance 
training period (30-60 min at 70% 'O2 max) resulted in an attenuated degranulation 
response of resting blood samples to bacterial stimulation (Blannin et al., 1997a). 
It has been speculated that falls in bacterially-stimulated neutrophil degranulation 
responses following exercise may be due to an inhibitory effect of plasma cortisol 
concentration, or may reflect a higher proportion of immature cells from the bone 
marrow into circulation that contain less cytotoxic granules and are therefore less 
responsive to stimulation (Robson et al., 1999). A further reason maybe that following 
an initial activation, the cells are less responsive to subsequent stimulation (Prasad et 
al., 1991). When CHO (6% w/v) was fed prior to and during submaximal exercise of 
fixed duration, the rise in plasma cortisol was attenuated and there was no fall in 
bacterially-stimulated neutrophil degranulation response (Bishop et al., 2000); 
however CHO (5% w/v) did not affect this response when exercise was performed to 
fatigue (Bishop et al., 2003). Furthermore, a number of studies have reported a 
reduced cortisol concentration following a number of dietary modifications both 
before and during exercise, but have reported no differences in bacterially-stimulated 
neutrophil elastase release, thus not supporting a role for cortisol in mediating the 
response (Bishop et al., 2001c; Lancaster et al., 2003; Bishop et al., 2004). It has also 
been reported that elastase availability is not a limiting factor for post-exercise 
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bacterially-stimulated elastase response on a per-cell basis (Bishop et al., 2003). 
Following exercise, the percentage of elastase release in response to bacterial 
stimulation fell to only 7-10% of the total elastase content, refuting the hypothesis that 
immature cells contain fewer cytotoxic granules that are available for release 
following bacterial stimulation (Bishop et al., 2003). 
2.7. Exercise and neutrophil oxidative burst activity 
As mentioned previously, the other major microbicidal process of neutrophils is the 
oxidative burst. This process is also referred to as the `respiratory burst, ' as it results 
in the production of superoxide anions (02-"), via the activation of NADPH oxidase. 
02-" is rapidly converted to H202 and a series of reactions result in the highly toxic 
end-products HOCI, *Off, and 
102 (Pyne, 1994; Smith, 1997). Although this is the 
most studied neutrophil function (Smith, 1997), researchers have reported conflicting 
findings from their studies. These equivocal results may have arisen due to 
differences in the intensity and duration of exercise protocols employed, the age, sex 
and training status of participants, the stimulant used to initiate the oxidative burst and 
assay techniques used to measure neutrophil function (Pyne, 1994; Peake, 2002). 
Several studies, employing relatively long-duration exercise protocols (1 h to 2.5 h) 
have reported an increased ROS production at post-exercise and in the recovery 
period following exercise (Smith et al., 1990; Singh et al., 1994; Smith et al., 1996; 
Suzuki et al., 1996a; Nieman et at., 1998). The capacity of neutrophils to generate 
H202 in response to PMA and opsonised zymosan (OZ) was significantly enhanced 
following Ih of exercise at 60% V02 max and at a heart rate of 140 b. min 1 (Smith 
et at., 1990; 1996). The authors reported that exercise `primes' neutrophils for 
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subsequent activation. Nieman et al. (1998) showed a slight increase of 7-18% in 
granulocyte and monocyte oxidative burst response to S. Aureus bacteria following 
running or cycling protocols for 2.5 h at 75% TOZ max. These findings supported the 
earlier research of Singh et al. (1994) and Suzuki et al. (1996a). Singh and colleagues 
(1994) reported a significantly increased production of 02-" in response to OZ 
stimulation following a run to exhaustion (approximately 2 h) at 70-75% VO2 max , 
that remained non-significantly elevated after a 24 h recovery period. Suzuki et at. 
(1996a) observed a 28% increased chemiluminescence (CL) response following a 90 
min cycle at 70% VO2 max in untrained participants. However, both of these studies 
used purified neutrophils, thereby removing other influencing mediators that may be 
present in whole blood, therefore these findings may not accurately reflect the in vivo 
situation. In contrast however, it is claimed that the problem with whole blood use is 
that radical scavengers within the plasma could impede ROS metabolism of 
neutrophils (Suzuki et al., 1996a). 
Following a marathon race, Hessel et al. (2000) noted a 1.5-fold increase in neutrophil 
luminol-dependent CL response to OZ stimulation. Using the same stimuli and 
exercise protocol, however, Suzuki et al. (2003) reported that luminol-dependent CL 
responses at post-race were reduced by 34% on a per-cell basis. In agreement with 
this, a number of studies have found that exercise decreases oxidative burst responses. 
For example, Davison and Gleeson (2005) reported that the PMA-stimulated 
neutrophil oxidative burst response was reduced by approximately 30% following 2.5 
h cycling at 60% "02 max. Stimulation with PMA also resulted in a 40% decreased 
H202 production following 1h cycling at 60% VO2 max (Macha et al., 1990) and 4h 
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cycling at 70% individual anaerobic threshold (IAT) reduced post-exercise f-MLP- 
stimulated neutrophil oxidative burst responses (Scharhag et al., 2002,2006). In line 
with the equivocal nature of research in this area, a number of studies have reported 
no change in neutrophil oxidative burst responses following prolonged duration 
exercise of submaximal-intensity. Both Suzuki et al. (1994) and Walsh et al. (2000) 
observed no change in the neutrophil oxidative burst response following exercise at 
60% V02 max for 1 and 2h respectively. 
It has been proposed that neutrophil oxidative burst responses are dependent upon 
exercise intensity (Smith et at., 1996; Quindry et al., 2003). Quindry and co-workers 
(2003) measured 02-" production before and after 4 exercise protocols: a 
VOZ max test, 10% above the lactate threshold (LT) for 45 min, 10% below LT for 45 
min and 10% below LT until calorific expenditure equalled that expended when 
exercising at 10% above LT. Elevations in 02-" were reported at 2h post-exercise 
following the V02 max test and the 10% above LT trial only, therefore it was 
concluded that exercise intensity is more important than total energy expenditure in 
the post-exercise neutrophil response. These findings are in contrast to those reported 
by Robson et al. (1999) who reported that approximately 3h cycling at 55% 
VO2 max tended to cause greater falls in PMA-stimulated neutrophil oxidative burst 
response at 0 h, 1h and 2.5 h post-exercise than cycling at 80% V02 Max to 
exhaustion. 
Along with endurance exercise of prolonged duration, research has also been 
conducted using brief, high-intensity and moderate-intensity exercise protocols. 
25 
Chapter 2 
Following high-intensity exercise to exhaustion, equivocal findings have been 
reported. Hack et al. (1994) reported that PMA-stimulated neutrophil 02-" production 
was reduced by 37% following a graded treadmill run to exhaustion. Using a similar 
exercise protocol, Morozov et al. (2003) showed no change in neutrophil CL 
response, whereas a 3-fold increase in OZ-stimulated neutrophil 02-" production was 
found following an incremental cycle ergometry test to exhaustion (Miyazaki et al., 
2001). In a study conducted by Pyne et al. (2000), neutrophil CL response was 
measured following 40 min of uphill interval treadmill running at 90% VO2 max , 
compared to downhill and near-level treadmill running at 52% V02 max. Neutrophil 
CL response was significantly lower than baseline response at immediately post and I 
h post-exercise after the intense running, but CL was significantly enhanced at 6h 
post-exercise following the 2 moderate-intensity exercise protocols. This evidence 
supports the notion that intense exercise may be immunosuppressive yet moderate 
exercise may have immunoenhancing effects. 
Pyne et al. (2000) reported a decline in the neutrophil oxidative burst response during 
40 min of moderate-intensity cycling that reached statistical significance after 30 min 
(53% reduction from pre-exercise values). This suggests that exercise impairs 
neutrophil oxidative burst activity on a per-cell basis for those cells in circulation. The 
authors subsequently termed this the `post-exercise refractory period' in which 
neutrophils are less able to respond to microbial challenge (Pyne et al., 2000), in 
agreement with the findings of Prasad et al. (1991). In support of this, both PMA and 
f-MLP-stimulated neutrophil oxidative burst responses were significantly reduced 
following treadmill running to exhaustion at 80% "02 max (Mooren et al., 2001). It 
would also appear that when ultra-long duration endurance exercise is performed, a 
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longer period is required for neutrophil function to recover (Gabriel et al., 1994). In 
this study, cyclists rode to exhaustion (approximately 20 min) prior to and 8 or 9 days 
after completing an ultra-endurance event (762 ± 74 min). PMA-induced neutrophil 
oxidative burst response was not affected prior to the endurance event, but a 34% 
decrease was found when the protocol was repeated following the ultra-endurance 
event. 
Many athletes train a number of times per day and as such, the effects of repeated 
bouts of exercise performed on the same day have been investigated. Boyum et al. 
(2002) compared the effects of I bout of 65 min exercise at 75% VOZ max with 2 
bouts performed on the same day, separated by a3 or 6h recovery. PMA-induced CL 
per 200,000 granulocytes increased in all exercise trials, yet the total oxidative 
potential of the blood was significantly higher when the exercise bouts were separated 
by a3h recovery. Two bouts of 90 min cycling at 60% V02 max separated by a3h 
recovery produced a larger total PMA-stimulated neutrophil oxidative burst response, 
but a greater decline when expressed on a per-cell basis than a single exercise bout (Li 
and Gleeson, 2005). In contrast, Pyne et at. (1996) reported that the magnitude of the 
initial decrease of the neutrophil oxidative burst response after I bout of treadmill 
running (40 min) was not exceeded by 2 bouts separated by aIh recovery period. 
The neutrophil oxidative burst response to exercise has been shown to differ between 
trained and untrained participants. Miyazaki et al. (2001) reported that OZ-stimulated 
neutrophil 02-" release was significantly lower after a cycle ergometry test to 
exhaustion following a 12-week training programme, than it was prior to the training 
period. Furthermore, the capacity of the PMA-stimulated oxidative burst response of 
elite swimmers at rest was approximately half that of age and sex-matched untrained 
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control subjects (Pyne et al., 1995). The neutrophil oxidative burst response of elite 
swimmers significantly decreased during a monitored 12-week training period, 
reaching a nadir at a time corresponding to the peak endurance and quality training 
phases, but this was not associated with an increased incidence of infection. 
2.8. Mechanisms of exercise-induced alterations in neutrophil response 
2.8.1. Adrenaline 
Neutrophils express adrenoreceptors of al, a2, ßl and 02 class. Ignarro and co-workers 
(1974) demonstrated that cAMP is increased within the neutrophil cell following 
incubation with the ß-agonist adrenaline. Stimulation by adrenergic agonists is 
reported to activate adenyl cyclase, inducing the synthesis of cAMP and this has been 
reported to decrease phagocytosis, chemotaxis, enzyme release and cellular adehesion 
of neutrophils (Ignarro et at., 1974; Dulis and Wilson, 1980; Chilcoat et al., 2002). An 
increase in cAMP concentration has specifically been shown to inhibit f-MLP- 
stimulated neutrophil oxidative burst responses but no effect was found when 
neutrophils were stimulated with PMA (Yu et al., 1995; Chilcoat et at., 2002; 
O'Dowd et al., 2004). Moreover, adrenaline decreased f-MLP-stimulated neutrophil 
CL measurements (Weiss et at., 1996) and 02-" generation (Wenisch et al., 1996; 
Tintinger et al., 2001) in a dose-dependent manner. The magnitude of the inhibitory 
effect was most pronounced at clinically high-doses; however, in the presence of low 
concentrations of adenosine, physiological concentrations of adrenaline have been 
shown to strongly inhibit f-MLP-stimulated neutrophil oxidative burst responses 
(Bazzoni et al., 1991). In a more recent study, 0' Dowd et al. (2004) reported that 
adrenaline can inhibit f-MLP-stimulated neutrophil OZ-" release at physiological 
concentrations starting as low as 1 nmol. L't, with a significant decrease from control 
28 
Chapter 2 
at 5 nmo1. L"1 adrenaline. Furthermore, a strong negative correlation (r = -0.75, 
P<0.01) between plasma adrenaline and PMA-stimulated neutrophil 02-" release has 
been reported following graded exercise to exhaustion (Hack et at., 1994). 
The inhibition of f-MLP-stimulated neutrophil oxidative burst responses by 
adrenaline has been specifically attributed to the 0-2 adrenoreceptor subtype (Weiss et 
at., 1996). The recorded increase in cAMP following ß-2 adrenoreceptor stimulation 
may inhibit the f-MLP-stimulated neutrophil oxidative burst response through 
activation of Protein Kinase A (PKA), which subsequently suppresses cPLA2- 
dependent arachidonic acid production. Arachidonic acid is a further pathway by 
which NADPH oxidase may be activated; however an adrenaline concentration of 5 
nmol. L"t was required for this effect to be observed (O'Dowd et al., 2004). It has also 
been speculated that adrenaline may deviate glucose from the NADPH producing 
pentose phosphate pathway, reducing substrate availability for 02-" generation by the 
NADPH oxidase (Garcia et al., 1999). 
2.8.2. Adenosine 
Adenosine is known as a potent anti-inflammatory agent (Cronstein, 1994). Since 
neutrophils are the first cells to respond to bacterial invasion or injury and play a 
major part in acute inflammation, adenosine is an important regulator of neutrophil 
function (Gessi et al., 2000). Adenosine mediates its effects via activation of at least 4 
cell surface receptors; Al, A2A, A2B and A3 (Fredholm et al., 2000) and human 
neutrophils are known to express all 4 adenosine receptor subtypes, that are coupled 
to G proteins (Gessi et al., 2002). 
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Early in vitro work conducted by Cronstein and colleagues (1983) reported that 
adenosine inhibited f-MLP-stimulated neutrophil 02-" generation but had minimal 
effect following PMA-stimulation. Maximal inhibition occurred with an adenosine 
concentration of 100 µmo1. L4 and the removal of adenosine by adenosine deaminase 
(ADA) led to a marked enhancement of neutrophil 02-0 generation in response to f- 
MLP. At physiological concentrations, adenosine has also been shown to specifically 
inhibit 02-" generation by f-MLP-stimulated neutrophils (Cronstein et al., 1985; 
Swain et at., 2003). f-MLP-stimulated neutrophil 02-" generation was reduced to 60% 
of control following incubation with 0.1 µmol. 1"1 of adenosine with a further 
reduction to 39% following incubation with 1 µmol. L"1 adenosine (Cronstein et al., 
1985). Furthermore, a significant inverse relationship between the individual in vivo 
plasma adenosine concentration and ex vivo f-MLP-stimulated neutrophil 02-" 
generation has been reported (Chouker et al., 2005). Inhibition of neutrophil OZ-" 
generation by adenosine is predominantly mediated via the A2A receptor subtype 
(Gessi et al., 2000). In contrast to this, acting via the Al receptor, adenosine is 
reported to promote positive neutrophil functions; chemotaxis (Cronstein et al., 1990), 
phagocytosis (Salmon and Cronstein, 1992) and endothelial adherence (Cronstein et 
at., 1992), however, the effects of adenosine acting at A2A receptors dominate the 
effects of Al receptors (Hasko and Cronstein, 2004). 
A number of intracellular mechanisms have been proposed to account for the 
inhibitory effect of adenosine on f-MLP-stimulated neutrophil oxidative burst 
responses. A2A receptors are coupled to activation of adenyl cyclase through Gs 
binding proteins, and their occupancy by adenosine causes an increased intracellular 
cAMP concentration in neutrophils, which acts as a second messenger to alter cellular 
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function (lannone et al., 1989; Thibault et at., 2002). Furthermore, Gessi et al. (2000) 
reported a significant correlation between cAMP accumulation and inhibition of 02-" 
generation by adenosine receptor agonists (Spearman rank correlation coefficient = 
1.00). However, a number of studies have not found evidence to support cAMP as the 
second messenger for adenosine inhibition of neutrophil oxidative burst responses 
(Cronstein et at., 1988; Cronstein, 1994). The same authors also reported that A2A 
receptor occupancy does not affect calcium (Ca2) mobilisation from intracellular 
stores (Cronstein et al., 1988). A2A receptor occupancy has also been reported to 
inhibit the neutrophil oxidative burst response by suppressing phospholipase-D (PL- 
D) activity (Thibault et al., 2000). Adenosine suppresses the signalling cascade in f- 
MLP-stimulated neutrophils since PL-D catalyzes the hydrolysis of 
phophatidylcholine to yield phosphatic acid, which is further metabolised. These PL- 
D second messengers regulate the oxidative burst and other neutrophil functions. 
Suppression of f-MLP-induced PL-D activity has been correlated with an increased 
cAMP concentration, that may activate PKA to mediate this suppression (Thibault et 
at., 2000; Thibault et al., 2002). A final mechanism by which adenosine can inhibit 
neutrophil oxidative burst responses is via an increased trafficking of 
Flavocytochrome b, a key component of the NADPH oxidase (Swain et al., 2003). 
The treatment of neutrophils with adenosine increased the trafficking of 
Flavocytochrome b between cellular compartments within the neutrophil cell and 
resulted in an increased movement from the plasma membrane to a higher density 
membrane, coinciding with an accelerated shut-down of ROS production by f-MLP- 
stimulated neutrophils. 
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While there is clear evidence for an inhibitory effect of adenosine on f-MLP- 
stimulated neutrophil oxidative burst responses, equivocal evidence has been 
presented with regards to the effect of adenosine on neutrophil degranulation 
responses. Adenosine has been reported to inhibit f-MLP-stimulated neutrophil 
lactoferrin release (Richter, 1992) and to dose-dependently inhibit neutrophil elastase 
release from neutrophils stimulated using LPS or TNF-a (Bouma et al., 1997). This 
was attributed to A2 and A3 receptor-mediated mechanisms, yet the concentrations of 
adenosine required to inhibit neutrophil degranulation were considerably higher than 
those required to inhibit neutrophil oxidative burst responses. At lower micromolar 
concentrations however, adenosine inhibited f-MLP-stimulated neutrophil lysozome 
release (Schmeichel and Thomas, 1987). In contrast however, a number of studies 
have reported no significant effects of adenosine on neutrophil degranulation 
responses (Marone et al., 1980; Cronstein et al., 1983; McGarrity et al., 1989; Swain 
et al., 2003). Reasons for the difference between studies may be related to the 
concentrations of adenosine used, incubation time prior to measurement, stimulation 
methods employed and the use of whole blood or isolated neutrophils. 
2.8.3. Neutrophil responsiveness 
As detailed in Section 2.4, endurance exercise increases the circulating number of 
leukocytes, of which neutrophils exhibit the greatest change in cell count. Suzuki et 
al. (1996b) characterised individual cell maturity and activation state using a 
histochemical nitro blue tetrazolium test. They reported that a neutrophil 
subpopulation with a less responsive Or" production to in vitro stimulation was 
mobilised following exercise. They concluded that the reported decrease in neutrophil 
oxidative burst response on a per-cell basis is due to the increase of less responsive 
32 
Chapter 2 
neutrophils into circulation. Following a marathon race, a 10-fold increase in the 
mobilisation of neutrophils from the bone marrow has been reported (Suzuki et al., 
2003). Immature neutrophils or those released from the bone marrow prematurely 
have a lower capacity to produce ROS following stimulation (Berkow and Dodson, 
1986), therefore the post-exercise neutrophilia may contribute to reduced neutrophil 
functional capacity. A further speculated mechanism for a reduced neutrophil 
functional response following exercise is provided by Prasad et al. (1991). In dogs, 
pre-stimulated neutrophils had a reduced capacity to release ROS after subsequent 
stimulation. Therefore exercise-induced activation of ROS release may reduce the 
capability of neutrophils to respond to a subsequent bacterial challenge. 
2.8.4. Other factors 
A number of other potential factors have been proposed to mediate the exercise- 
induced neutrophil oxidative burst response. The cytokines IL-6, IL-8, IL-10, 
granulocyte-colony stimulating factor (G-CSF) and stress hormones, such as cortisol 
and growth hormone that increase following prolonged and intensive exercise have 
also been implicated as modulators of neutrophil function (Suzuki et al., 2003). Both 
IL-6 and growth hormone are immunopotentiating (Smith, 1997) and IL-6 has been 
positively correlated with neutrophil CL responses at post and 1h post-exercise 
(Suzuki et al., 1999). IL-6 may enhance G protein activity, contributing to the 
assembly of NADPH oxidase formation (Peake, 2002). Furthermore, the activity of 
several components of the signal transduction pathway are enhanced by IL-8 and G- 
CSF, but IL-10 may attenuate neutrophil oxidative burst responses (Peake, 2002). The 
effects of cortisol on neutrophil oxidative burst responses are equivocal. Robson et al. 
(1999) attributed the lower tendency for PMA-stimulated oxidative burst response 
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following prolonged duration cycling to the effects of cortisol but Nieman et al. 
(1997) showed no relationship after prolonged and intensive running. Mooren and co- 
workers (2001) determined the alterations in intracellular Ca2+ signalling following 
exercise to exhaustion. Intracellular Ca2+ concentration increased following f-MLP- 
stimulation, reflecting an activated or primed neutrophil state, but oxidative burst 
responses were attenuated at post-exercise. This suggests an uncoupling of 
intracellular Ca2+ signals from other aspects of the neutrophil oxidative burst pathway 
following exhaustive exercise. 
2.9. Caffeine 
Athletes commonly consume caffeine as an ergogenic aid (Tarnopolsky, 1994). The 
effect of caffeine ingestion on the neutrophil oxidative burst response in humans, and 
in particular following exercise, has not been extensively researched (Section 2.10). 
Caffeine ingestion, however, is consistently associated with an increased secretion of 
adrenaline (Graham and Spriet, 1991,1995) and is also reported to increase plasma 
cortisol concentration (Laurent et al., 2000). Furthermore, the main action of caffeine 
at physiological concentrations is that of adenosine-receptor antagonism (Ongini & 
Fredholm, 1996). Adenosine receptors are found in most tissues, including immune 
cells, therefore there are a number of potential mechanisms by which caffeine may 
affect neutrophil functional responses to exercise. Caffeine is a chemical substance 
that has been identified in about sixty plants and is obtained as a white, odourless, 
crystalline, bitter-tasting powder (Debry, 1994). It is a trimethyl purine base, 
trimethylxanthine (1,3,7-trimethylxanthine) with a molecular weight of 194.2. The 
chemical structure of caffeine is shown in Figure 2.2. 
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Figure 2.2. Chemical structure of caffeine (from Debry, 1994). 
Caffeine is a legal and socially acceptable drug (Graham, 2001 a). It is the most widely 
consumed behaviourally active substance in the world (Fredholm et al., 1999), yet it is 
not a typical nutrient nor is it essential for health (Graham, 2001a). Caffeine is 
contained in various foods, beverages and medications. Coffee undoubtedly serves as 
the primary source of caffeine in the adult, but caffeine is also contained in tea and 
cocoa, many soft drinks, chocolate and several drug preparations, including many 
over-the-counter products (Mandel, 2002). Energy drinks represent a relatively new 
category of beverages that contain caffeine in amounts that exceed those found in soft 
drinks, approaching the low end of the concentration range found in coffee (Magkos 
and Kavouras, 2005). Table 2.1 shows the content of common caffeine-containing 
products. Caffeine consumption from all sources is reported to be 70-76 mg. day"1 
worldwide; however, this is much higher in the Western and developed world 
(Fredholm et al, 1999). It is estimated that caffeine consumption in the UK and US is 
approximately 200 mg. day' (3 mg. kg' body mass), whereas in parts of Scandinavia it 
may be as high as 400 mg. day' (6 mg. kg'1 body mass). There is considerable 
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variation in habitual caffeine intake, since half of the population do not consume 
coffee and some individuals consume substantial amounts (Mandel, 2002). 
The liver demethylates this trimethylxanthine to three dimethylxanthines: 
paraxanthine, theophylline and theobromine, which are then further catabolised 
(Graham, 2001 a). Caffeine absorption from the gastrointestinal tract is rapid and 
reaches 99% in humans approximately 45 to 60 min following ingestion, with a half- 
life in humans of between 2.5 and 4.5 h (Debry, 1994). It has been reported that 
gender, exercise and thermal stress have no effect on caffeine pharmacokinetics in 
men and women (Mclean and Graham, 2002). 
Table 2.1. Caffeine content of common foods and beverages (from Maughan, 2002 
and Mag_kos and Kavouras, 2005). 
Source (serving size) Caffeine content (mg) 
Coffee (150 ml) 40 - 180* 
Tea (150 ml) 25 - 50* 
Cola (330 ml) 50 
Energy drinks (250 ml) 30 - 85 
Chocolate bars (50 g) 40 
Over the counter medication (1 tablet) 30 - 200 
* Large variation in caffeine content due to source and preparation of product. 
Anecdotal evidence has shown that caffeine occupies a prominent position in the 
athletic world. A 1993 survey of Canadian teenagers showed that 27% of athletes had 
used caffeine in the previous year (Graham, 200Ia), and approximately 70% of US 
young athletes claimed to have used caffeine for social reasons (Wagner, 1991), yet it 
appears to be more prevalent in the sport of amateur and professional cycling 
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(Delbeke and Debackere, 1984). A 1997 survey conducted during the US Professional 
Championship road race found that roughly 90% of the teams consumed caffeine, 
usually in the form of Coca-Cola at some point during the race (Martin, 1997). 
Cyclists that completed the survey were largely from North America, Europe and 
Australia. 
Prior to 2004, the International Olympic Committee's acceptable maximum level of 
caffeine was 12 µg. m1l of urine, however this was identified as a poor reflection of 
either dose or plasma caffeine concentration due to large individual variability 
(Graham, 2001a). With effect from January 2004, the WADA removed caffeine from 
its list of prohibited substances and caffeine is currently placed on a monitoring 
programme for 2006. The removal of caffeine from the WADA prohibited list may 
lead to an increased use by athletes during training and competition. 
2.9.1. Caffeine consumption and exercise performance 
Self-reported anecdotal evidence has shown that caffeine is consumed, particularly by 
endurance athletes as it has been demonstrated to provide an ergogenic benefit 
(Tarnopolsky, 1994). Initial research was conducted by Costill and colleagues (1978) 
who examined the effects of adding 330 mg of caffeine to decaffeinated coffee, that 
was given to trained cyclists 60 min prior to completing an exhaustion ride at 80% 
VO2 max. Time to exhaustion was increased from 76 f5 min to 90 f7 min 
following the ingestion of caffeine. Subsequent work was conducted by Ivy et al. 
(1979) who reported an increased work output (7.4%) with caffeine ingestion (250 
mg) before and during 2h of isokinetic cycling exercise, than when an equivalent 
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dose of a glucose polymer drink or placebo was administered. Following on from this 
early research, many studies have also reported an ergogenic benefit of caffeine 
ingestion, which due to its rapid absorption from the gastrointestinal tract, is generally 
given 60 min prior to the start of exercise (Graham and Spriet., 1991; Spriet et at., 
1992; Pasman et at., 1995; Cohen et al., 1996; Jackman et at., 1996; Van Soeren and 
Graham, 1998; Bruce et al., 2000 amongst many others). A caffeine dose of 6 mg. kg" 
body mass increased cycling endurance capacity at 80% VO2 max by 22% (Greer et 
at., 2000) and doses of 9 mg. kg'1 body mass increased running and cycling time to 
exhaustion at 85% 
V02 max by 21 and 20 min respectively (Graham and Spriet, 
1991). The mode of caffeine intake is important as it appears that coffee alone does 
not produce the ergogenic benefits of pure caffeine (Graham et al., 1998). The authors 
concluded that other compounds present in the coffee act to antagonise the responses 
occurring when caffeine is consumed alone, even in the presence of elevated plasma 
caffeine concentrations. A summary of studies investigating the effects of caffeine 
ingestion on endurance capacity at >_ 80% V02 max is provided in Table 2.2. 
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The dose of caffeine administered has also been extensively studied. Graham and 
Spriet (1995) gave a 3,6 or 9 mg. kg' body mass dose of caffeine 60 min before a run 
to exhaustion at 85% VO2 max . 
The low and moderate doses increased time to 
exhaustion by approximately 22%, yet there was no significant increase with the high 
caffeine dose. Similarly, caffeine ingestion significantly increased cycling time to 
exhaustion at 80% VOZ max but there were no differences between 5,9 and 13 
mg. kg 1 body mass doses of caffeine (Pasman et al., 1995). Collectively, these studies 
demonstrate that there is not a linear relationship between intake and ergogenic 
benefit. A study by Conway et al. (2003) compared the effect of a single caffeine dose 
(6 mg. kg"i body mass) versus a divided caffeine dose containing the same amount of 
caffeine (3 mg. kg 
1 body mass given at 60 min prior to exercise and again at the mid- 
point of a 90 min cycle at 68% 
VO2 max). Following the fixed duration ride, a time- 
trial showed that performance did not significantly differ between doses, yet there was 
a clear trend of an ergogenic benefit of caffeine versus a placebo condition. A similar 
study reported that when a large bolus of caffeine (5 mg. kg"1 body mass) is given, the 
need to consume additional smaller doses of caffeine in order to maintain blood 
caffeine concentration is not required (Bell and McLellan, 2003). The effect of adding 
caffeine to a carbohydrate (CHO) electrolyte solution has also been shown to provide 
ergogenic benefit. Participants completed a cycling time-trial (TT) faster when 225 
and 320 mg. L'1 caffeine were added to a 7% CHO-electrolyte solution than when 
CHO alone was consumed (Kovacs et at., 1998). An 11% CHO solution containing 
1.5 mg. kg"1 body mass of caffeine (Coca-Cola) was also associated with a 
performance enhancement (3.3%) in a cycling TT following 2h of submaximal 
intensity cycling. The improved performance was similar to that associated with 
larger caffeine doses (Cox et al., 2002). 
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Although it is clear that caffeine improves exercise time to exhaustion, there is 
equivocal evidence for the effect of caffeine on performance outcomes when there is a 
fixed end-point. Cohen et at. (1996) reported no significant differences between 0,5 
and 9 mg. kg'' body mass of caffeine on 21 km race time performed in a hot 
environment (25°C-28°C), yet a 4% body mass loss may have confounded the 
ergogenic benefits of caffeine. In the laboratory setting, no effect of caffeine was 
found on 10 km treadmill time when participants could control their treadmill running 
velocity (Bell et al, 2002). Similarly, caffeine did not affect the time to completion or 
average power output throughout a 100 km cycling TT (Hunter et al., 2002). The 
authors argued that when a trial is close-ended with a fixed end-point, caffeine does 
not affect an athlete's pacing strategy. However, this is in contrast to a number of TT 
and work output studies (Kovacs et al., 1998; Cox et al., 2002; Conway et al., 2003). 
Recently, a field-based study reported that a single dose of caffeine (3 mg. kg'l body 
mass) ingested 1h before exercise significantly reduced 8 km race time by 23.8 s, 
resulting in a 1.2% improvement in running performance (Bridge and Jones, 2006). A 
summary of studies investigating the effects of caffeine ingestion on performance 
outcomes in laboratory and field-based settings is shown in Table 2.3. 
The effect of caffeine on brief and intense exercise has also produced equivocal 
findings. A6 mg. kg4 body mass dose of caffeine provided a significant increase in 
cycling time to exhaustion at 100%1702 max (Jackman et al., 1996), yet in a mock 
TT following a 10 min cycle at 90% VOZ max, an absolute caffeine dosage of 250 
mg did not affect mean power output. The participants used in the study however, 
were normally active and were non-cyclists, thus they may have been unaccustomed 
to cycling at heavy workloads (Collomp et al., 2002). In highly trained athletes, 2000 
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m row time was significantly improved by 1.3% with a 3% increased power output 
following the ingestion of 6 or 9 mg. kg" body mass of caffeine. The lower dose 
resulted in a slightly faster rowing performance time (Bruce et al., 2000). 
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2.9.2. Potential mechanisms for ergogenic benefit 
It is well understood that caffeine provides ergogenic benefit in the majority of 
exercise protocols investigated. However, the precise mechanism by which this occurs 
remains less clear and a number of potential mechanisms have been proposed to 
explain the ergogenic benefit of caffeine ingestion. In the late 1970's and early 
1980's, a number of researchers (Costill et al., 1978; Ivy et al., 1979; Essig et al., 
1980) proposed a theory that caffeine ingestion resulted in an increased mobilisation 
of free fatty acids (FFA), leading to a sparing of muscle glycogen stores. These 
studies reported an increased rate of FFA oxidation and a decreased respiratory 
exchange ratio (RER) during exercise performed following caffeine ingestion. Spriet 
et al. (1992) reported that muscle glycogenolysis was reduced by 55% following 
caffeine ingestion but only during the first 15 min of exercise. It was hypothesised 
that the spared glycogen was available late in exercise, coinciding with an increased 
endurance capacity. More recent studies have reported no glycogen sparing during 
exercise following caffeine ingestion (Jackman et al., 1996; Greer et al., 2000; 
Laurent et at., 2000). It is difficult to explain why early studies consistently reported a 
glycogen sparing effect whereas latter studies have consistently not found such an 
effect, given that the exercise protocols employed were similar. Furthermore, caffeine 
has been shown to provide ergogenic benefit in activities lasting only a few minutes in 
which glycogen depletion could not be a limiting factor (Jackman et at., 1996; Bruce 
et at., 2000). 
Caffeine ingestion has consistently been reported to increase plasma adrenaline 
concentration but not plasma noradrenaline concentration (Graham and Spriet, 1991; 
Graham et al., 1991; Spriet et at., 1992; Graham and Spriet, 1995; Jackman et at., 
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1996; Graham et al., 2000 amongst numerous others). Collectively this would suggest 
that caffeine acts on the sympathetic nervous control of the adrenal medulla rather 
than increasing the activity of the sympathetic nervous system in general (Graham and 
Spriet, 1991). It was initially thought that an increased plasma adrenaline 
concentration, occurring with caffeine ingestion would stimulate FFA mobilisation; 
however, a number of studies have found an increased adrenaline response without a 
similar increase in FFA (Tamopolsky et al., 1989; Graham and Spriet, 1991; Graham 
et at., 2000; Laurent et al., 2000). Alternatively, in spinal cord injury patients, in 
which the entire sympathetic and motor outflow is separated from the brain, the 
ingestion of 6 mg. kg'1 body mass of caffeine did not increase plasma adrenaline 
concentration, yet plasma FFA and glycerol concentration increased rapidly and 
remained elevated throughout the experimental protocol (Van Soeren et at., 1996). 
Following on from these findings, Mohr et al. (1998) administered the same caffeine 
dose to tetraplegic patients 1h prior to the electrical stimulation of their paralysed 
limbs to exhaustion. Caffeine ingestion significantly increased time to exhaustion 
(6%) and was associated with a significant increase of serum FFA concentration 
without a significant increase in adrenaline concentration. Furthermore, Graham and 
Spriet (1995) reported a 22% increase in endurance capacity following the ingestion 
of 3 mg. kg'1 body mass of caffeine without a significant increase in adrenaline 
concentration, leading to the conclusion that a rise in adrenaline is not essential for the 
ergogenic benefit of caffeine. 
Numerous other studies have failed to support the classical metabolite theory 
proposed in the 1970's. A lowering of the RER with caffeine ingestion has frequently 
been opposed (Graham and Spriet, 1991,1995; Graham et a)., 2000). Furthermore, in 
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a well controlled study using techniques of direct Fick measures and muscle biopsies 
during a J-h cycle at 70% V02 max , 
Graham et at. (2000) reported an increased 
arterial FFA concentration following the ingestion of 6 mg. kg'1 body mass of caffeine, 
yet the net uptake by the exercising leg was not enhanced. Net leg uptake of FFA was 
calculated by multiplying the blood flow by the arterial-venous difference in 
concentration. 
Greer et al. (2000) speculated that there are three possible mechanisms through which 
caffeine and other methylxanthines produce their effects at the cellular metabolic level 
including an increased Ca2+ release, inhibition of cAMP phosphodiesterase and 
antagonism of adenosine receptors. Caffeine induces the mobilisation of intracellular 
Ca2+ from the sarcoplasmic reticulum and may improve neuromuscular function 
(Debry, 1994). A concentration of 100 µmol. L"1 caffeine is reported to increase the 
sensitivity of Ca 
2+ release channels to endogenous activators, however 
pharmacological caffeine concentrations (mmol. L"1) are required to directly activate 
Ca2+ release channels (Magkos and Kavouras, 2005). At concentrations that have 
provided ergogenic benefit, however, caffeine (9 mg. kg'I body mass) is reported to 
attenuate the exercise-induced increase in plasma K+ by stimulating Na+/+ pump 
activity in contracting and inactive skeletal muscles (Lindinger et al., 1993). These 
changes may help maintain the membrane potential in contracting muscle and produce 
increases in skeletal muscle force production that may contribute to the ergogenic 
effect of caffeine during exercise (Spriet and Howlett, 2000). Caffeine can also inhibit 
phosphodiesterase activity leading to an accumulation of intracellular cAMP, yet 
pharmacological doses of methylxanthines are required to elicit these effects that are 
not achievable in vivo (Fredholm et al., 1999). It is now agreed that the most relevant 
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mechanism of action of caffeine at physiological doses (µmo1. L"1) is that of adenosine 
receptor antagonism. Methylxanthines are non-selective adenosine receptor 
antagonists at Al and A2 receptors (Biaggioni et at., 1991). Adenosine receptors are 
found in most tissues of the body, including the brain, heart, adipocytes, skeletal 
muscle, smooth muscle and immune cells (Gessi et al., 2000; Graham et at., 2001 a). 
The effects of caffeine on immune responses and potential mechanisms for action are 
described in Section 2.10. The increases in FFA concentration that occur with caffeine 
ingestion have been attributed to a stimulation of lipolysis as caffeine directly 
antagonises the Ai receptors on adipocytes. Strong correlations between caffeine and 
FFA (r=0.93) and caffeine and glycerol (r=0.94) have been reported (Van Soeren et 
al., 1996). A strong correlation between paraxanthine (major metabolite of caffeine) 
and the appearance of FFA (r = 0.93) has also been observed (Hetzler et al., 1990). 
Paraxanthine is a more potent adenosine receptor antagonist than caffeine, hence may 
increase lipolysis further. These reports are in support of the spinal cord injury studies 
previously discussed (Van Soeren et al.,. _j996; Mohr et al., 1998) supporting the 
theory that methylxanthines act directly on the tissues, independent of the central 
nervous system. 
Anecdotal evidence has suggested that caffeine can `stimulate the mind' (Graham, 
2001b) and is reported to improve alertness during prolonged wakefulness (Kamimori 
et al., 2000). In scientific terms, it is known that caffeine can cross the blood/brain 
barrier due to its lipophilic properties (Oldendorf, 1971). The CNS contains areas of 
adenosine-receptor populations and adenosine is known to inhibit the release of a 
number of brain excitatory transmitters, particularly dopamine (Okada et al., 1997). 
Decreases in dopamine and an increase in serotonin haven linked to the 
r 
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development of central fatigue during exercise (Davis and Bailey, 1997). In support of 
this, the intracerebroventricular administration of a small dose of caffeine (200 µg) 
significantly increased run time to exhaustion by 60% compared to a placebo 
condition in rats. Following the administration of an A! /A2 adenosine receptor 
agonist, run time compared to placebo was reduced by 68%. When caffeine was 
administered 5 min prior to the Al/A2 agonist drug, it blocked the reduction in time to 
fatigue and was comparable with placebo (Davis et al., 2003). The same dose of 
caffeine (-'0.6 mg. kg"1 body mass) given peripherally was ineffective. The authors 
suggested that the blockade of adenosine receptors by caffeine within the CNS may 
explain the fatigue-delaying effects observed. As caffeine is likely to alter the release, 
binding or activity of neurotransmitters in the brain, it may alter the perception of 
work intensity. It has been reported that work output is increased at a given RPE 
following caffeine ingestion (Ivy et al., 1979; Cole et al., 1996) or more typically, a 
reduced RPE is reported for a given work intensity (Costill et al., 1978; Doherty et al., 
2002,2004). Caffeine ingestion may also provide ergogenic benefit by lowering the 
threshold for exercise-induced ß-endorphin release (Laurent et al., 2000). An increase 
in ß-endorphin is reported to promote euphoria and decrease pain perception and 
hypoalgesia has been reported during exercise following caffeine ingestion (O'Connor 
et al., 2004). Caffeine also affects changes in cognitive function after exercise. This 
may be important in many sports where reaction time, thought processes and tactical 
decisions are vital to success. Furthermore caffeine ingestion is also associated with 
increased feelings of happiness and pleasure during exercise (Backhouse et al., 2004). 
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2.9.3. Habitual caffeine consumption 
There are surprisingly few studies that have determined the effect of caffeine 
ingestion on physiological and performance responses in habituated and naive users. 
Equivocal findings have been reported. In animal models, habitual caffeine 
consumption is associated with an upregulation of adenosine receptors in the vascular 
and neural tissue of the brain (Fredholm et al., 1999). In habitual caffeine users (200 
mg. day-1), Tarnopolsky et at. (1989) reported no neuromuscular or metabolic effects 
(with the exception of increased FFA concentration) that would be beneficial for 
endurance exercise following the ingestion of 6 mg. kg" body mass caffeine. This was 
attributed to caffeine tolerance. Similarly, the ingestion of a high caffeine dose (500 
mg. day') for a 6-week habituation period, significantly reduced the adrenaline 
concentration in response to an acute caffeine dose compared to that of naive users 
(Bangsbo et at., 1992). Given the lack of a clear relationship between adrenaline 
concentration and endurance capacity (Graham and Spriet, 1995), the significance of 
this finding is unknown. Bell and McLellan (2002) determined the effects of 5 mg. kg" 
1 body mass of caffeine on cycling time to exhaustion at 80% VO2 max in caffeine 
users versus non-users. The magnitude of the effect differed between users and non- 
users, with a 19% improved performance for users but a 28% increase for non-users. 
The majority of studies that have determined the influence of caffeine on 
physiological and performance parameters have employed a 48 - 72 h caffeine 
abstention, prior to dose administration. Following a 48 h withdrawal, caffeine 
ingestion did not effect substrate utilization during 60 min running (Hetzler et al., 
1994). Caffeine ingestion also increased endurance capacity in both users and non- 
users following a similar abstention period (Graham and Spriet, 1991; Spriet et al., 
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1992). Furthermore, adrenaline responses were similar at exhaustion with caffeine 
ingestion regardless of 0,2 or 4 days withdrawal in users with a high caffeine intake 
(760 mg. day4). Caffeine provided a clear ergogenic benefit on time to exhaustion at 
80 - 85% 
t102 max but there was no effect of the number of days of withdrawal on 
the magnitude of the ergogenic impact (Van Soeren and Graham, 1998). Similarly, 
Tarnopolsky and Cupido (2000) showed that 6 mg. kg4 body mass caffeine 
potentiated dorsiflexor muscle force development during electrical stimulation with 
no difference between habituated and naive users. 
2.9.4. Negative effects of caffeine 
Caffeine has a number of unwanted side effects that may limit its use in high doses by 
sensitive individuals: these effects include insomnia, headache and gastrointestinal 
distress (Maughan, 2002). The most widely held notion is that as caffeine is a mild 
diuretic it should not be consumed by athletes, since exercise stimulates sweating that 
may lead to dehydration. The belief is that caffeine exaggerates dehydration and 
impairs exercise performance. This viewpoint, however, is formed in the absence of 
any real supporting scientific evidence (Grandjean et al., 2000). Following a6 day 
period of caffeine ingestion (3 mg. kg"1 body mass), the ingestion of 0,3 or 6 mg. kg"r 
body mass caffeine for an additional 5 days did not affect any indices of hydration 
(Armstrong et al., 2005). Furthermore, during an exercise heat tolerance test, acute 
caffeine ingestion did not alter fluid-electrolyte or thermoregulatory responses in 
habituated caffeine consuming subjects (Roti et al., 2006). There is therefore no 
evidence to suggest that moderate caffeine ingestion results in a fluid imbalance that 
is detrimental to health or performance (Armstrong, 2002). 
50 
Chapter 2 
2.10. Caffeine and immune function 
A number of studies have demonstrated that caffeine can modulate various aspects of 
both innate and adaptive immune function (Horrigan et al., 2004,2005,2006). Very 
few studies, however, have been conducted using human subjects and fewer still using 
physiological caffeine concentrations that are relevant to normal consumption. 
2.10.1. Innate Immunity 
In vivo administration of 6 mg. kg. day"' dose of caffeine significantly inhibited NK 
cell cytotoxicity to pokeweed mitogen (PWM) in rats but there was no effect of either 
2 or 18 mg. kg. day4 caffeine doses. In vitro, caffeine had no effect on NK activity 
(Kantamala et al., 1990). Also in rats, caffeine ingestion has been shown to increase 
02-'* production of macrophages lavaged from the lung; however, this response was 
only seen with pharmological caffeine doses in the mmol. L'1 range (Jafari and Rabani, 
2000). Ramanaviciene et al. (2004) reported that serum lysozyme activity was 1.4,1.6 
and 1.8 times higher than control when caffeine doses of 2 mg. kg", 20 mg. kg"1, and 
40 mg. kg't were administered to mice. Circulating neutrophil counts were also 
significantly elevated by approximately 2.5-fold following the ingestion of 20-40 
mg. kg-1 caffeine. 
In blood obtained from healthy humans, 100 µmol. L'1 caffeine enhanced the CL 
response of mixed leukocytes (neutrophils and PBMC) primed by LPS but the same 
caffeine dose had no effect on neutrophil 02-" production (Sullivan et al., 1995). 
Caffeine also enhanced MPO release from neutrophils and as the luminol-enhanced 
CL response is dependent upon both 02-" production and MPO release, this 
accounted for the increased CL response following caffeine incubation. This response 
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only occurred in the presence of adenosine (30 nmol. L't), yet there was no effect at 
higher adenosine concentrations (µmol. L'1 range). The authors concluded that 
adenosine is necessary for the actions of caffeine to occur. The potential mechanisms 
by which caffeine may affect neutrophil function following exercise are detailed in 
Section 2.10.3. A further in vitro study reported that caffeine suppressed TNF-a 
production in LPS-stimulated whole-blood cultures (Horrigan et al., 2004). The 
response was reduced in each and every human subject to 47-69% of control but 
caffeine had no effect on IL-lß, IL-12 or IL-10 responses. The authors reported that 
as TNF-a production is an essential part of a healthy immune response, the 
impairment of TNF-a production by caffeine may have implications for the immune 
response to an infectious challenge. In contrast to these potentially negative effects of 
caffeine ingestion, Bishop et al. (2006) reported that caffeine ingestion (6 mg-kg") 1h 
prior to prolonged and intensive submaximal exercise is associated with elevations in 
salivary-IgA concentration, salivary-IgA secretion rate and a-amylase during exercise. 
These findings tentatively suggest that caffeine can enhance measures of mucosal 
immune function, since negative associations between resting salivary-IgA 
concentration and risk for URTI have been reported in elite swimmers during a 
training season (Gleeson et al., 1999a). 
2.10.2. Adaptive Immunity 
Kantamala et al. (1990) reported differential effects of caffeine on lymphocyte 
proliferation in rats. In vivo 6 mg. kg" caffeine significantly reduced B lymphocyte 
responses following PWM stimulation, yet 18 mg. kg" caffeine significantly increased 
T lymphocyte proliferative response to PHA-P. Caffeine dose-dependently inhibited 
both T and B lymphocyte responses in vitro. Caffeine also significantly inhibited 
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human T lymphocyte proliferative responses to tetanus toxoid, staphylococcal 
endotoxin B and PHA in a dose-dependent manner (Rosenthal et al., 1992). The 
authors argued that T lymphocyte function is inhibited via a cAMP dependent 
pathway as caffeine can inhibit specific cAMP-phosphodiesterases. Similarly, 
Horrigan et al. (2005) reported that caffeine reduced T lymphocyte proliferation in 
humans following Con A stimulation. The only published study that has investigated 
the in vivo effects of caffeine on adaptive immunity in humans, reported an 
immunostimulatory role for caffeine in T lymphocytes (Bishop et al., 2005). A6 
mg. kg 1 body mass dose of caffeine increased the natural state of lymphocyte 
activation, assessed by an increased percentage of CD4+ and CD8+ cells expressing 
the early activation marker CD69, both before and after a bout of prolonged intensive 
submaximal exercise. CD69 is expressed rapidly following T lymphocyte receptor 
expression and is associated with T lymphocyte proliferation and cytotoxic activity 
(Mueller et at., 2002); however, as the study did not expose the cells to mitogenic or 
antigenic challenge, it is unclear if this would lead to an altered T lymphocyte 
responsiveness. 
In summary, caffeine has been demonstrated to have immunomodulatory properties, 
that are potentially both positive and negative for immune response. Few studies have 
been conducted using human subjects and of those that have used `physiological' 
concentrations, it is unlikely that even these can be achieved with normal caffeine 
consumption. For example, Varani et al. (2005) reported a mean peak plasma 
concentration of 63 tmo1. L'1 following the ingestion of 600 mg. day'1 caffeine for 7 
days. Furthermore at 1h following the ingestion of a9 mg. kg"1 body mass caffeine 
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dose, plasma caffeine only increased to approximately 60 µmol. L'l (Graham and 
Spriet, 1995). 
2.10.3. Potential effects of caffeine on neutrophil function following exercise 
Plasma adenosine concentration is known to increase during periods of metabolic 
stress such as ischaemia, hypoxia and exercise (Hasko and Cronstein, 2004). As 
detailed in Section 2.8.2, adenosine has been reported to stimulate chemotaxis and 
phagocytosis in vitro via the At adenosine receptor expressed by neutrophils, but 
inhibit neutrophil oxidative burst responses via the A2A receptor. Caffeine is a none 
selective At and A2A adenosine receptor antagonist, therefore it can inhibit the 
occupancy and/or action of adenosine receptors on neutrophil responses. Furthermore, 
caffeine ingestion is consistently associated with an increased secretion of adrenaline 
(Section 2.9.2). Stimulation of neutrophil ßz-adrenoreceptors by adrenaline is 
frequently reported to increase cAMP synthesis, leading to decreased neutrophil 
functional responses. Caffeine also increases the release of Ca2+ from the endoplasmic 
reticulum of cells (Biaggini et at., 1991) and is a phosphodiesterase inhibitor (Sullivan 
et at., 1995). Phosphodiesterase breaks down cAMP to the inactive 5'-AMP, therefore 
inhibition by caffeine and its metabolites can stimulate measurable concentrations of 
cAMP within neutrophils, potentially decreasing neutrophil function. However, 
caffeine concentrations of between I and 100 mmol. L't are required to cause these 
events, which are not achievable at physiological doses in vivo (Biaggioni et al., 
1991). A summary of the potential mechanisms by which caffeine may affect 
neutrophil function is outlined in Figure 2.3. 
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Figure 2.3. A summary of the proposed mechanisms by which caffeine can affect 
neutrophil function. 
55 
Chapter 3 
Chapter 3 
General Methods 
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3.1. Ethical Approval 
All study protocols presented in this thesis received prior approval by Loughborough 
University Ethical Advisory Committee. Each participant was fully informed about 
the rationale for the particular study, the experimental procedures to be undertaken 
and possible risks and discomforts that may have been experienced during the 
investigation. This was explained both verbally and in writing. Following an 
opportunity to ask any questions, participants provided written informed consent and 
were made aware that they could withdraw from the study at any time without 
providing reason. 
Participants completed an initial health screening questionnaire (Appendix A) and a 
physical activity questionnaire (Appendix B) to ascertain if they were suitable 
candidates for the study. If participants reported taking any medication or 
experiencing symptoms of infection in the 4 weeks prior to participating in the study, 
they were unable to take part. A habitual caffeine consumption questionnaire 
(Appendix C) was also administered at the beginning of each study to classify 
participants as low, moderate or high habitual caffeine users, according to Daly 
(1993). On the day of each experimental trial, participants were required to complete 
a health questionnaire (Appendix D) to confirm that they were not experiencing any 
symptoms of URTI. 
3.2. Preliminary procedures 
Preliminary experimental measurements were conducted within a 2-week period prior 
to the beginning of the main trials. Maximal oxygen uptake (VOZ max) was 
estimated using a continuous incremental exercise test performed on an 
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electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, 
Netherlands). Following an explanation of the protocol, participants began cycling at 
a work rate of 95 W, with increments of 35 W every 3 min and continued until 
volitional fatigue. Verbal encouragement was provided to each participant to ensure a 
maximum effort. Maximal work rate (Wmax) was determined according to the 
following formula: Wmax = Wout + (d180) * 35, where Wout is the last completed 
stage and t is the time in seconds in the final stage (Jeukendrup et al., 1996). Samples 
of expired gas were collected into Douglas bags during the third min of each work 
rate increment and the final min of the exercise test. Heart rates were recorded 
continuously using short-range telemetry (Polar Beat, Polar Electro, Oy, Finland). The 
percentages of 02 and CO2 in the expired gas samples were measured using a 
paramagnetic 02 analyser (Servomex 1420B, Crowborough, UK) and an infrared CO2 
analyser (Servomex 1415B) respectively. These were used alongside a dry gas meter 
(Harvard Apparatus, Edenbridge, UK) to determine ft, Y 02, and V CO2. From the 
V 02 (l. min 4) - Work rate (W) relationship, the work rate equivalent to 70% 
VOZ max (Chapters 5,6,7) or 65% 
VO2 max (Chapter 9) for each participant was 
interpolated. 
Participants returned to the laboratory on a second occasion to undertake a 
familiarisation period that consisted of cycling for 60 min at a work rate 
corresponding to 65% or 70% 
VO2 max. Heart rates were monitored continuously 
and 1-min expired gas samples were taken at 15 min intervals to ensure that the 
participants were exercising at the correct intensity. Work rate was adjusted if 
intensity was more than 5% higher or lower than the required intensity. 
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3.3. Standardisation of pre-trial conditions 
Each participant was provided with a list of caffeine containing products (Appendix 
E) and instructed to abstain from these during the 60 h prior to each main 
experimental trial. They were also instructed to avoid strenuous physical activity and 
to record their dietary intake in the 24 h prior to the first experimental trial. This diet 
was then replicated as closely as possible in the 24 h prior to each additional trial in 
an attempt to standardise their nutritional status. 
For each trial, participants arrived at the laboratory following an overnight fast of 
between 10 and 12 h. All participants were instructed to ingest -300 ml of water upon 
waking on the morning of each trial in an attempt to standardise their hydration status 
prior to the exercise bouts. 
3.4. Main trial procedures 
In the experimental trials of Chapters 4-7, the method of caffeine administration was 
identical. Participants received 6 mg. kg'1 body mass of caffeine (BDH Laboratory 
Supplies, Poole, UK) or placebo (dextrose powder; BDH Laboratory Supplies, Poole, 
UK) dissolved in 200 ml no-added sugar pink grapefruit juice drink. Grapefruit juice 
was used to disguise the taste of the treatments. In Chapter 9 the same quantity of 
caffeine or placebo (6 mg. kg"' body mass) was taken in the form of a cellulose capsule 
(Blackfirs Health, Cheshire, UK) with 2 ml. kg-1 body mass of water. 
The mode of exercise in all exercise chapters was cycling performed using a 
electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, 
Netherlands). The ergometer saddle and handlebar height was specifically adjusted to 
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each participant's physical characteristics to optimise cycling performance and 
comfort. These parameters were recorded at the initial visit to the laboratory and set 
prior to each additional visit to speed up the transition time from rest to exercise. 
Heart rate was recorded continuously during the exercise bouts via short range 
telemetry (Polar Beat, Polar Electro, Oy, Finland). Subjective ratings of perceived 
exertion (RPE) were measured every 15 min throughout each exercise protocol, 
according to Borg (1982). In addition, 1-min expired gas samples were collected 
throughout exercise to determine Y 02 and Y C02, to ensure that the participants were 
exercising at the correct intensity and to estimate carbohydrate and fat oxidation and 
contribution towards energy expenditure, as described by Peronnet and Massicote 
(1991). 
3.5. Blood sampling and analysis 
This section details blood analyses methods that have been used on more than one 
occasion throughout this thesis. All blood samples were collected by venepuncture 
from an antecubital forearm vein with the participant in the seated position. For each 
sample, approximately 23 ml of blood was collected into four evacuated monovette 
tubes (Sarstedt, Leicester, UK), two containing K3EDTA (1.6 mg. ml"1), one 
containing lithium heparin (1.5 IU. m1"1) and one containing no additive to obtain 
serum. 
3.5.1. Haematological analysis 
Blood collected into one of the K3EDTA monovettes (2.7 ml) was used to determine 
the total and differential leukocyte count, haematocrit and haemoglobin content using 
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a haematology analyser (AC-TM 5diff analyser, Beckman Coulter, UK). The intra- 
assay coefficient of variation was 1.3%, 0.9% and 1.1% for leukocyte counts, 
haemoglobin content and haematocrit respectively. Plasma volume changes were 
estimated from haemoglobin and haematocrit values according to Dill and Costill 
(1974) and cell counts were corrected for these plasma volume changes relative to the 
initial blood sample. 
3.5.2. Measures of neutrophil function 
PAM-stimulated oxidative burst response 
In vitro neutrophil oxidative burst response following PMA-stimulation was measured 
using the ABEL®1 (Analysis By Emitted Light) cell activation test kit on a microplate 
according to manufacturer's instructions (Knight Scientific Limited, Plymouth, UK). 
In duplicate analysis, 10 µl K3EDTA blood was diluted 1: 100 with blood dilution 
buffer (Hank's Balanced Salt Solution; HBSS containing 20 mM Hepes, pH 7.4 but 
without magnesium or calcium). A 20 µl sample of this solution was added to the 
microplate, followed by the addition of 90 µl reconstitution and assay buffer (HBSS 
containing 20 mM Hepes, pH 7.4), 20 p1 Adjuvant-K and 50 µl Pholasin (10 pg. mi"). 
For stimulated oxidative burst response, 20 pl of PMA stimulant (5 pg. ml"1 working 
solution) was added to the microplate. Unstimulated oxidative burst response was 
determined by adding 20 pl reconstitution and assay buffer to the appropriate well of 
the microplate, which was placed in a luminometer (Anthos Lucy I Microplate 
Luminometer, Anthos, Labtec Instrument, Austria) and shaken for 60 s at 37°C. 
Pholasin-enhanced CL was measured every min for 30 min and the incremental area 
under the curve (IAUC) for stimulated and unstimulated oxidative burst responses 
were determined. Unstimulated IAUC was subtracted from stimulated IAUC to give 
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total oxidative burst response, which was divided by the neutrophil count per well to 
give oxidative burst response per neutrophil. Neutrophil count per well was 
determined from the cell counter results which were adjusted for the dilution of whole 
blood at the beginning of the assay. The intra-assay coefficient of variation was 6.4% 
for the PMA-stimulated oxidative burst response. 
f-MLP-stimulated neutrophil oxidative burst response 
In vitro neutrophil oxidative burst response following f-MLP-stimulation was 
measured using the ABEL®'(Analysis By Emitted Light) cell activation test kit on a 
microplate according to manufacturer's instructions (Knight Scientific Limited, 
Plymouth, UK). The process of whole blood dilution and microplate preparation was 
identical to that of PMA-stimulated oxidative burst response to the point of cell 
stimulation. Briefly, upon the addition of 20 µd f-MLP stimulant (10 µmol. L't 
working solution), the microplate was placed in a luminometer (Anthos Lucy I 
Microplate Luminometer, Anthos, Labtec Instrument, Austria) and incubated for 30 s 
at 37 °C. Following the 30 s incubation, CL was recorded every 1s for 100 s and peak 
CL (total oxidative burst response) was determined. This value was then divided by 
the neutrophil count per well to calculate the oxidative burst response per neutrophil. 
The intra-assay coefficient of variation was 9.0% for the f-MLP-stimulated oxidative 
burst response. 
In vitro neutrophil degranulation assay 
Neutrophil plasma elastase release was determined as according to Robson et al. 
(1999). Briefly, 1 ml of heparinised whole blood was added to an eppendorf tube 
containing 50 µl of stimulant (10 mg. mi'), containing a mixture of both gram positive 
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and gram negative bacterial extracts (Sigma, Poole, UK). The contents were mixed by 
inversion and incubated at 37°C for 1 h, with a gentle inversion of the eppendorf tubes 
at 30 min. Following the incubation period, the eppendorf tubes were centrifuged at 
5000 g for 2 min and the supernatant was immediately stored at -80°C for later 
analysis. The elastase concentration in plasma before and after bacterial stimulation 
was determined using an Enzyme-Linked Immunosorbent Assay (ELISA) kit 
(BioVendor Laboratory Medicine Inc, Brno, Czech Republic). Unstimulated 
neutrophil plasma elastase concentration was determined and subtracted from the 
stimulated elastase concentration to give a total neutrophil release. This was adjusted 
for neutrophil count to calculate elastase release on a per-cell basis in response to the 
bacterial stimulant. The intra-assay coefficient of variation was 3% for the 
degranulation assay. 
3.5.3. Stress hormones and IL-6 
The remaining heparinised blood (approximately 6.5 ml) and blood collected into the 
second K3EDTA monovette (7.5 ml) were spun at 1500 g for 10 min in a refrigerated 
centrifuge (4 °C) to obtain plasma. Of the heparinised plasma obtained, 2 ml was 
immediately added to chilled tubes containing 200 pl of a glutathione (100 mM) and 
EGTA (100 mM) anti-oxidant preservative (pH 6.5). Tubes were mixed and frozen at 
-80°C before 
later determination of plasma adrenaline and noradrenaline 
concentration by high-performance liquid chromatography with electrochemical 
detection, as previously described (Forster and MacDonald, 1999). The remaining 
heparinised plasma was stored at -80°C for later analysis of plasma cortisol, which 
was determined using a commercially available ELISA method (DRG Diagnostics, 
DRG instruments, Germany). The K3EDTA plasma was also stored at -80°C until 
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later analysis for IL-6 cytokine concentration using a commercially available ELISA 
procedure (Diaclone, Besancon Cedex, France). The intra-assay coefficient of 
variation was 6.6%, 1.9%, 1.6% and 2.9% for adrenaline, noradrenaline, cortisol and 
IL-6 respectively. 
3.5.4. Blood-borne metabolites 
Serum was obtained from whole blood which was left to clot on ice for 1 h, then spun 
at 1500 g for 10 min at 4 °C. Serum was transferred to eppendorf tubes and frozen at - 
80°C. Serum caffeine concentration was determined using a commercially available 
kit (Emit Caffeine Assay, Dade-Behring, Milton Keynes, UK) on an automatic 
photometric analyser (COBAS Miras Plus, Roche Diagnostic Systems, Switzerland). 
Aliquots of K3EDTA plasma were used for determination of glucose (GOD-PAP 
method, Randox Laboratories, Co. Antrim, N. Ireland, UK) and free fatty acids (FFA) 
(Wako Chemicals, Neuss, Germany) on an automatic photometric analyser. Aliquots 
of heparinised plasma were also deproteinised by adding 100 µl plasma to 1 ml 
perchloric acid (0.3 M). Lactate concentration was determined in the deproteinised 
samples using a spectrophotometric method as described by Fink and Costill (1995). 
The intra-assay coefficient of variation was 2.9% and 3.3% for caffeine and lactate 
respectively and was less than 1% for both glucose and FFA. 
3.6. Statistical analysis 
All statistical analysis was conducted using SPSS 12.0 software for Windows (SPSS 
Inc., Chicago IL, USA). Statistical significance was accepted at the P<0.05 level and 
all data presented in the text, tables and figures throughout this thesis are expressed as 
mean values and the standard errors of the mean (± SEM). The data was checked for 
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normality and examined using two-factor (trial x time-point) analysis of variance 
(ANOVA) with repeated measures design. If the data was not normally distributed, 
analysis was performed on logarithmic transformed data. Assumptions of sphericity 
were checked and appropriate adjustments in the degrees of freedom of ANOVA, as 
according to Atkinson (2001) were made. Any significant differences were assessed 
using Student's paired t-tests with Holm-Bonferroni adjustments for multiple 
comparisons. Single comparisons between trials were assessed using Student's paired 
t-tests with Bonferroni adjustment. 
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Chapter 4 
The effect of caffeine ingestion on resting 
hormonal and neutrophil functional responses. 
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4.1. Abstract 
The aim of the study was to determine the effect of a single 6 mg. kg" body mass dose 
of caffeine on both PMA and f-MLP-stimulated neutrophil oxidative burst responses 
and bacterially-stimulated neutrophil degranulation response when participants rested 
for 3.5 h following caffeine ingestion. In a single-blind, counter-balanced design, 6 
male participants (mean ± SEM: age 25 ±2 years; body mass 75.6 ± 3.8 kg; height 
1.79 ± 0.05 m) ingested 6 mg. kg 1 body mass of caffeine (CAF) or placebo (PLA) and 
rested in the laboratory for a 3.5 h period. During this time water was consumed ad 
libitum. Venous blood samples were obtained upon arrival (0 h), 60 min after CAF or 
PLA ingestion (1 h), 2.5 h after CAF or PLA ingestion (2.5 h) and a further sample I 
h later (3.5 h). The sampling points were chosen to coincide with the time-points that 
were used in the exercise trials of Chapters 5 and 6. CAF ingestion did not affect the 
neutrophil oxidative burst response following PMA (Time, P=0.55; Trial, P=0.99) 
or f-MLP-stimulation (Time, P=0.46; Trial, P=0.63) nor did it effect bacterially- 
stimulated neutrophil elastase release (Time, P=0.28; Trial, P=0.84). Plasma 
adrenaline concentration was significantly higher on CAF than PLA at Ih and 2.5 h 
(both P<0.05), but there were no significant differences for plasma noradrenaline 
concentration. There were no significant differences between CAF and PLA trials for 
either total leukocyte, neutrophil or lymphocyte count. Plasma FFA concentration was 
significantly elevated from rest at 2.5 h and 3.5 h on CAF trial only (P<0.05) but there 
were no differences between CAF and PLA for plasma glucose or cortisol 
concentrations. The findings of the study suggest that caffeine ingestion does not 
affect the PMA or f-MLP-stimulated neutrophil oxidative burst response or 
bacterially-stimulated neutrophil elastase release when participants are at rest. 
67 
Chapter 4 
4.2. Introduction 
Caffeine is a legal, socially acceptable drug and is the most widely consumed 
behaviour influencing substance in the world (Graham, 2001 a). Caffeine is contained 
in various foods, beverages and medications, yet caffeine is not a typical nutrient and 
is not essential for health. It is estimated that approximately 200 mg caffeine per 
person per day is consumed in the UK and US, whereas this intake may be doubled in 
certain Scandinavian countries (Fredholm et al., 1999). 
There are relatively few studies that have investigated the effects of caffeine on 
specific indices of immune function in healthy volunteers using `normal' caffeine 
doses. In vitro, caffeine has been demonstrated to have little effect on the production 
of the anti-inflammatory cytokine IL-10 or the pro-inflammatory cytokines IL-1ß or 
IL-12, but it suppressed TNF-a production in LPS-stimulated human whole blood 
(Horrigan et al., 2004). Caffeine has also been reported to inhibit the proliferative 
responses of human lymphocytes to PHA, SEB and tetanus toxoid (Rosenthal et al., 
1992). In contrast however, an immunostimulatory role for caffeine in T cells has 
been reported (Bishop et al., 2005). In this study, a6 mg. kg'1 body mass dose of 
caffeine increased the natural state of lymphocyte activation, assessed by an increased 
number of CD4+ and CD8+ cells expressing the early activation marker CD69, both 
before and after a bout of submaximal intensity exercise. Furthermore, the same 
caffeine dose was associated with increased salivary-IgA concentration and secretion 
rate during exercise, suggesting that mucosal immunity may be enhanced by caffeine 
(Bishop et al., 2006). 
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It is possible that caffeine may affect neutrophil function via a number of speculated 
mechanisms. Adenosine is reported to inhibit f-MLP-stimulated neutrophil oxidative 
burst responses (Cronstein et al., 1983,1985; Swain et al., 2003) and may also inhibit 
neutrophil degranulation responses (Bouma et al., 1997). As caffeine is an antagonist 
of adenosine receptors, caffeine may modulate the effects of endogenous adenosine 
on neutrophil function. It has been reported that 100 pmol. L"1 caffeine had no effect 
on neutrophil luminol-enhanced CL response when adenosine was not present. In the 
presence of adenosine however, the response was significantly increased (Sullivan et 
al., 1995). The same authors also reported no effects of caffeine on neutrophil 02-" 
production, therefore an increased CL response was probably due to increased MPO 
release as luminol-enhanced CL reflects both 02-" production and the release of MPO 
from neutrophilic granules. Caffeine ingestion also increases the secretion of 
adrenaline (Graham and Spriet, 1991,1995; Jackman et al., 1996; Bishop et al., 2005) 
that is known to stimulate the ß-2 adrenoreceptors expressed by neutrophils. 
Adrenaline has previously been reported to inhibit both PMA (Garcia et al., 1999) and 
f-MLP (Wenisch et al., 1996) stimulated neutrophil oxidative burst responses and 
may also inhibit neutrophil degranulation responses following stimulation (Tintinger 
et al., 2000). 
The purpose of the present study, therefore, was to determine the effects of a single 6 
mg. kg-4 body mass dose of caffeine on both PMA and f-MLP-stimulated neutrophil 
oxidative burst responses and bacterially-stimulated neutrophil degranulation 
responses when participants rested for 3.5 h following ingestion. It was hypothesised 
that caffeine ingestion would have little effect on neutrophil functional responses 
when participants were at rest. 
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4.3. Methods 
Participants 
Six healthy males (mean ± SEM: age 25 ±2 years; body mass 75.6 ± 3.8 kg; height 
1.79 ± 0.05 m) volunteered to participate in the study. Participants were informed of 
the rationale and experimental procedures involved in the study, before providing 
written consent to participate. The study protocol had earlier received approval by 
Loughborough University Ethical Advisory Committee. Average daily caffeine intake 
was 242 ± 72 mg. day"1. One participant was characterised as a light user (< 50 
mg. day''), 2 as moderate users (50-250 mg. day4) and 3 as having a high caffeine 
intake (> 250 mg-day I). 
Experimental procedures 
Participants undertook 2 trials separated by 7 days. In a single-blind, counter-balanced 
design, participants were randomly assigned to one of two experimental conditions: 
ingesting caffeine (CAF) or placebo (PLA). Participants arrived at the laboratory at 
10.00 am following an overnight fast of between 10 and 12 h. Following a void, 
participants ingested 6 mg. kg" body mass of either CAF or PLA dissolved in 200 ml 
no-added sugar pink grapefruit juice drink and rested in the laboratory for a 3.5 h 
period. During this time, water was consumed ad libitum. Venous blood samples were 
obtained upon arrival (0 h), 60 min after CAF or PLA ingestion (1 h), 2.5 h after CAF 
or PLA ingestion (2.5 h) and a further sample Ih later (3.5 h). The sampling points 
were chosen to coincide with the time-points that were used during the exercise trials 
described in Chapters 5 and 6. Laboratory conditions were 23.0°C ± 0.3 °C and 45 f 
2% relative humidity. 
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Blood analytical methods 
Blood sampling and analyses methods are detailed in Chapter 3.5. 
Statistical analysis 
Statistical analysis methods are detailed in Chapter 3.6. 
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4.4. Results 
Blood metabolites and hormones 
Serum caffeine was significantly higher at 1 h, 2.5 h and 3.5 h on CAF compared with 
PLA (all P<0.01; Figure 4.1). Plasma adrenaline concentration was significantly 
elevated above 0h at 1h and 2.5 h on CAF (both P<0.01) but there was no change on 
PLA. At 1h and 2.5 h, plasma adrenaline concentration was significantly higher on 
CAF than PLA (both P<0.05; Figure 4.2). There were no significant differences over 
time or between CAF and PLA trials for either plasma noradrenaline, cortisol or 
glucose concentrations (Table 4.1). Plasma FFA concentration was significantly 
higher than 0h at 2.5 h and 3.5 hon CAF only (both P<0.05; Table 4.1). 
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Figure 4.1. Serum caffeine concentration on CAF and PLA trials. Significantly higher 
on CAF than PLA at that time point (tt P<0.01). Significantly higher than rest within 
trial (** P<0.01). 
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Figure 4.2. Plasma adrenaline concentration on CAF and PLA trials. Significantly 
higher on CAF than PLA at that time point (t P<0.05). Significantly higher than rest 
within trial (* * P<0.01). 
Table 4.1. Plasma concentrations of noradrenaline, cortisol and blood-borne 
metabolites on CAF and PLA trials. 
Oh Ih 2.5 h 3.5 h 
Noradrenaline (nmol. L' ) 
CAF 1.59 (0.17) 1.91 (0.22) 1.77 (0.28) 
PLA 1.35 (0.26) 2.26 (0.81) 1.63 (0.42) 
Cortisol (nmoLL'') 
CAF 301 (43) 297 (38) 295 (32) 243 (34) 
PLA 315 (44) 272 (35) 261 (25) 270 (32) 
FFA (mmoLL'') 
CAF 0.30 (0.09) 0.52 (0.11) 0.71 (0.14)* 0.86 (0.21)* 
PLA 0.36 (0.08) 0.34 (0.07) 0.41 (0.08) 0.54 (0.10) 
) Glucose (mmo1. L" 
CAF 5.8 (0.4) 5.7 (0.2) 5.1 (0.3) 4.9 (0.3) 
PLA 5.6 (0.4) 5.6 (0.3) 5.9 (0.4) 5.2 (0.3) 
Significantly higher than 0h within trial (*P<0.05). 
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Total and differential leukocyte counts 
There were no significant differences between CAF and PLA trials for circulating 
leukocyte, neutrophil or lymphocyte counts. These counts did not significantly change 
throughout the course of the experimental protocol. Total and differential blood 
leukocyte count during the 3.5 h resting period is presented in Table 4.2. 
Table 4.2. Total and differential blood leukocyte counts on CAF and PLA trials. 
Oh 1h2.5 h 3.5 h 
Leukocytes (x 109. L') 
CAF 5.0 (0.4) 5.6 (0.4) 5.5 (0.6) 5.8 (0.5) 
PLA 4.6 (0.5) 5.0 (0.4) 5.0 (0.4) 4.8 (0.3) 
Neutrophils (x 109. L'ß) 
CAF 2.5 (0.3) 2.7 (0.3) 3.1 (0.4) 3.4 (0.4) 
PLA 2.2 (0.2) 2.6 (0.2) 2.6 (0.2) 2.6 (0.2) 
Lymphocytes (x 109. L-1) 
CAF 1.6g(0.17) 2.00 (0.14) 1.73 (0.13) 1.73 (0.15) 
PLA 1.68 (0.17) 1.71 (0.12) 1.79 (0.19) 1.63 (0.13) 
Neutrophil Function 
There were no significant differences between CAF and PLA trials (P = 0.99; Figure 
4.3) for PMA-stimulated neutrophil oxidative burst responses. The response did not 
change over time throughout the resting protocol (P = 0.55). Likewise, there were no 
significant differences between CAF and PLA trials (P = 0.63), or over time (P = 
0.46) for f-MLP-stimulated neutrophil oxidative burst responses (Figure 4.4). 
Neutrophil elastase release in response to bacterial stimulation was similar between 
CAF and PLA conditions (P = 0.84; Figure 4.5). Elastase release did not significantly 
change over the 3.5 h resting period (P = 0.28). 
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Figure 4.3. PMA-stimulated neutrophil oxidative burst response expressed as total 
chemiluminescence (IAUC) in relative light units on CAF and PLA trials. 
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Figure 4.4. f-MLP-stimulated neutrophil oxidative burst response expressed as peak 
chemiluminescence per neutrophil cell on CAF and PLA trials. 
75 
Oh 1h2.5h 3.5h 
Oh 1h2.5h 3.5h 
Chapter 4 
140 f . CAF 120 1- -a-- PlA m 
0 100 0 
a) 80 
c 
ý 60 
0 40 
15, 
20 
0 
Oh 1h2.5h 3.5h 
Figure 4.5. Neutrophil elastase release (expressed as a% of baseline response) 
following bacterial stimulation on CAF and PLA trials. 
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4.5. Discussion 
The main findings of the present study suggest that caffeine ingestion (6 mg. kg" body 
mass) has no effect on either PMA or f-MLP-stimulated neutrophil oxidative burst 
responses or bacterially-stimulated neutrophil degranulation responses when 
participants rested for 3.5 h following caffeine ingestion. Although CAF was 
associated with an increased adrenaline concentration above PLA, it was not 
associated with a decreased neutrophil function. In vitro studies have shown that 
PMA-stimulated rat neutrophils have a reduced capacity to produce 02-" following 
incubation with 5 nmol. L'1 adrenaline (Garcia et al., 1999). A similar adrenaline 
concentration is known to inhibit the f-MLP-stimulated neutrophil oxidative burst 
response (Wenisch et al., 1996) whereas incubation of isolated human neutrophils 
with 0-2 adrenoreceptor agonists may inhibit neutrophil degranulation responses 
following stimulation (Tintinger et at., 2000). In the present study, it is likely that an 
increase of approximately 0.3 nmol. L'1 adrenaline following caffeine ingestion is 
insufficient to produce these immunosuppressive effects observed with higher 
adrenaline concentrations. 
The major action of caffeine at physiological concentrations is as an adenosine 
receptor antagonist (Ongini and Fredholm, 1996). Adenosine is reported to inhibit f- 
MLP-stimulated oxidative burst responses when incubated with neutrophils in vitro 
(Cronstein et al., 1985; Swain et al., 2003). Incubation with 100 nmol. L'1 and I 
µmol. L' adenosine inhibited neutrophil ROS production by 38% and 60% 
respectively (Swain et al., 2003). Adenosine, acting via A2 and A3 receptors has also 
been shown to inhibit LPS stimulated human neutrophil elastase release with an IC50 
of 14 pmol. L-1 (Bouma et al., 1997). As the participants were at rest in the present 
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study, their basal adenosine concentrations would be expected to be low. Mean 
plasma adenosine concentrations of 50 nmo1. U1 (Chouker et al., 2005) and 82 nmol. L- 
1 (Moser et al., 1989) have been reported in humans at rest, therefore this would 
suggest that in the present study, caffeine ingestion has no effect on neutrophil 
responses when endogenous adenosine concentration is low. It is likely that caffeine 
may exert greater effects in situations such as intense exercise where there is a 
discrepancy between the rate of ATP consumption and ATP synthesis in muscle, 
leading to an increased adenosine concentration in blood that may exert suppressive 
effects upon neutrophil function (Fredholm et al., 1999). 
A study conducted by Sullivan et at. (1995) reported no effect of caffeine (100 
µmol. L-') on 02-" generation in an LPS-stimulated mixed leukocyte mixture and in 
pure neutrophils primed with rhTNF-a. Similarly in the present study, caffeine did not 
affect PMA or f-MLP stimulated neutrophil oxidative burst responses at serum 
concentrations of 40 to 50 µmol. L'4. The average caffeine dose administered in the 
present study was 450 mg, equating to 3 or 4 cups of very strong coffee (Fredholm, 
1980). It is likely therefore, that 100 µmol. L"1 caffeine concentrations that previous 
studies have termed `physiological' are not possible for the average person unless 
extraordinarily large caffeine doses are consumed. For example, Varani et al., (2005) 
reported a mean peak plasma concentration of only 63 µmol. L'1 following the 
ingestion of 600 mg caffeine per day for 7 days. 
As mentioned previously, CAF significantly increased plasma adrenaline 
concentration, but had no effect on plasma noradrenaline concentration. An increased 
secretion of adrenaline following caffeine ingestion has consistently been reported in 
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both resting and exercise studies (Spriet et al., 1992; Graham and Spriet, 1995; 
Jackman et al., 1996; Graham et al., 2000; Bishop et al., 2005). In contrast to the 
findings for adrenaline, studies have rarely found an increase in plasma noradrenaline 
concentrations, which is consistent with the findings of the present study. CAF 
increased FFA concentration at 2.5 h and 3.5 h following ingestion but there was no 
difference for blood glucose concentration. Since adenosine is known to inhibit 
lipolysis (Fredholm, 1978), it is likely that caffeine antagonises Al receptors of 
adipocytes and this enhances lipolysis (Graham, 2001a). It may also be that caffeine- 
induced increases in adrenaline concentration augment lipolysis via ß-adrenergic 
receptor stimulation (Kobayashi-Hattori et at., 2005); however, it has been reported 
that FFA mobilisation occurred without an increased adrenaline concentration in 
tetraplegic participants at rest (Van Soeren et al., 1996). 
There was no effect of CAF on resting total leukocyte count, neutrophil or 
lymphocyte count for 3.5 h following ingestion. In mice studies, doses of 2 mg. kg'' 
and 40 mg. kg4 body mass caffeine did not influence neutrophil count, whereas 20 
mg. kg"' body mass caffeine significantly increased neutrophil count by 2.5 fold 
(Ramanaviciene et al., 2004). In humans, a6 mg. kg'1 body mass dose of caffeine 
significantly increased circulating lymphocyte count above PLA at 60 min following 
caffeine ingestion and was attributed to an increased adrenaline concentration at that 
time (Bishop et al., 2005). In the present study, circulating lymphocyte count was 2.0 
x 109. L4 on CAF and 1.71 x 109. L'1 on PLA in the presence of a significantly higher 
adrenaline concentration on CAF than PLA, yet this difference was not statistically 
significant. 
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In summary, the findings of this study suggest that caffeine ingestion significantly 
increased plasma adrenaline concentration but had no effect on neutrophil function as 
measured by PMA and f-MLP-stimulated oxidative burst and bacterially-stimulated 
degranulation responses when participants rested for 3.5 h following caffeine 
ingestion. 
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Chapter 5 
The effect of caffeine ingestion on hormonal and 
neutrophil functional responses following 
prolonged and intensive submaximal cycling. 
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5.1. Abstract 
The purpose of the present study was to determine the effect of caffeine ingestion on 
PMA-stimulated neutrophil oxidative burst and bacterially-stimulated neutrophil 
degranulation responses following exercise. Eleven endurance trained males (mean ± 
SEM: age 23 ±1 years; body mass 73.0 ± 2.6 kg; V02 max 61.0 ± 1.6 ml. kg'i. min 
'; Peak Power Output 327 ± 10 W) ingested 6 mg. kg" body mass of caffeine (CAF) 
or placebo (PLA) 60 min before cycling for 90 min at 75% 
VO2 max. Venous blood 
samples were obtained at rest, 60 min after CAF or PLA ingestion (pre-exercise), 
immediately post-exercise and at Ih post-exercise. CAF ingestion did not affect 
either PMA-stimulated oxidative burst or bacterially-stimulated elastase release of 
neutrophils compared with PLA. Regardless of condition, PMA-stimulated oxidative 
burst was decreased at post-exercise on a per-cell basis (P<0.01) whereas elastase 
release (% of baseline response) tended to be lower at this time-point (P = 0.076). 
CAF was associated with increased plasma adrenaline at pre (P<0.01) and post- 
exercise (P<0.05). There was no effect of CAF on circulating leukocyte or neutrophil 
count but lymphocyte count was significantly higher at pre-exercise on CAF 
(P<0.05). The RPE of participants was significantly lower from mid-way (P<0.05) 
through to the end of the exercise protocol on CAF than PLA (P<0.01). These results 
suggest that CAF does not affect PMA-stimulated oxidative burst or bacterially- 
stimulated neutrophil degranulation responses following exercise. The insensitivity of 
the PMA-activated response of human neutrophils to cAMP elevating agents suggests 
that PMA may not be a suitable stimulant for investigating the influence of caffeine 
ingestion on neutrophil oxidative burst responses. 
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5.2. Introduction 
The findings of Chapter 4 suggest that caffeine ingestion (6 mg. kg"1 body mass) does 
not affect either PMA or f-MLP-stimulated neutrophil oxidative burst response in 
humans at rest. To the author's knowledge there are no studies that have specifically 
investigated the influence of caffeine ingestion on neutrophil responses following 
exercise. In response to prolonged and intensive submaximal exercise, PMA- 
stimulated neutrophil oxidative burst (Robson et al., 1999; Davison and Gleeson, 
2005) and bacterially stimulated neutrophil degranulation responses typically decrease 
on a per-cell basis (Bishop et at., 1999,2003; Walsh et at., 2000). 
There are a number of speculated mechanisms by which caffeine may affect 
neutrophil function following exercise. Plasma adenosine concentration increases 
during exercise by the dephosphorylation of AMP (Vizi et al., 2002). Human 
neutrophils express all four classes of adenosine receptor subtypes on their surfaces 
(Gessi et al., 2002) and adenosine is well known to modulate neutrophil functional 
responses (Cronstein, 1994). Adenosine, acting via Al receptors promotes neutrophil 
chemotaxis and phagocytosis (Cronstein et al., 1990), whereas acting through A2A 
receptors, it has opposite effects, inhibiting phagocytosis and superoxide generation 
(Cronstein et al., 1983,1990; Gessi et al., 2002). This inhibition occurred following f- 
MLP but not PMA-stimulation of neutrophils (Cronstein et al., 1983). Adenosine may 
also inhibit neutrophil degranulation responses (Sullivan et al., 1995; Bouma et al., 
1997), but this has not been consistently reported (Cronstein et al., 1985; Swain et al., 
2003). Caffeine and its derivatives are non-selective adenosine receptor antagonists 
(Ongini and Fredholm, 1996), hence their action may affect both oxidative burst and 
degranulation aspects of neutrophil function. 
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It is well known that caffeine increases plasma levels of catecholamines, particularly 
adrenaline (Graham and Spriet, 1991,1995; Jackman et al., 1996; Graham et al., 2000 
amongst others) which stimulates 0-2 adrenoreceptors expressed by neutrophils. This 
stimulation activates adenyl cyclase, inducing cAMP synthesis which is reported to 
decrease the phagocytosis, chemotaxis and enzyme release of neutrophils (Dulis and 
Wilson, 1980). In rats, the rate of PMA-induced neutrophil 02-" production was 
significantly reduced by 5 nmol. L4 adrenaline in the presence of glucose (Garcia et 
al., 1999), whereas the incubation of isolated human neutrophils with 0-2 
adrenoreceptor agonists may (Tintinger et al., 2000) or may not (Barnett et al., 1997) 
inhibit neutrophil degranulation response following stimulation. 
Taking this information together, caffeine may affect neutrophil functional responses 
following prolonged exercise via adenosine receptor antagonism, or via enhanced 
adrenaline concentrations. The purpose of the present study therefore, was to 
investigate the influence of caffeine ingestion on the PMA-stimulated oxidative burst 
response and bacterially-stimulated degranulation response of human neutrophils 
following prolonged intensive submaximal exercise. 
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5.3. Methods 
Participants 
Eleven endurance trained males (mean ± SEM: age 23 f1 years; body mass 73.0 f 
2.6 kg; 'O2 max 61.0 ± 1.6 ml. kg'l. min'; Peak Power Output 327 ± 10 W) 
volunteered to participate in the study. Participants were informed of the rationale and 
experimental procedures involved in the study, before providing written consent to 
participate. The study protocol had earlier received approval by Loughborough 
University Ethical Advisory Committee. Average daily caffeine intake was 160 ± 39 
mg. day 1. Four participants were characterised as light users (< 50 mg. day''), 5 as 
moderate users (50-250 mg. day') and 2 as having a high caffeine intake (> 250 
mg. day-1). 
Experimental procedures 
Preliminary measurements (VOZ max and familiarisation) were conducted within a 
2-week period prior to the start of the main trials. Preliminary measurements and pre- 
trial standardisation procedures are described in Chapter 3. Participants performed 2 
sessions of exercise separated by 7 days. The participants acted as their own controls 
in a repeated-measures, single-blind, cross-over design and were randomly assigned 
to one of two experimental conditions: ingesting caffeine (CAF) or placebo (PLA). 
Participants arrived at the laboratory at 10.00 am following an overnight fast of 
between 10 and 12 h. Following a void, body mass was recorded before participants 
ingested 6 mg. kg'i body mass of either CAF or PLA dissolved in 200 ml no-added 
sugar pink grapefruit juice drink. After resting quietly for 60 min, participants began 
cycling for 90 min at 75% 
V0 
2 max . Heart rate and RPE were measured every 15 
min throughout exercise and 2 ml. kg' body mass of water was administered at these 
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time points. At 20,50 and 80 min of exercise, 1-min expired gas samples were 
collected. Following the cessation of exercise, body mass was recorded and 
participants consumed 3 ml. kg" body mass of water before resting for a further 60 
min. Venous blood samples were obtained at rest, 60 min after CAF or PLA ingestion 
(pre-exercise), immediately post-exercise and at 1h post-exercise. Laboratory 
conditions were 16°C - 20°C and 57 ± 3% relative humidity. 
Blood analytical methods 
Blood sampling and analyses methods are detailed in Chapter 3.5. 
Statistical analysis 
Statistical analysis methods are detailed in Chapter 3.6. 
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5.4. Results 
Physiological variables and RPE 
Exercise intensity did not significantly differ between trials; mean % V02 max 
throughout exercise was 74.9 ± 0.8% and 74.2 ± 0.6% on CAF and PLA trials, 
respectively. Following exercise, body mass change (corrected for fluid consumed) 
fell similarly on both trials (-I. 8 ± 0.2 kg and -1.7 ± 0.2 kg on CAF and PLA 
respectively). At post-exercise, plasma volume had decreased by 9.2 ± 1.8% on CAF 
and 6.6 ± 2% on PLA compared with resting values, but this difference was not 
statistically significant (P = 0.375). Heart rate during exercise was similar between 
trials (157 ±I beats. min 1 and 156 ±1 beats. min-1 on CAF and PLA respectively, 
mean of all recordings). RPE increased on both trials with exercise duration but was 
significantly lower at 45 (P<0.05), 60,75 and 90 min on CAF than PLA (P<0.01; 
Figure 5.1). 
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Figure 5.1. Perceived ratings of exertion (RPE) during 90 min cycling at 75% 
VO2max on CAF and PLA conditions. Significantly lower on CAF than PLA at that 
time point (t P<0.05, tt P<0.01). Significantly higher RPE than at 15 min within trial 
(* * P<0.01). 
Substrate Oxidation and Energy Expenditure 
Mean RER was similar between CAF and PLA trials during the 90 min exercise 
period (CAF: 0.93 ± 0.01, PLA: 0.92 ± 0.01, P=0.552). CHO oxidation rate 
decreased during the exercise period (main effect of time, P<0.05) but was similar 
between trials throughout, with mean values of 3.47 ± 0.13 g. min 1 and 3.40 ± 0.1 S 
g. min71 on CAF and PLA trials respectively. Similarly there were no significant 
differences between fat oxidation rates between trials (CAF: 0.40 ± 0.03 g. min', 
PLA: 0.44 ± 0.04 g. min') however, a main effect of time showed that fat oxidation 
significantly increased throughout the exercise period (P<0.05; Table 5.1). Total 
energy expenditure was similar for both trials with mean values of 69 ±1 kJ. min 1 and 
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68 ±I kJ. min 1 on CAF and PLA respectively. Likewise, the energy derived from the 
oxidation of CHO (CAF: 55.6 ± 2.0 kJ. min', PLA: 54.5 ± 2.4 kJ. min 
4) and fat (CAF: 
15.6 ± 1.2 kJ. min', PLA: 17.1 ± 1.6 kJ. miri-') did not significantly differ between 
trials throughout the exercise period. The energy derived from CHO oxidation 
decreased and contribution from fat increased with exercise duration (main effect of 
time, P<0.05). There were no significant differences between trials for the percentage 
contribution of fat (CAF: 23 ± 2%, PLA: 25 ± 2%) and CHO (CAF: 77 ± 2%, PLA: 
75 ± 2%) towards energy expenditure during the exercise period. 
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Table 5.1: Substrate oxidation rates and contribution towards energy expenditure 
during the exercise period in the CAF and PLA trials. 
Time during Exercise 20 50 80 Mean 
CHO oxidation (g. min') 
CAF 3.67 (0.29) 3.51 (0.20) 3.24 (0.17) 3.47 (0.13) 
PLA 3.55 (0.29) 3.59 (0.31) 3.07 (0.15) 3.40 (0.15) 
Fat oxidation (g. min"') 
CAF 0.31 (0.03) 0.35 (0.04) 0.47 (0.05) 0.40 (0.03) 
PLA 0.32 (0.06) 0.41 (0.15) 0.52 (0.05) 0.44 (0.04) 
Energy derived from CHO oxidation (. Jmin !) 
CAF 58.7 (4.4) 56.2 (3.2) 51.9 (2.7) 55.6 (2.0) 
PLA 56.8 (4.6) 57.5 (5.0) 49.2 (2.3) 54.5 (2.4) 
Energy derived from fat oxidation (kJ. min') 
CAF 12.2 (1.3) 13.8 (1.7) 14.1 (1.9) 15.6(t. 2) 
PLA 12.5 (2.2) 15.9 (3.1) 20.3 (1.9) 17.1 (1.6) 
contribution to total energy expenditure from CHO 
CAF 81(2) 80 (3) 74 (3) 77 (2) 
PLA 80 (4) 77 (5) 71(3) 75 (2) 
% contribution to total energy expenditure from fat 
CAF 19(2) 20(3) 26(3) 23(2) 
PLA 20 (3) 23 (4) 29 (3) 25 (2) 
Blood metabolites and hormones 
Serum caffeine was significantly higher at pre-exercise, post-exercise and 1h post- 
exercise on CAF compared with PLA (all P<0.01; Figure 5.2). Plasma adrenaline 
concentration was significantly higher on CAF compared with PLA at pre-exercise 
(P<0.01) and increased significantly above resting values on both trials by post- 
exercise (CAF: P<0.01, PLA: P<0.05). At this point, plasma adrenaline was 
significantly higher on CAF than PLA (P<0.05; Figure 5.3). There were no significant 
differences between trials for plasma noradrenaline or cortisol concentrations, which 
both increased to a similar extent on CAF and PLA trials following exercise (main 
effect of time, P<0.01; Table 5.2). 
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Figure 5.2. Serum caffeine concentration on CAF and PLA trials. Significantly higher 
on CAF than PLA at that time point (tt P<0.01). Significantly higher than rest within 
trial (** P<0.01). 
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Figure 5.3. Plasma adrenaline concentration on CAF and PLA trials. Significantly 
higher on CAF than PLA at that time point (-fit P<0.01, t P<0.05). Significantly higher 
than rest within trial (* * P<0.01, * P<0.05). 
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Plasma FFA concentration increased significantly from rest to pre-exercise on CAF 
trial only (P<0.01). FFA concentration increased significantly from pre to post- 
exercise on both trials (P<0.01), however at 1h post-exercise, plasma FFA 
concentration was significantly higher on CAF than PLA (P<0.01; Table 5.2). Plasma 
glucose concentration was similar between trials and no significant main effects were 
observed. Plasma lactate concentration increased significantly from rest to pre- 
exercise on CAF only (P<0.05) and was significantly increased at post-exercise on 
both trials (P<0.01). At this time-point, plasma lactate concentration was significantly 
higher on CAF than PLA (P<0.01; Table 5.2). 
Table 5.2. Plasma concentrations of noradrenaline, cortisol and blood-borne 
metabolites on CAF and PLA trials. 
Rest Pre Exercise Post Exercise 1h Post 
Noradrenaline (nmo1. L") a 
CAF 1.81(0.24) 2.42 (0.19) 8.63 (0.92) - 
PLA 1.66 (0.20) 2.08 (0.16) 6.23 (0.66) - 
Cortisol (nmoLL-1) b 
CAF 370 (58) 
PLA 369 (50) 
FFA (mmoLL") 
CAF 0.24 (0.04) 
PLA 0.28 (0.06) 
Glucose (mmol. L'') 
CAF 5.3 (0.2) 
PLA 5.4(0.2) 
344 (42) 612 (55) 512 (66) 
315 (51) 545 (65) 482(43) 
0.54 (0.06)**$ 1.60 (0.11)** 1.38 (0.14)**l 
0.24 (0.02) 1.30 (0.13) ** 0.95 (0.12)** 
5.9 (0.2) 5.3 (0.2) 4.8 (0.2) 
5.3 (0.2) 4.9 (0.4) 5.0 (0.3) 
Lactate (mmo1. L'') 
CAF 1.5 (0.1) 1.9 (0.2)* *t 4.1 (0.2)**$ 
PLA 1.4(0.1) 1.4(0.1) 3.0(0.3)** 
Significantly higher on CAF than PLA at that time point ($ P<0.01, t P<0.05). 
Significantly higher than rest within trial (**P<0.01). a Main effect of time, 
Significantly higher at post-exercise than rest and pre-exercise (P<0.01). b Main effect 
of time, significantly higher at post-exercise than pre-exercise. Significantly lower at 
1h post-exercise than post-exercise (both P<0.01). 
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Total and differential leukocyte counts 
All participants had resting total and differential blood leukocyte counts within the 
normal range for healthy adults. There were no significant differences for total 
number of circulating leukocytes or neutrophils between CAF and PLA trials. There 
was however, a significant main effect of time (P<0.01; Table 5.3) for total 
leukocytes with a leukocytosis evident at post-exercise which increased further at 1h 
post-exercise. Likewise, neutrophil count was significantly higher following the 
cessation of exercise with a delayed neutrophilia at 1h post-exercise compared with 
resting values (main effect of time, P<0.01; Table 5.3). Circulating lymphocyte count 
increased from rest to pre-exercise on CAF trial only and was significantly higher at 
this point on CAF compared with PLA, in which counts remained at resting levels 
(P<0.05; Table 5.3). Immediately following the exercise bout, a marked 
lymphocytosis was evident on both trials (both P<0.05 compared to resting values). 
There was a significant main effect of time for the neutrophiVlymphocyte ratio with 
higher values at 1h post-exercise compared to rest, pre and post-exercise values 
(p<0.01), yet this occurred independent of trial. 
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Table 5.3. Total and differential blood leukocyte counts and the neutrophil/ 
lymphocyte ratio on CAF and PLA trials. 
Rest Pre-Exercise Post-Exercise Ih Post 
Leukocytes (x 10U-7) a 
CAF 4.8 (0.4) 5.9 (1.3) 9.1 (0.9) 12.2 (1.4) 
PLA 5.6 (0.5) 5.8 (0.5) 9.3 (0.8) 12.9 (1.0) 
Neutrophils (x 109. L'1) a 
CAF 2.5 (0.3) 
PLA 3.1 (0.5) 
Lymphocytes (x 109. L"1) 
CAF 1.63 (0.17) 
PLA 1.75 (0.15) 
3.2 (0.3) 5.4 (0.6) 9.7 (1.2) 
3.4 (0.5) 5.7 (0.7) 10.0 (1.0) 
1.98 (0.16) *t 2.74 (0.28)* 1.52 (0.11) 
1.69 (0.11) 2.51 (0.20)* 1.64 (0.07) 
Neutrophil/Lymphocyte ratio b 
CAF 1.6 (0.2) 1.7 (0.2) 2.0 (0.2) 6.4 (0.6) 
PLA 1.9 (0.3) 2.2 (0.4) 2.4 (0.3) 6.3 (0.6) 
Significantly higher on CAF than PLA at that time point (tP<0.05). Significantly 
higher than resting values within trial (*P<0.05). a Main effect of time, significantly 
higher at post-exercise and Ih post-exercise than rest (P<0.01). b Main effect of time, 
significantly higher at 1h post-exercise than rest, pre and post-exercise (P<0.01). 
Neutrophil Function 
There were no significant differences between trials for PMA-stimulated neutrophil 
oxidative burst response expressed as total CL response. Total CL response was 
significantly higher at post-exercise and 1h post-exercise than resting values (main 
effect of time, P<0.01; Figure 5.4). When total CL was adjusted for neutrophil count, 
a significant main effect of time showed that the response on a per-cell basis was 
significantly lower at pre-exercise, post-exercise and Ih post-exercise than at rest 
(P<0.01; Figure 5.5). This decrease occurred independently of the trial followed. 
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Figure 5.4. Neutrophil oxidative burst response expressed as total CL (relative light 
units) following PMA stimulation. Main effect of time (P<0.01). 
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Figure 5.5. Neutrophil oxidative burst response expressed per neutrophil cell (relative 
light units) following PMA stimulation. Main effect of time (P<0.01). 
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In response to bacterial stimulation, neutrophil degranulation response was similar 
between CAF and PLA trials. Neutrophil elastase release tended to be lower at post- 
exercise, however this did not reach statistical significance (main effect of time, P= 
0.076; Figure 5.6). 
500 
a) U 
rn 
400 
Q 0 
I::: 
a) 2 100 
m 
Co w0 
Rest Pre Exercise Post Exercise 1h Post 
Figure 5.6. Neutrophil elastase release following bacterial stimulation. 
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5.5. Discussion 
The main findings of the present study suggest that caffeine ingestion (6 mg. kg"1 body 
mass) has no effect on PMA-stimulated oxidative burst or bacterially-stimulated 
neutrophil degranulation responses following prolonged submaximal intensity 
cycling. 
Regardless of experimental condition, the total neutrophil oxidative burst response (as 
indicated by IAUC CL values) increased with exercise and was approximately 2 to 3- 
fold higher than rest at 1h post-exercise. Similar findings have been previously 
reported (Smith et at., 1996; Suzuki et at., 1996a). Using PMA as a stimulant, Smith 
et at. (1996) reported a 3-fold increase in neutrophil H202 production following 1h of 
cycling at a heart rate of 140 beats. min 
4. Average heart rate in this study was 158 
beats. mir 1 in which similar findings were observed. In accordance with Boyum et at. 
(2002), the present findings suggest that the oxidative potential of the blood 
(calculated as the CL response multiplied by the circulating neutrophil count) is 
increased following exercise; however, when the response was adjusted to account for 
the increases in neutrophil number, a significant reduction on a per-cell basis was 
found at post-exercise and at 1h post-exercise compared with resting values. These 
findings support previous work (Pyne et al., 1996; Robson et al., 1999; Davison and 
Gleeson, 2005) yet are in contrast to the findings of Walsh et al. (2000) who reported 
no effect of 2h cycling at 60% 
"02 max on the PMA-stimulated oxidative burst 
response of isolated neutrophils. A reduced PMA-stimulated oxidative burst response 
per neutrophil may be explained by the post-exercise neutrophilia, as it is known that 
immature neutrophils have a lower activity of NADPH oxidase and a reduced 
capacity to generate 02-" than fully mature neutrophils (Berkow and Dodson, 1986). 
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There are a number of possible reasons to explain why CAF did not affect the PMA- 
stimulated neutrophil oxidative burst response compared with PLA. One of the 
speculated mechanisms for caffeine affecting neutrophil function is via adenosine 
receptor antagonism as caffeine and its metabolites are non-selective Al and A2A 
adenosine receptor antagonists (Ongini and Fredholm, 1996). Adenosine acting via 
A2A adenosine receptors is widely reported to inhibit the oxidative burst response 
when stimulated by f-MLP (Cronstein et al., 1983,1985; Thibault et al., 2002; Swain 
et al., 2003), whereas minimal inhibition was observed following PMA stimulation 
(Cronstein et al., 1983). Furthermore, it is reported that cAMP elevating agents such 
as adrenaline, do not affect the PMA stimulated oxidative burst response in humans 
(Yu et al., 1995; Tintinger et at., 2001). In rat studies however, PMA stimulated 
oxidative burst response was significantly reduced following incubation with 5 
nmol. L' adrenaline (Garcia et al., 1999). The findings of the present study are in 
accordance with the previous research involving human subjects as plasma adrenaline 
was approximately 2-fold higher at post-exercise on CAF compared with PLA trial, 
yet there was no difference in oxidative burst response. It should be noted however, 
that plasma adrenaline concentration in the CAF trial only reached 1.8 nmol. L''. 
Neutrophils are activated by a number of different pathways depending on the 
stimulant used to initiate the oxidative burst response. PMA is known to directly 
activate protein kinase C in blood neutrophils (Lopez et al., 1995; Hazan et al, 1997) 
producing a prolonged and maximum response. Alternatively, f-MLP acts via aG 
protein-coupled receptor (Lopez et al., 1995) invoking a shorter and more subtle 
response than PMA. It has been reported that an increase in CAMP by physiological 
CAMP agonists (ie. adenosine or ß-adrenergic stimulants) exerts an effect on the 
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receptor-mediated oxidative burst of neutrophils but has no effect on neutrophils 
stimulated with PMA (Bengis-Garber et al., 1996). The insensitivity of the PMA- 
activated response of human neutrophils to cAMP elevating agents (Tintinger et al., 
2001) may suggest that PMA is not a suitable stimulant for investigating the influence 
of caffeine ingestion on neutrophil oxidative burst responses. 
The effect of adenosine and adrenaline on neutrophil degranulation responses in vitro, 
have produced equivocal findings. It is reported that adenosine acts via A2 and A3 
receptors to dose-dependently inhibit degranulation responses (Bouma et al., 1997), 
whereas others have reported no effects (Cronstein et al., 1985; Swain et al., 2003). In 
addition, incubation of neutrophils with adrenaline has also been found to inhibit 
(Tintinger et al., 2001) or have no effect (Barnett et al., 1997) upon neutrophil elastase 
release. In the present study, there was no effect of CAF on neutrophil elastase release 
following bacterial stimulation even in the presence of an increased adrenaline 
concentration. This suggests that at physiological doses, adrenaline has no effect on 
bacterially stimulated neutrophil degranulation response. Neutrophil elastase release 
at post-exercise was reduced to 65% and 67% of baseline response on CAF and PLA 
respectively but this did not reach statistical significance (P = 0.076). A decreased 
elastase release per neutrophil cell has been frequently reported following prolonged 
intensive submaximal cycling (Bishop et al., 1999; Walsh et al., 2000; Li and 
Gleeson, 2004). It is likely that this non-significant difference is due to large inter- 
individual variation of neutrophil elastase release in the present study. 
Caffeine ingestion did not affect the leukocyte and neutrophil counts in response to 
exercise yet it was associated with a significant increase in circulating lymphocyte 
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number at pre-exercise (i. e. 1h following caffeine ingestion). This is in accordance 
with Bishop et al. (2005) who reported similar findings using the same exercise 
protocol and method of caffeine administration as that employed in the present study. 
An increase in circulating lymphocyte count may be due to the elevated plasma 
adrenaline concentration at this time point altering endothelial adhesion via activation 
of ß-adrenoreceptors present on lymphocytes. A greater number of ß-adrenoreceptors 
are present on lymphocytes than neutrophils (Mackinnon, 1999) which may explain 
the relatively small influence that caffeine exerts on this leukocyte subset. 
Participants on the CAF trial reported a significantly lower RPE from the mid-point of 
exercise through to completion of the exercise protocol. It has been suggested that 
caffeine may alter the release, binding or activity of neurotransmitters in the brain 
(Davis et al., 2003). This may affect the perception of work intensity (Cole et al., 
1996) or reduce feelings of leg pain associated with strenuous cycle exercise 
(O'Connor et al., 2004). The ability to influence pain perception and psychological 
state is an important factor in the physiological performance of athletes during periods 
of training and competition. 
In summary, the findings of this study suggest that caffeine ingestion has no effect on 
either the PMA-stimulated neutrophil oxidative burst response or bacterially- 
stimulated neutrophil degranulation response following prolonged and intensive 
submaximal cycling exercise. This effect was observed despite a higher adrenaline 
concentration on the CAF trial. 
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Chapter 6 
The effect of caffeine ingestion on f-MLP- 
stimulated neutrophil oxidative burst responses 
following prolonged and intensive submaximal 
cycling. 
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6.1. Abstract 
The purpose of the present study was to determine the effect of caffeine ingestion on 
f-MLP-stimulated neutrophil oxidative burst responses following exercise. Eight 
endurance trained male cyclists (mean ± SEM: age 24 ±1 years; body mass 72.8 ± 
2.8 kg; height 1.79 ± 0.03 m, VO, max 65.6 ± 1.9 ml. kg-l. min', Peak Power Output 
344 ±5 W) ingested 6 mg. kg'' body mass of caffeine (CAF) or placebo (PLA) 60 
min before cycling for 90 min at 70% 
VOZ max. Venous blood samples were 
obtained at rest, 60 min after CAF or PLA ingestion (pre-exercise), immediately post- 
exercise and at 1h post-exercise. f-MLP-stimulated neutrophil oxidative burst 
response decreased following the exercise period, but was significantly lower at post- 
exercise compared with rest and pre-exercise values on the PLA trial only (both 
P<0.01). When neutrophil oxidative burst was expressed as a percentage of baseline 
response, values were significantly higher on CAF compared with PLA (main effect 
of trial, P<0.05). CAF was associated with significantly elevated plasma IL-6 
response at post-exercise (P<0.05), which may in part be the result of an increased 
adrenaline response at post-exercise on the CAF trial (P<0.05). There was no effect of 
CAF on circulating leukocyte or neutrophil count but lymphocyte count was 
significantly higher at pre-exercise on CAF (P<0.05). The RPE of participants was 
significantly lower during the exercise protocol on CAF than PLA (main effect of 
trial, P<0.01). Therefore, although CAF ingestion was associated with an increase in 
adrenaline, this was not associated with an expected decrease in neutrophil function. 
This suggests that in the present study, CAF ingestion influenced neutrophil oxidative 
burst responses via alternative mechanisms. 
102 
Chapter 6 
6.2. Introduction 
The neutrophil oxidative burst response consists of a pathway of complex events and 
results in the formation of 02-" anions via the activation of the NADPH oxidase 
(Peake, 2002). A cascade of reactions may follow forming ROS and other reactive 
species (Pyne, 1994). Neutrophils are activated by both protein kinase C-mediated 
and receptor-coupled mechanisms (Peake, 2002). PMA is known to directly activate 
protein kinase C in blood neutrophils (Lopez et at., 1995) producing a prolonged and 
maximum response. f-MLP on the other hand, acts via aG protein-coupled receptor 
(Lopez et al., 1995) invoking a quicker yet more subtle response than PMA. The 
stimulant used to initiate the oxidative burst has been proposed as a factor for the 
equivocal findings that are frequently published in the literature (Peake, 2002). 
The findings of the study described in Chapter 5 demonstrated that there was no effect 
of caffeine ingestion on PMA-stimulated neutrophil oxidative burst responses 
following 90 min cycling at 70% '°2 max . It has been reported that the PMA- 
stimulated neutrophil response is 
insensitive to cAMP elevating agents such as 
adenosine or ß-adrenergic agonists (Bengis-Garber et al., 1996; Tintinger et al., 
2001), suggesting that PMA is not a suitable stimulant for investigating the influence 
of caffeine ingestion on neutrophil oxidative burst reponses. When neutrophils are 
stimulated by f-MLP however, adenosine is widely reported to inhibit the oxidative 
burst response (Cronstein et al., 1983; 1985; 1990; Thibault et al., 2002; Swain et al., 
2003), mediating these effects via the A2A adenosine receptor expressed on neutrophil 
cell surfaces (Thibault et al., 2000; Gessi et al., 2002). The methylxanthine caffeine is 
a non-selective adenosine receptor antagonist with affinity in the µmol. L" range 
(Ongini and Fredholm, 1996). Furthermore, it has been reported that neutrophil 
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activation is inhibited following 0-2 adrenoreceptor stimulation (Chilcoat et al., 2002) 
and catecholamines are reported to decrease f-MLP stimulated neutrophil oxidative 
burst responses in a dose-dependent manner (Wenisch et al., 1996). 
Therefore, the purpose of the present study was to investigate the influence of caffeine 
ingestion on the f-MLP-stimulated neutrophil oxidative burst response (ie. the 
production of reactive species by neutrophils when stimulated in vitro by f-MLP) 
following prolonged intensive submaximal exercise. It was hypothesised that if 
adenosine receptor antagonism was the predominant mechanism involved, caffeine 
ingestion would attenuate the exercise-induced fall in neutrophil oxidative burst 
responses. However, if an increased adrenaline response was the overriding influence, 
caffeine ingestion would be detrimental to the neutrophil response. 
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6.3. Methods 
Participants 
Eight endurance trained male cyclists (mean ± SEM: age 24 ±1 years; body mass 
72.8 f 2.8 kg; height 1.79 ± 0.03 m, VO2 max 65.6 ± 1.9 ml. kg"l. min', Peak Power 
Output 344 ±5 W) volunteered to participate in the study. Participants were informed 
of the rationale and experimental procedures involved in the study, before providing 
written consent to participate. The study protocol had earlier received approval by 
Loughborough University Ethical Advisory Committee. Average daily caffeine intake 
was 201 ± 38 mg. day'1. One participant was characterised as a light user (< 50 
mg. day''), 4 as moderate users (50-250 mg. day" ) and 3 as having a high caffeine 
intake (> 250 mg. day"1). 
Experimental Procedures 
Preliminary measurements (VOZ max and familiarisation) were conducted within a 
2-week period prior to the start of the main trials. Preliminary measurements and pre- 
trial standardisation procedures are described in Chapter 3. Participants performed 2 
sessions of exercise separated by 7 days. The participants acted as their own controls 
in a repeated-measures, single-blind, counter-balanced, cross-over design and were 
randomly assigned to one of two experimental conditions: ingesting caffeine (CAF) or 
placebo (PLA). Participants arrived at the laboratory at 10.00 am following an 
overnight fast of between 10 and 12 h. Following a void, body mass was recorded 
before participants ingested 6 mg. kg'1 body mass of either CAF or PLA dissolved in 
200 ml no-added sugar pink grapefruit juice drink. After resting quietly for 60 min, 
participants began cycling for 90 min at 70% 
VO2 max . Heart rate and RPE were 
measured every 15 min throughout exercise and 2 ml. kgl body mass of water was 
105 
Chester 6 
administered at these time points. At 20,50 and 80 min of exercise, 1-min expired gas 
samples were collected. Following the cessation of exercise, body mass was recorded 
and participants consumed 3 ml. kg" body mass of water before resting for a further 
60 min. Venous blood samples were obtained at rest, 60 min after CAF or PLA 
ingestion (pre-exercise), immediately post-exercise and at 1h post-exercise. 
Laboratory conditions were 23.5 ± 0.6°C and 42 ± 2% relative humidity. 
Blood analytical methods 
Blood sampling and analyses methods are detailed in Chapter 3.5. 
Statistical analysis 
Statistical analysis methods are detailed in Chapter 3.6. 
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6.4. Results 
Physiological variables and RPE 
There was no difference in overall exercise intensity between trials; mean % 
VOZ max was 72.3 ± 0.6% and 72.0 ± 0.9% on CAF and PLA trials, respectively. 
Following exercise, body mass change (corrected for fluid intake) fell similarly on 
both trials (-2.0 ± 0.2 kg on both CAF and PLA) as did plasma volume (CAF: -12.9 ± 
0.9%, PLA: -12.8 ± 1.9%). Mean heart rate during exercise was similar on both trials 
(160 ±2 beats-min 1 and 162 ±I beats. min 1 on CAF and PLA, respectively). Mean 
RPE throughout the 90-min exercise bout was significantly lower on CAF than PLA 
(CAF: 13.3 ± 0.3, PLA: 14.0 ± 0.2, P<0.01). 
Substrate Oxidation and Energy Expenditure 
Mean RER was similar between CAF and PLA trials during the 90 min exercise 
period (CAF: 0.92 ± 0.01, PLA: 0.92 ± 0.01). CHO oxidation rate decreased during 
the exercise period (main effect of time, P<0.05; Table 6.1) but was similar between 
trials throughout, with mean values of 3.41 ± 0.17 g. miri' and 3.43 ± 0.18 g. miri 
4 on 
CAF and PLA trials, respectively. Similarly there were no significant differences for 
fat oxidation rates between trials (CAF: 0.46 ± 0.03 g. min 
1, PLA: 0.43 ± 0.04 g. min 
1) however, fat oxidation significantly increased throughout the exercise period (main 
effect of time, P<0.05; Table 6.1). 
Mean rate of energy expenditure was similar for both trials with values of 72 ±2 
kJ. min I and 71 ±2 kJ. min' on CAF and PLA respectively. Accordingly, the energy 
derived from the oxidation of CHO (CAF: 54.5 ± 2.7 kJ. min 1, PLA: 54.8 ± 2.9 
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kJ. min 1) and fat (CAF: 17.3 ± 1.6 kJ. min 
1, PLA: 16.7 ± 1.4 kJ. min 1) did not 
significantly differ between trials throughout the exercise period. The energy derived 
from the oxidation of CHO decreased and contribution from fat increased with 
exercise duration (main effect of time, P<0.05). There were no significant differences 
between trials for the percentage contribution of CHO (CAF: 74 ± 3%, PLA: 76 ± 
2%) or fat (CAF: 26 ± 2%, PLA: 24 ± 2%) towards energy expenditure during the 
exercise period. The percentage CHO contribution decreased and fat contribution 
increased as a function of exercise duration (P<0.01). 
Table 6.1: Substrate oxidation rates and contribution towards energy expenditure 
during the exercise period in the CAF and PLA trials. 
Time during Exercise 20 50 80 Mean 
CHO oxidation (g. min"') 
CAF 3.80 (0.31) 3.29 (0.28) 3.13 (0.25) 3.39 (0.20) 
PLA 3.67 (0.35) 3.41 (0.21) 3.23 (0.30) 3.43 (0.18) 
Fat oxidation (g. min-) 
CAF 0.31 (0.06) 0.49 (0.06) 0.57 (0.06) 0.47 (0.04) 
PLA 0.32 (0.06) 0.42 (0.03) 0.51 (0.06) 0.43 (0.04) 
Energy derived from CHO oxidation (kl. min- ) 
CAF 60.9 (5.0) 52.7 (4.4) 50.1 (4.0) 54.3 (3.2) 
PLA 58.8 (5.7) 54.5 (3.4) 51.7 (4.9) 54.8 (2.9) 
Energy derived from fat oxidation (kJ. min- ) 
CAF 10.7 (2.7) 19.1 (2.2) 22.2 (2.2) 17.6 (1.7) 
PLA 12.6 (2.2) 16.2 (1.3) 19.7(2.5) 16.4(1.4) 
contribution to total energy expenditure from CHO 
CAF 82(4) 73 (4) 69 (3) 74(3) 
PLA 81(4) 77 (2) 72 (4) 76 (2) 
% contribution to total energy expenditure from fat 
CAF 18(4) 27(4) 31(3) 27(2) 
PLA 19(4) 23 (2) 28 (4) 24(2) 
108 
Chapter 6 
Blood metabolites and hormones 
Serum caffeine was significantly higher at pre-exercise, post-exercise and 1h post- 
exercise on CAF compared with PLA (all P<0.01; Figure 6.1). Plasma adrenaline 
concentration was higher than rest at post-exercise on both trials (P<0.05). At this 
time, plasma adrenaline concentration was significantly higher on CAF than PLA 
(P<0.05; Figure 6.2). Plasma noradrenaline concentration was significantly higher 
than rest at post-exercise (P<0.01; Table 6.2) but there were no significant differences 
between CAF and PLA trials. A significant main effect of trial (P<0.01) for plasma 
cortisol was observed with values significantly higher on CAF compared with PLA 
(mean values were 489 ± 34 nmol. L" and 391 ± 25 nmol. L'1 on CAF and PLA 
respectively; Table 6.2). Plasma FFA was significantly higher on CAF compared with 
PLA (mean values were 1.13 ± 0.15 mmol. 1"1 and 0.76 ± 0.11 mmol. l't for CAF and 
PLA respectively, main effect of trial, P<0.05; Table 6.2) whereas there were no 
significant differences for plasma glucose. Plasma lactate concentration was 
significantly higher at post-exercise than rest (P<0.01; Table 6.2) yet this occurred 
independently of the trial followed. 
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Figure 6.1. Serum caffeine concentration on CAF and PLA trials. Significantly 
higher on CAF than PLA at that time point (tt P<0.01). Significantly higher than 
rest within trial (**P<0.01). 
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Figure 6.2. Plasma adrenaline concentration on CAF and PLA trials. Significantly 
higher on CAF than PLA at that time point (t P<0.05). Significantly higher than rest 
within trial (* P<0.05). 
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Table 6.2. Plasma concentrations of noradrenaline, cortisol and blood-borne 
metabolites on CAF and PLA trials. 
Rest Pre Exercise Post Exercise 1h Post 
Noradrenaline (nmol. L') a 
CAF 1.43 (0.18) 1.68 (0.12) 11.66 (1.44) 
PLA 1.59 (0.34) 1.84 (0.30) 8.57 (1.88) 
Cortisol (nmoLL'') $ 
CAF 414 (61) 447 (52) 597 (59) 462 (81) 
PLA 384 (45) 386 (47) 402 (53) 355 (45) 
FFA (mmoLL"') b 
CAF 0.32 (0.06) 0.70 (0.10) 1.71 (0.22) 1.78 (0.30) 
PLA 0.29 (0.05) 0.25 (0.05) 1.28 (0.14) 1.23 (0.19) 
Glucose (mmol. L"1) 
CAF 5.5 (0.2) 5.8 (0.2) 5.7 (0.2) 5.5 (0.3) 
PLA 5.5 (0.3) 5.5 (0.3) 5.3 (0.2) 5.0 (0.2) 
Lactate (mmol. L'r) 
CAF 1.3 (0.1) 1.6 (0.2) 3.8(0.6) - 
PLA 1.2 (0.1) 1.5 (0.3) 2.7 (0.2) - 
Main effect of trial, significantly higher on CAF than PLA ($ P<0.01, t P<0.05). 
b Main effect of time, significantly higher than rest at post-exercise and 1h post- 
exercise (P<0.01). a'` Main effect of time, significantly higher than rest at post- 
exercise (P<0.01). 
Total and differential leukocyte counts 
All participants had resting total and differential leukocyte counts within the normal 
range for healthy adults. There was a significant leukocytosis and neutrophilia evident 
at post-exercise and 1h post-exercise (main effect of time; P<0.01; Table 6.3) but 
there were no significant differences between CAF and PLA trials. At pre-exercise, 
circulating lymphocyte count was significantly higher on CAF compared with PLA 
(P<0.05; Table 6.3). Immediately post-exercise, a marked lymphocytosis was evident 
on both trials that reached statistical significance on CAF trial only (P<0.05) and a 
lymphocytopenia was observed at 1h post-exercise. There was a significant main 
effect of time for the neutrophil/lymphocyte ratio with higher values at Ih post- 
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exercise compared to rest, pre and post-exercise values (P<0.01), yet this occurred 
independently of the trial followed. 
Table 6.3. Total and differential blood leukocyte counts and the 
neutrophil/lymphocyte ratio on CAF and PLA trials. 
Rest Pre-Exercise Post-Exercise 1h Post 
Leukocytes (x 10U-1) a 
CAF 4.6 (0.3) 5.0 (0.4) 8.7 (0.7) 12.0 (1.2) 
PLA 4.8 (0.3) 4.8 (0.3) 8.0 (0.9) 10.1 (1.1) 
Neutrophils (x 109. L"') a 
CAF 2.3 (0.2) 
PLA 2.5 (0.2) 
Lymphocytes (x 109 L"1) 
CAF 1.64 (0.16) 
PLA 1.71 (0.17) 
2.6 (0.3) 5.5 (0.5) 9.4 (1.1) 
2.7 (0.3) 5.3 (0.9) 7.7 (1.0) 
1.79 (0.17) *t 2.37 (0.26)* 1.53 (0.17) 
1.56 (0.14) 2.00 (0.25) 1.54 (0.17) 
Neutrophil/Lymphocyte ratio b 
CAF 1.5 (0.1) 1.4 (0.2) 2.2 (0.2) 6.4 (0.9) 
PLA 1.5 (0.2) 1.8 (0.3) 2.5 (0.5) 5.3 (0.6) 
Significantly higher on CAF than PLA at that time point (tP<0.05). Significantly 
higher than resting values within trial (*P<0.05). a Main effect of time, significantly 
higher at post-exercise and 1h post-exercise than rest (P<0.01). b Main effect of time, 
significantly higher at 1h post-exercise than rest, pre and post-exercise (P<0.01). 
Neutrophil Function 
The peak neutrophil CL response to f-MLP stimulation decreased following the 
exercise period, but was significantly lower at post-exercise compared with rest and 
pre-exercise values on the PLA trial only (both P<0.01; Figure 6.3). When peak 
neutrophil CL was expressed as percentage of baseline response, values were 
significantly higher on CAF compared with PLA (main effect of trial: P<0.05; Figure 
6.4). 
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Figure 6.3. Neutrophil oxidative burst response expressed as peak CL values in relative 
light units (RLU) following f-MLP stimulation. Significant decrease from rest within 
trial (** P<0.01). Significant decrease from pre-exercise within trial ( P<0.01). 
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Figure 6.4. f-MLP stimulated neutrophil oxidative burst (peak CL) expressed as % of 
baseline response. Main effect of trial (P = 0.019). 
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IL-6 
There were no differences in IL-6 concentration between rest and pre-exercise (ie. 60 
min following CAF or PLA ingestion). Plasma IL-6 concentration increased 
significantly on both trials following the exercise bout (P<0.01). At this time (post- 
exercise), plasma IL-6 concentration was significantly higher on CAF than PLA 
(CAF: 5.2 ± 0.8 ng. L-1; PLA: 3.3 ± 0.8 ng. U', P<0.05; Figure 6.5), which 
corresponded to a 436 ± 81% and 249 ± 43% change from pre-exercise values on the 
CAF and PLA trials, respectively. 
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Figure 6.5. Plasma IL-6 concentration. Significantly higher on CAF than PLA at 
that time point (t P<0.05). Significantly higher than rest within trial (** P<0.01, 
P<0.05). 
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6.5. Discussion 
The major finding of the present study suggests that caffeine (6 mg. kg" body mass) 
attenuated the exercise-induced fall in f-MLP-stimulated neutrophil oxidative burst 
response when ingested 60 min prior to cycling for 90 min at 70% V02 max . At post- 
exercise, f-MLP-stimulated neutrophil oxidative burst responses (as indicated by peak 
CL values) were significantly decreased after the PLA trial only. A decline in f-MLP- 
stimulated response following exercise has been previously reported (Scharhag et al., 
2002). This finding cannot be explained as a diurnal effect as a resting control study 
(Chapter 4) used the same treatment and time course as that employed in the current 
study. The results of Chapter 4 demonstrated that there were no significant changes in 
f-MLP-stimulated neutrophil oxidative burst response over time, or differences 
between the CAF and PLA trials when exercise is not performed. 
A study conducted by Sullivan and colleagues (1995) reported that caffeine had no 
direct action on the in vitro f-MLP stimulated neutrophil CL response; however, 
caffeine enhanced the response when neutrophils had been previously treated with 
physiological concentrations of adenosine. In the present study, when expressing the 
f-MLP stimulated neutrophil oxidative burst data as a% decline from resting values, a 
main effect of trial was found with higher neutrophil oxidative burst responses on 
CAF than PLA. Although plasma adenosine concentration was not measured in the 
present study, it is known that adenosine is produced during ATP metabolism and is 
increased during times of metabolic stress such as exercise (Vizi et al., 2002; Chouker 
et al., 2005). Adenosine produced intracellularly or formed extracellularly, diffuses to 
cell membranes of surrounding cells where it binds to adenosine receptors. Acting via 
A2A receptors expressed on neutrophils, adenosine is known to inhibit phagocytosis 
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and neutrophil 02-" generation (Cronstein et at, 1985; 1990; Gessi et at., 2002; 
Thibault et at., 2002). Specifically, in vitro studies have shown that incubation with 
relatively low physiological concentrations of adenosine (100 nmol. L'1) for 3 to 5 min 
can reduce f-MLP stimulated neutrophil oxidative burst responses by approximately 
40% (Cronstein et al., 1985; Swain et al., 2003). Furthermore, Chouker et al., (2005) 
observed a significant inverse relationship between in vivo plasma adenosine 
concentration and ex vivo neutrophil oxidative burst response following f-MLP 
stimulation. These negative effects may be caused by an increased synthesis of cAMP 
(Thibault et at., 2000), an inhibition of PL-D activation (Thibault et at., 2002) or a 
redistribution of a key component of the NADPH oxidase, Flavocytochrome b (Swain 
et at., 2003). 
The potency of caffeine to antagonise A2A receptors occurs at a K; of 40-44 µmo1. L"1 
(Daly, 1993). In the present study, the caffeine concentrations measured at pre, post 
and 1h post-exercise were 53 gmol. L'', 46 gmol. L'' and 42 µmol. L"1 respectively, 
suggesting that caffeine may possibly inhibit the occupancy and/or activation of A2A 
adenosine receptors. Since inhibition of oxidative burst is predominantly AZA- 
mediated (Gessi et al., 2002) it could be argued that in the present study, caffeine 
attenuated the post-exercise decline in neutrophil oxidative burst response following 
f-MLP-stimulation by inhibiting the occupancy and/or activation of A2A adenosine 
receptors. Alternatively, it could be argued that caffeine affects the intracellular 
calcium signalling process at post-exercise following stimulation with f-MLP. It is 
reported that post-exercise decreases in neutrophil oxidative burst responses are 
related to a decoupling of intracellular calcium signalling with cellular function, 
suggesting a blockade in intracellular signalling pathways (Mooren et al., 2001). In 
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the present study, caffeine may have interfered with this blockade leading to further 
effects downstream on the signalling pathway and the observed attenuation of the 
post-exercise neutrophil oxidative burst response. 
It has been suggested that elevated concentrations of adrenaline stimulate 0-2 
adrenoreceptors expressed on neutrophils (Weiss et al., 1996; Tintinger et at., 2000), 
activating adenyl cyclase and inducing the synthesis of cAMP (Chilcoat et al., 2002; 
O'Dowd et al., 2004). An increase in cAMP has been shown to specifically inhibit 
neutrophils stimulated with f-MLP (Yu et at., 1995) via activation of PKA and 
suppression of PLA2-dependent arachidonic acid production (O'Dowd et al., 2004). It 
has frequently been reported that adrenaline can inhibit f-MLP stimulated neutrophil 
oxidative burst response in a dose-dependent manner (Weiss et al., 1996; Tintinger et 
at., 2001; O'Dowd et al., 2004). In the present study, CAF was associated with a 
significant increase in plasma adrenaline concentration above values on PLA after 
exercise but there were no differences between trials for noradrenaline concentration, 
which is consistent with previous findings (Tamopolsky et al., 1989; Graham and 
Spriet, 1991; Jackman et al., 1996; Graham et at., 1998; Bishop et al., 2005). 
However, the elevated levels of adrenaline did not appear to inhibit oxidative burst 
response following stimulation with 
f-MLP. It has been reported that an adrenaline 
concentration of 5 nmol. L"' significantly inhibits f-MLP-stimulated neutrophil 
oxidative burst response in humans (O'Dowd et al., 2004). However, in the present 
study, post-exercise adrenaline values were only 2.8 nmol. L-1 and 1.3 nmol. L'' for the 
CAF and PLA trials, respectively. It is likely that any effect of caffeine is multi- 
factorial and the net result of a number of positive and negative influences. In the 
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present study, there may be a stronger influence on neutrophils from A2A adenosine- 
receptor antagonism than a catecholamine effect. 
Caffeine ingestion did not affect the leukocyte and neutrophil counts in response to 
exercise yet it was associated with a significant increase in circulating lymphocyte 
number at pre-exercise (i. e. 1h following caffeine ingestion). Similar findings were 
reported in Chapter 5 in which the same method of caffeine administration, exercise 
protocol and sampling time points were used. As previously discussed, an increase in 
circulating lymphocyte count may be due to the elevated plasma adrenaline 
concentration at this time point altering endothelial adhesion via activation of ß- 
adrenoreceptors present on lymphocytes. 
In accordance with frequently reported findings, plasma IL-6 concentration was 
significantly elevated following exercise (Nehlsen-Canarella et al., 1997; Bishop et 
at., 2001b; Starkie et at., 2001; Febbraio et at., 2003 amongst numerous others). The 
magnitude of the increase however (approximately 3-fold), was much smaller than 
previous reports of 20 to 30-fold increases following 60 to 150 min of submaximal 
intensity exercise (Nieman et at., 1998; Starkie et al., 2001; Steensberg et al., 2001). 
Plasma IL-6 concentration was significantly higher at post-exercise on CAF compared 
with PLA. As adrenaline concentration at this time was also significantly higher on 
CAF than PLA, it may be speculated that adrenaline lead to an increased IL-6 
production. Increases in adrenaline concentration have previously been related to 
increased IL-6 production in both rats (Yu et at., 2001; Frost et al., 2004) and humans 
(Sondergaard et al., 2001; Papanicolaou et al., 1996). Adrenaline infusion at 
concentrations that are reached during strenuous exercise has been reported to elicit a 
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6-fold increase in plasma IL-6 concentration (Steenberg et al., 2001). In this study 
the IL-6 response was of a significantly lower magnitude than that observed following 
strenuous exercise and the authors' concluded that adrenaline plays a relatively minor 
role in stimulating IL-6 during exercise (Steensberg et at., 2001). Alternatively, 
adrenaline may affect IL-6 clearance from the circulation in humans. It is known that 
hepatosplanchnic viscera remove IL-6 from the circulation (Febbraio et at., 2003) thus 
adrenaline mediated vasoconstriction of hepatosplanchic viscera may augment the 
level of IL-6 through a decreased rate of clearance. Furthermore, adenosine receptors 
are present on smooth muscle of various organs such as the liver (Graham, 2001a), 
therefore a vasoconstriction due to adenosine-receptor antagonism by caffeine may 
also contribute to reduced clearance of IL-6 from the systemic circulation. 
CAF was associated with a lower RPE response compared with PLA (mean RPE was 
13.3 ± 0.3 and 14.0 ± 0.2 on CAF and PLA respectively, main effect of trial). An 
attenuated RPE during submaximal-exercise following caffeine ingestion has been 
consistently reported (Cole et al., 1996; Cox et al., 2002; Doherty et al., 2004; 
Doherty and Smith, 2005). It has been suggested that caffeine may alter the release, 
binding or activity of neurotransmitters in the brain (Davis et al., 2003), release j3- 
endorphins into plasma during physical exertion (Laurent et al., 2000) and reduce 
feelings of leg muscle pain during exercise (O'Connor et al., 2004). In addition, mood 
states and feelings of pleasure during exercise are increased following caffeine 
ingestion (Backhouse et al., 2004 ). 
In summary, the main findings of this study indicate that caffeine ingestion attenuated 
the exercise-induced fall in f-MLP-stimulated neutrophil oxidative burst response 
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(measured as peak CL values). Although caffeine ingestion was associated with an 
increase in plasma adrenaline concentration, it would appear that this is not the major 
pathway by which caffeine affected neutrophil function in this study. This suggests 
that other actions of caffeine may have exerted a stronger influence here. 
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Chapter 7 
The effect of caffeine ingestion on 
immunoendocrine responses following time-trial 
cycling. 
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7.1. Abstract 
Following high-intensity, fixed duration exercise, caffeine ingestion has been 
associated with an attenuation of the exercise-induced decline in f-MLP-stimulated 
neutrophil oxidative burst response (i. e. the capacity to generate reactive oxygen 
species in response to in vitro stimulation). However, the response following high- 
intensity exhaustive exercise is unknown. In this study, nine highly endurance-trained 
male cyclists (mean ± SEM: age 23 ±1 years; body mass 67.4 ± 1.7 kg; 'O2 max 
71.2 f 2.3 ml. kg 1. min 1; Peak Power Output 362 ± 13 W) ingested 6 mg. kg"1 body 
mass of caffeine (CAF) or placebo (PLA) 60 min before cycling for 90 min at 70% 
VO2 max. This was followed by a time-trial (TT) requiring an energy expenditure 
equivalent to cycling for 30 min at 70% Wmax. Participants completed the TT faster 
in CAF than PLA, resulting in a 4% improvement in performance (P<0.05). CAF was 
associated with increased plasma adrenaline concentration at post-90 min and post-TT 
(P<0.05) and increased serum caffeine concentration (P<0.01, at all time points), yet 
there were no significant differences observed for f-MLP-stimulated neutrophil 
oxidative burst responses. CAF was also associated with significantly increased 
plasma IL-6 concentration at post-TT compared with PLA (P<0.05) but had no effect 
on IL-ira concentration. There was no effect of CAF on circulating leukocyte or 
neutrophil count, but lymphocyte count was significantly higher at post-TT on PLA 
(P<0.05). These data suggest that high-intensity exhaustive exercise negates the 
attenuation of the exercise-induced decline in the f-MLP-stimulated neutrophil 
oxidative burst response previously observed when caffeine is ingested prior to 
exercise of fixed duration and intensity. This may be associated with the greater 
increase in adrenaline concentration observed in the present study. 
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7.2. Introduction 
Athletes commonly consume caffeine as an ergogenic aid (Tarnopolsky, 1994). The 
use of caffeine is highly prevalent in the sport of amateur and professional cycling 
(Martin, 1997). Following the relatively recent removal of caffeine from WADA list 
of prohibited substances, its usage is expected to increase considerably amongst 
athletes during periods of training and competition. Laboratory based studies have 
reported increases in performance following the ingestion of 3-6 mg. kg"1 body mass 
of caffeine. For example, 6 mg. kg"t body mass of caffeine was associated with a 3.4% 
increase in performance time to completion of a pre-loaded TT (Cox et al., 2002) 
while divided caffeine doses have also been shown to enhance pre-loaded TT 
performance (Kovacs et at., 1998; Conway et at., 2003). It has been reported however, 
that similar caffeine doses have not altered performance during a 100 km cycling TT 
(Hunter et al., 2002). 
There is limited published literature that has looked specifically at the effects of 
caffeine ingestion on neutrophil oxidative burst responses following exercise. It has 
previously been reported (Chapter 6) that caffeine ingestion attenuated the decline of 
f-MLP stimulated neutrophil oxidative burst responses observed at post-exercise 
following submaximal intensity cycling of fixed duration. Since caffeine and its 
derivatives are potent adenosine receptor antagonists (Ongini & Fredholm, 1996) the 
attenuated decline was hypothesised to have been due to caffeine acting to antagonise 
A2A adenosine receptors expressed on neutrophils. The occupancy of A2A receptors is 
linked to an increase in cAMP (Thibault et al., 2002), inhibition of PL-D activation 
(O'Dowd et al., 2004) and a redistribution of Flavocytochrome b (Swain et al., 2003); 
all factors that may contribute to the 
inhibition of the f-MLP stimulated neutrophil 
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oxidative burst response which occurs following the incubation of neutrophils with 
physiological concentrations of adenosine (Cronstein et al., 1985; Swain et al., 2003). 
Caffeine ingestion also increases plasma adrenaline concentration (Graham, 2001a). 
Stimulation of neutrophil 0-2 adrenoreceptors by adrenaline activates adenyl cyclase 
and induces cAMP synthesis which has been demonstrated to inhibit the activation of 
neutrophils (Chilcoat et al., 2002). It is reported that catecholamines decrease 
neutrophil ROS production in a dose-dependent manner at pharmacological (-65 
mnol. L"1) (Wenisch et al., 1996). At physiological concentrations, however, 
adrenaline (5 nmol. L't) inhibits f-MLP-stimulated 02-" release (O'Dowd et al., 2004) 
and the reported decline in neutrophil oxidative burst activity following exercise is 
attributed to elevated concentrations of adrenaline (Hack et al., 1994). 
Given this information and the reported ergogenic benefit of caffeine ingestion on TT 
performance, the aim of the study was to investigate the influence of 6 mg. kg-1 body 
mass of caffeine on f-MLP-stimulated neutrophil oxidative burst responses (i. e. the 
capacity to generate ROS in response to in vitro stimulation) following a TT after 90 
min cycling at 70% 
V02 max . 
It is well known that the magnitude of adrenaline 
release is related to the intensity of exercise (Kotchen et al., 1971); therefore, the 
current study was designed to determine the effect of caffeine ingestion on neutrophil 
oxidative burst responses when adrenaline concentration increases to a greater extent 
than during prolonged submaximal exercise of fixed intensity. It was hypothesised 
that a higher adrenaline concentration following the TT may become the predominant 
mechanism mediating the f-MLP-stimulated neutrophil oxidative burst response, and 
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thus may negate the attenuating effects of caffeine ingestion previously observed 
following submaximal exercise of fixed duration. 
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7.3. Methods 
Participants 
Nine highly-endurance trained male cyclists (mean f SEM: age 23 f1 years; height 
1.77 ± 0.03 m; body mass 67.4 ± 1.7 kg; VO2 max 71.2 ± 2.3 ml. kg''. miri-'; Peak 
Power Output 362 ± 13 W) volunteered to participate in the study. Participants were 
informed of the rationale and experimental procedures involved in the study, before 
providing written consent to participate. The study protocol had earlier received 
approval by Loughborough University Ethical Advisory Committee. Average daily 
caffeine intake was 172 ± 66 mg. day''. Three participants were characterised as light 
users (< 50 mg. day'1), 4 as moderate users (50-250 mg. day'') and 2 as having a high 
caffeine intake (> 250 mg. dayy1). 
Experimental procedures 
Preliminary measurements (VO2 max and familiarisation) were conducted within a 
2-week period prior to the start of the main trials. Preliminary measurements and pre- 
trial standardisation procedures are described in Chapter 3. This preliminary period 
also allowed the participants to familiarise themselves with the TT protocol that was 
to be used in the main experimental trials as a performance measure. The TT was 
performed on an electromagnetically braked ergometer interfaced with a computer 
and required the participants to complete a predetermined quantity of work (in joules) 
equal to cycling for 30 min at 70% Wmax, as described by Jeukendrup et al. (1996). 
Participants performed 2 sessions of exercise separated by 7 days. The participants 
acted as their own controls in a repeated-measures, single-blind, cross-over design 
and were randomly assigned to one of two experimental conditions: ingesting caffeine 
(CAF) or placebo (PLA). Participants arrived at the laboratory at 10.00 am following 
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an overnight fast of between 10 and 12 h. Following a void, body mass was recorded 
and a resting blood sample obtained, before participants ingested 6 mg. kg'1 body mass 
of either CAF or PLA dissolved in 200 ml no-added sugar pink grapefruit juice drink. 
After resting quietly for 60 min, participants began cycling for 90 min at 
70% "°2 max . 
Heart rate and RPE were measured every 15 min throughout exercise 
and 2 ml. kg-1 body mass of water was administered at these time points. At 20,50 and 
80 min of exercise, 1-min expired gas samples were collected. A further blood sample 
was collected immediately post-90 min exercise. 
Immediately following the post-90 min exercise blood sample, participants completed 
a TT that required them to complete a predetermined amount of work corresponding 
to an energy expenditure equivalent to cycling for 30 min at 70% Wmax. Participants 
were given an instruction to complete the amount of work as quickly as they were 
able to do so. During the TT, the only on-screen information available to the 
participants was the total amount of work (joules) that they had completed, the 
percentage of the work they had completed and a general profile of their power output 
to provide an indication of their progress. Feedback such as total exercise time, pedal 
cadence, power output and heart rate was not available to the participants. No 
motivational factors (i. e. music, encouragement etc. ) were permitted during the TT. 
Heart rate was recorded at 5-min intervals and water was available ad libitum during 
the TT. Upon completion of the TT, a blood sample (post TT) was obtained and body 
mass (shorts only) was recorded. Following this, participants consumed 3 ml. kg'1 
body mass of water and rested for a further 60 min before a final blood sample was 
taken (1 h post TT). Laboratory conditions were 17.3 f 0.3°C and 46 f 2% relative 
humidity. 
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Blood analytical methods 
Blood sampling and analyses methods are detailed in Chapter 3.5. In addition to these 
procedures, IL-ira was determined from K3EDTA plasma using a commercially 
available ELISA method (R &D Systems Inc., Abingdon, Oxfordshire, UK). 
Statistical analysis 
In addition to the statistical analysis methods detailed in Chapter 3.6, associations 
between plasma adrenaline concentration and f-MLP-stimulated neutrophil oxidative 
burst responses were determined using Pearson's Product Moment correlation and 
linear regression analysis. 
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7.4. Results 
Physiological variables and RPE 
Following the exercise protocol, body mass change (corrected for fluid intake) fell 
similarly on both trials (-2.1 ± 0.2 kg and -2.0 ± 0.2 kg on CAF and PLA, 
respectively) as did plasma volume (CAF: -10.4 ± 1.8%, PLA: -11.7 ± 2%). There 
was no difference in overall exercise intensity during the 90 min steady state exercise 
between trials; mean % VO2 max was 73.7 ± 0.6% and 72.6 ± 0.5% on CAF and PLA 
trials, respectively. Mean heart rates during the 90 min exercise were similar between 
the two experimental conditions (158 ±2 beats. miri 
1 and 160 ±I beats. min 1 on CAF 
and PLA, respectively) as were mean perceived ratings of exertion (RPE; CAF: 11.9 
± 0.1, PLA: 12.3 ± 0.2). Significant main effects of time were found for both heart 
rate and RPE (P<0.01) with values increasing as a function of exercise duration. 
Substrate Oxidation and Energy Expenditure 
There was no significant difference between the two experimental conditions for RER 
during the first 90 min of exercise (0.93 ± 0.01 on CAF and PLA, mean of all 
recordings). CHO oxidation rates were similar between trials throughout the exercise 
bout with mean values of 3.58 ± 0.16 g. min 
1 and 3.55 ± 0.13 g. miri' on CAF and 
PLA trials respectively (Table 7.1). Similarly there were no significant differences for 
fat oxidation rates between trials (CAF: 0.39 ± 0.06 g. min 
1, PLA: 0.38 ± 0.04 g. min 
however, fat oxidation significantly increased throughout the 90 min exercise 
period (P<0.05; Table 7.1). Mean rates of energy expenditure was similar on both 
trials with values of 73 ±2 kJ. miri 
1 and 71 ±I kJ. miii 1 on CAF and PLA 
respectively. Likewise, the energy derived from the oxidation of CHO (CAF: 57.3 ± 
2.7 kJ. miri t, PLA: 56.5 ± 2.1 kJ. min 
t) and fat (CAF: 15.4 ± 2.2 kJ. min 1, PLA: 14.9 
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± 1.4 kJ. miri ") did not significantly differ between trials throughout the 90 min 
exercise period, but the energy derived from the oxidation of fat increased throughout 
this period (P<0.05; Table 7.1). There were no significant differences between trials 
for the % contribution to total energy expenditure from CHO (CAF: 78 ± 3%, PLA: 
79 ± 2%) or fat (CAF: 22 ± 3%, PLA: 21 ± 2%) during the 90 min steady state 
exercise bout. However, the contribution from fat increased and CHO contribution 
decreased as the exercise duration increased (both P<0.05; Table 7.1). 
Table 7.1: Substrate oxidation rates and contribution towards energy expenditure 
during the steady state exercise period in the CAF and PLA trials. 
Time during Exercise 20 50 80 Mean 
CHO oxidation (g. min') 
CAF 3.80 (0.27) 3.65 (0.36) 3.30 (0.25) 3.58 (0.16) 
PLA 3.69 (0.20) 3.55 (0.28) 3.35 (0.21) 3.55 (0.13) 
Fat oxidation (g. min"') 
CAF 0.29 (0.06) 0.36 (0.10) 0.54 (0.11) 0.39 (0.06) 
PLA 0.30 (0.07) 0.40 (0.08) 0.43 (0.04) 0.38 (0.04) 
Energy derived from CHO oxidation (kJ min") 
CAF 60.8 (4.3) 58.3 (5.8) 52.9 (4.0) 57.3 (2.7) 
PLA 59.1(3.2) 56.7 (4.5) 53.6 (3.4) 56.5 (2.1) 
Energy derived from fat oxidation (7cJ. min 
1) 
CAF 11.2 (2.5) 13.9 (3.8) 21.1 (4.3) 15.4 (2.2) 
PLA 11.9 (2.4) 15.7 (1.7) 17.0 (1.4) 14.9(l. 4) 
% contribution to total energy expenditure 
from CHO 
CAF 84 (4) 80 (4) 72 (3) 78 (3) 
PLA 83 (3) 78 (4) 76 (3) 79 (2) 
% contribution to total energy expenditure 
from fat 
CAF 16(4) 20(6) 28 (5) 22(3) 
PLA 17(3) 22(4) 25(3) 21(2) 
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Time-Trial Performance 
Participants completed the 17 faster in the CAF (27.1 ± 0.6 min) compared with PLA 
trial (28.2 ± 0.7 min, P<0.05). This corresponded to a 4% improvement in TT 
performance. Mean power output during the TT was 282 ± 14 W and 271 ± 15 W in 
the CAF and PLA trials, respectively. Mean heart rate during the TT tended to be 
higher on CAF compared with PLA but this did not reach statistical significance (177 
±2 beats. miri 1 and 175 ±I beats. min'1 on CAF and PLA, respectively, P=0.064). 
Blood metabolites and hormones 
Serum caffeine was significantly higher at post-90 min, post-TT and at 1h post-TT on 
CAF compared with PLA (all P<0.01; Figure 7.1). Plasma adrenaline was 
significantly increased from rest at post-90 min and immediately post-TT on both 
trials (P<0.01). However, at these time points, plasma adrenaline concentration was 
significantly higher on CAF compared with PLA (both P<0.05: Figure 7.2). Plasma 
cortisol concentration was higher than resting values at post-TT on both CAF and 
PLA trials '(P<0.01; Table 7.2). At Ih post-TT, plasma cortisol concentration tended 
to be higher on CAF than PLA (P = 0.054). There were no significant differences 
between CAF and PLA trials for plasma free fatty acid (FFA) concentration. At Ih 
post-TT, plasma glucose concentration was significantly lower than resting values on 
PLA trial only (P<0.01; Table 7.2) and at immediately post-TT, plasma lactate 
concentration tended to be higher on CAF than PLA (P = 0.051; Table 7.2). 
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Figure 7.1. Serum caffeine concentration on CAF and PLA trials. Significantly higher 
on CAF than PLA at that time point (tt P<0.01). Significantly higher than rest within 
trial (** P<0.01). 
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Figure 7.2. Plasma adrenaline concentration on CAF and PLA trials. Significantly 
higher on CAF than PLA at that time point (t P<0.05). Significantly higher than rest 
within trial (** P<0.01). 
132 
Chapter 7 
Table 7.2. Plasma concentrations of cortisol and blood-borne metabolites on CAF and 
PLA trials. 
Rest Post-90 min Post-TT 1h Post-TT 
Cortisol (nmo1. L' ) 
CAF 388(30) 478 (27) 590 (23)** 597 (38)** 
PLA 421 (44) 469 (29) 598 (25)** 497 (22) 
FFA (mmoLL'') $ 
CAF 0.23(0.04) 1.19 (0.15) 1.08 (0.13) 1.60 (0.19) 
PLA 0.21 (0.03) 0.93 (0.11) 1.07 (0.12) 1.38 (0.18) 
Glucose (mmol. L"! ) 
CAF 4.7 (0.1) 4.9 (0.1) 6.1 (0.6) 4.7 (0.3) 
PLA 4.8 (0.1) 5.0 (0.1) 5.1 (0.5) 4.1 (0.1)** 
Lactate (mmol. L"') 
CAF 0.9 (0.1) 2.6 (0.3)** 9.3 
PLA 1.3 (0.2) 2.1 (0.2)** 6.6 (1.0)** 
Significantly different from rest within trial (**P<0.01). $ Main effect of time, 
significantly higher than rest at all time points (P<0.01). 
Total and differential leukocyte counts 
All participants had resting total and differential blood leukocyte counts within the 
normal range for healthy adults. 
There was a significant leukocytosis and neutrophilia 
evident at post-90 min, post-TT and 
1h post-TT (main effect of time; P<0.01; Table 
7.3) but there were no significant differences between CAF and PLA trials. A 
significant lymphocytosis occurred on 
both trials at post-90 min (P<0.01); however, 
at post-TT, values were significantly 
higher on PLA than CAF (P<0.05; Table 7.3). 
There was a significant main effect of time (P<0.01; Table 7.3) for the 
neutrophilllymphocyte ratio with 
higher values calculated at post-TT than at rest and 
post-90 min. A further 
increase was evident at 1h post-TT which occurred 
independent of trial. 
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Table 7.3. Total and differential blood leukocyte counts and the 
neutrophil/lymphocyte ratio on CAF and PLA trials. 
Rest Post-90 min Post-TT 1h Post-TT 
Leukocytes (x WE) $ 
CAF 5.5 (0.3) 8. l(0.5) 13.2 (1.6) 14. g(1.4) 
PLA 5.2 (0.1) 8.3 (0.7) 15.6 (1.4) 15.6 (1.5) 
Neutrophils (x 109. L"') $ 
CAF 2.9 (0.3) 
PLA 2.6(0.1) 
Lymphocytes (x 109. L"') 
CAF 1.90 (0.15) 
PLA 1.86 (0.10) 
5.9 (0.3) 8.1 (1.3) 12.1 (1.3) 
4.9 (0.5) 10.4 (1.2) 12.5 (1.3) 
2.16 (0.18)** 2.98 (0.26)** 1.46 (0.13) 
2.30 (0.23)** 3.61 (0.27)**t 1.55 (0.15) 
Neutrophil/Lymphocyte ratio a 
CAF 1.5 (0.1) 2.4 (0.2) 3.0 (0.4) 8.4 (0.6) 
PLA 1.4 (0.1) 2.3 (0.3) 2.9 (0.3) 8.2 (0.6) 
Significantly higher on PLA than CAF at that time point (t P<0.05). Significantly 
higher than rest within trial (* *P<0.01). Main effect of time, significantly higher than 
rest at all time points ($P<0.01). Main effect of time, significantly higher than rest at 
Post-TT and Ih Post-TT 0 P<0.01). 
Neutrophil Function 
f"MLP-stimulated neutrophil oxidative burst response (as indicated by peak CL) was 
significantly lower at post-90 min, post-TT and 1h post-TT compared with resting 
values (P<0.01; Figure 7.3) but there were no differences between CAF and PLA 
conditions. Neutrophil oxidative burst response (expressed as a% of resting response) 
was significantly lower than rest at post-TT and 1h post-TT (P<0.01; Figure 7.4), yet 
occurred independent of trial. A significant negative correlation was found between 
the increase in plasma adrenaline concentration and neutrophil oxidative burst 
response at post-TT in the CAF trial only (r =-0.836, P<0.01). 
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Figure 7.3. Neutrophil oxidative burst response expressed as peak CL values in relative 
light units (RLU) following f-MLP-stimulation. Main effect of time, significantly lower 
than rest at Post-90, Post-TT and 1h Post-TT (P<O. 01). 
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Figure 7.4. f-MLP-stimulated neutrophil oxidative burst (peak CL) expressed as % of 
baseline response. Main effect of time, significantly lower than rest at Post-TT and I 
hPost-TT (P<O. 01). 
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Cytokine Response 
Plasma IL-6 concentration was significantly higher than resting values at post-90 min, 
post-TT and Ih post-TT on both CAF and PLA trials (P<0.01). At post-TT, plasma 
IL-6 concentration was significantly higher on CAF than PLA (P<0.05; Figure 7.5). 
Plasma IL-6 on CAF increased 22-fold above resting values to 15.2 ± 2.3 ng. L't 
compared with a 17-fold increase in PLA to values of 11.1 ± 1.7 ng. L"'. 
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Figure 7.5. Plasma IL-6 concentration on CAF and PLA trials. Significantly higher 
on CAF than PLA at that time point (t P<0.05), significantly higher than rest within 
trial (** P<0.01). 
Plasma IL-ira concentration was significantly higher than resting values at post-90 
min, post-TT and 1h post-TT on 
both CAF and PLA trials (P<0.05). Plasma IL-Ira 
values peaked at Ih post-TT on 
both trials (CAF: 1226 ± 398 ng. L'', PLA: 755: 6 244 
ng. L'' Figure 7.6); this represented 
increases of 12- and 7- fold on CAF and PLA, 
respectively, but there were no significant 
differences between trials. 
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Figure 7.6. Plasma IL-Ira concentration on CAF and PLA trials. Main effect of time, 
significantly higher than rest at post-90 min, post-TT and 1h post-TT (P<0.05). 
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7.5. Discussion 
The results of the present study demonstrate that ingesting 6 mg. kg" body mass of 
caffeine 60 min prior to the onset of exercise significantly improves pre-loaded TT 
performance following prolonged submaximal intensity cycling. CAF ingestion was 
associated with increased adrenaline concentration at post-90 min and post-TT, yet 
there were no significant differences observed for f-MLP-stimulated neutrophil 
oxidative burst responses following exercise. CAF ingestion was also associated with 
significantly increased IL-6 concentration at post-TT compared with PLA but had no 
effect on IL-Ira concentration. 
The time taken to complete a pre-loaded TT performance test was significantly faster 
on CAF than PLA, corresponding to a 4% improvement in performance. The 
ergogenic effect of caffeine found here is 
in accordance with the findings of a number 
of recent studies (Kovacs et al., 1998; Cox et al., 2002; Conway et al., 2003). It is 
generally agreed that caffeine produces 
its effects at physiological concentrations via 
adenosine receptor antagonism. The antagonism of adenosine receptor subpopulations 
within the central nervous system may explain caffeine's fatigue-delaying effects 
(Davis et al., 2003), by decreasing perceptions of work intensity. In addition, a 
reported increase in the release of 
ß-endorphin associated with caffeine ingestion 
(Laurent et al., 2000) may reduce feelings of pain associated with intense exercise 
(O'Connor et al., 2004). These effects may be reflected here in the 11 W higher 
average power output on CAF 
during the TT performance test. 
There were no significant main effects of caffeine ingestion on f-MLP-stimulated 
neutrophil oxidative burst responses, which fell significantly from resting values 
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following the exercise protocol. A decline in the f-MLP-stimulated response 
following exercise has been previously reported (Scharhag et al., 2002) and may be 
attributed to increases in plasma adenosine and/or adrenaline concentration following 
exercise. Plasma adenosine concentration is reported to increase during exercise (Vizi 
et al., 2002; Chouker et al., 2005) by the dephosphorylation of AMP. As plasma 
adenosine is increased during times of metabolic stress, it is likely to be higher 
following the TT performance test than following submaximal exercise due to the 
higher overall exercise intensity (mean power output was 232 W during steady state 
exercise compared with 276 W during TT); however, plasma adenosine concentration 
was not measured in the present study. 
Caffeine and its metabolites are non-selective neutrophil Al and A2A adenosine 
receptor antagonists (Ongini & Fredholm, 1996). As the potency for caffeine to 
antagonise A2A receptors occurs at a K; of 40-44 gmol. L-t (Daly, 1993), the serum 
caffeine concentrations of 37 µmo1. L't and 34 gmol. L'1 obtained at post-TT and 1h 
post-TT in the present study may not inhibit the occupancy and/or activation of 
neutrophil A2A adenosine receptors and therefore not attenuate the exercise-induced 
response as previously observed (Chapter 6). At immediately post-90 min, however, 
caffeine concentration was 42 gmol. L71 and f-MLP stimulated oxidative burst values 
at this time had only fallen by 9% below resting values on CAF. This is compared 
with a 26% fall on PLA at the same time. However, this difference was not 
statistically significant. 
Neutrophil oxidative burst responses are also influenced by elevations in plasma 
catecholamine concentration, particularly adrenaline (Peake, 2002). It is known that 
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caffeine ingestion increases plasma adrenaline concentration (Graham, 2001a) and 
this is supported by significantly higher values in the present study on CAF than PLA 
at both post-90 min and post-TT. Stimulation of neutrophil 0-2 adrenoreceptors by 
adrenaline activates adenyl cyclase and induces cAMP synthesis, which has been 
demonstrated to inhibit the activation of neutrophils (Chilcoat et al., 2002). At low 
physiological levels adrenaline has little effect on neutrophil oxidative burst responses 
(Wenisch et al., 1996); however, adrenaline at a concentration of 5 nmol. L" has been 
reported to inhibit f-MLP-stimulated 02-" release (O'Dowd et al., 2004). In the 
present study, adrenaline values at post-TT were 5.2 nmol. L'1 and 3.7 nmol. L'1 on 
CAF and PLA trials, respectively, suggesting a possible inhibitory effect on 
neutrophil function in the CAF trial. Moreover, a significant negative correlation was 
found between the increase in plasma adrenaline concentration and f-MLP-stimulated 
neutrophil oxidative burst response at post-TT in the CAF trial. Since the effect of 
caffeine ingestion on neutrophil function following exercise is likely to be multi- 
factorial and the net result of both stimulatory and inhibitory factors, these findings 
may suggest that during high-intensity exhaustive exercise the inhibitory effects of 
adrenaline on neutrophil function occur alongside the potentially positive effects of 
A2A adenosine receptor antagonism by caffeine. Therefore, such negative effects may 
be speculated to effectively cancel out the effects of caffeine that have previously 
been observed following submaximal exercise of a fixed intensity and duration 
(Chapter 6). 
Increases in plasma adrenaline concentration have also been linked to an increased IL- 
6 release into circulation in both rats (Yu et al., 2001; Frost et al., 2004) and humans 
(Papanicolaou et at., 1996). The increase in CAMP production from 0-2 
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adrenoreceptor stimulation has been shown to enhance IL-6 production (Dendorfer et 
al., 1994). IL-6, however, is largely produced in contracting skeletal muscle and is 
released into circulation, where it is reported to produce a number of anti- 
inflammatory effects, one of these being to stimulate the appearance of IL-Ira in the 
circulation (Steensberg et al., 2003). IL-Ira is an anti-inflammatory cytokine, with a 
function to bind to the IL-1 receptor and inhibit the functions of IL-1 (Dinarello, 
1998). 
Plasma IL-6 concentration was significantly elevated at post-90 min, with an 
approximate 20-fold increase at post-TT. The magnitude of IL-6 elevation reported 
here is in accordance with previously reported findings (Nieman et al., 1998; Starkie 
et al., 2001). Plasma IL-6 concentration was significantly higher at immediately post- 
TT on CAF than PLA. It was previously speculated that a significantly higher 
adrenaline concentration on CAF may have lead to an increased IL-6 production 
(Papanicolaou et al., 1996, Sondergard et al., 2000) or may have increased IL-6 
concentration via reduced clearance from the circulation by the hepatosplanchnic 
tissues due to adrenaline mediated vasoconstriction. It has been previously reported 
that following adrenaline infusion at physiological concentrations, the IL-6 response 
is of a lower magnitude than that observed during exercise, leading to the conclusion 
that adrenaline plays a minor role in stimulating IL-6 during exercise (Steenberg et 
al., 2001). It is also reported, however, that adrenaline infusion peaking with a plasma 
adrenaline concentration of 2.1 nmol. 
L"1 caused a 26-fold increase in IL-6 mRNA 
expression in adipose tissue with only a small increase in systemic IL-6 (Keller et al., 
2004). It could be argued therefore, that the higher adrenaline concentration in the 
CAF trial (5.2 nmo1. L"1 vs. 3.7 nmol. L'1) may also increase IL-6 in adipose tissue to a 
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greater extent than the PLA trial without a further increase of systemic IL-6. There 
were no significant effects of caffeine ingestion on plasma IL-Ira concentration 
following exercise. In accordance with previous published literature (Nieman et al., 
1998; Bishop et al., 2001b; Steensberg et al., 2001., Ronsen et al., 2002), plasma IL- 
Ira concentration exhibited a delayed response, peaking at Ih post-TT. Plasma IL-Ira 
concentration increased by 12-fold on CAF compared with a 7-fold increase on PLA. 
However, it is likely that no significant differences between trials were observed due 
to a large inter-individual variation of IL-Ira response in the present study. 
Caffeine ingestion did not affect the total or differential blood leukocyte counts in 
response to exercise, however there was a significant increase in lymphocyte number 
at post-TT on the PLA trial only. At the corresponding time-point, plasma adrenaline 
concentration was significantly higher on 
CAF than PLA. This is in contrast to our 
previous findings and would appear an unusual 
finding as it is known that adrenaline 
can alter endothelial adhesion via activation of ß-adrenoreceptors present on 
lymphocytes, recruiting them into the circulation (Mackinnon, 1999). One possible 
reason for this is a different power output 
distribution between the two conditions in 
the latter stages of the TT. However, upon closer examination of the power output 
profile, which was recorded every 
20 s throughout the TT, one can discount this as 
power output was similar between 
CAF and PLA trials during both the final 10 and 5 
min of the performance test. 
The reason for the increased lymphocytosis at post-TT 
on PLA is therefore unclear. 
In summary, the ingestion of 
6 mg. kg'1 body mass of caffeine 60 min prior to the 
onset of exercise significantly 
improved TT performance following 90 min cycling. 
142 
Chapter 7 
Caffeine ingestion was associated with increased adrenaline concentration at post-90 
min and post-TT, yet there were no significant differences observed for f-MLP- 
stimulated neutrophil oxidative burst responses following exercise. This is in contrast 
to our previous observation of an attenuation of the exercise-induced fall in peak f- 
MLP-stimulated oxidative burst response with caffeine ingestion following 
submaximal intensity exercise of a fixed duration. Therefore, the findings of the 
present study may suggest that during high-intensity exhaustive exercise, adrenaline 
exerts a greater negative influence on neutrophil function. From a performance 
perspective, however, caffeine provided an ergogenic benefit for a TT without 
exacerbating the exercise-induced decline in neutrophil function. 
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Chapter 8 
The effect of physiological concentrations of 
caffeine, adenosine and adrenaline on the 
oxidative burst response of isolated human 
neutrophils in vitro. 
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8.1. Abstract 
The effects of caffeine ingestion on f-MLP-stimulated neutrophil oxidative burst 
responses, reported in the previous experimental chapters were speculated to be the 
net result of adenosine receptor antagonism and adrenaline-mediated inhibition. The 
purpose of the present study was to determine the relative contribution of 
physiological concentrations of adenosine, caffeine and adrenaline on the f-MLP- 
stimulated neutrophil oxidative burst response in an attempt to mimic the conditions 
of the exercise trials. A resting blood sample was obtained by venepuncture from 6 
healthy males (age: 27 ±1 years) following an overnight fast and 60 h abstention 
from caffeine containing products. Neutrophils were separated from whole blood, 
washed and re-suspended in reconstitution and assay buffer at a final concentration of 
Ix 106 neutrophils/ml. The incubation of isolated human neutrophils with 100 
nmol. L'' adenosine for 2 min at 37°C decreased oxidative burst response by 40% 
compared with control (P = 0.001). Following the addition of 50 µmo1. L'' caffeine, 
the response was 9% lower than control but this difference was not statistically 
significant (P = 0.58). The response of neutrophils incubated with adenosine, caffeine 
and adrenaline was 37% and 40% 
lower than control for 2 nmol. L'1(P = 0.002) and 5 
nmol. L'1 (P = 0.002) adrenaline respectively. There was no significant difference in 
the f-MLP-stimulated neutrophil oxidative burst response to the different 
concentrations of adrenaline added to the suspension (P = 0.78). This suggests that 
caffeine attenuates the decline in the 
f-MLP-stimulated oxidative burst response in the 
presence of adenosine alone, 
but not when adrenaline is also present. These findings 
do not easily explain the apparent attenuating effect of caffeine on post-exercise 
neutrophil oxidative burst responses 
(i. e. when both adenosine and adrenaline are 
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present), however, it may be that in this in vitro environment, adenosine may 
potentiate the potency of adrenaline to inhibit the oxidative burst response. 
146 
Chapter 8 
8.2. Introduction 
It is well known that adenosine is produced during adenine nucleotide breakdown and 
that its rate of production is increased during metabolic stress (Klinger et at., 2002; 
Hasko and Cronstein, 2004). An interest in the immunomodulatory effects of 
adenosine arose following the discovery that patients with abnormally high plasma 
adenosine levels due to defective ADA expression developed severe combined 
immuno-deficiency (SCID), characterised by a marked susceptibility to infection 
(Giblett et al., 1972). A number of in vitro studies have shown that adenosine at 
physiological concentrations can inhibit f-MLP-stimulated neutrophil 02-" production 
(Cronstein et al., 1985; Swain et al., 2003). Indeed, a significant inverse relationship 
was observed between in vivo plasma adenosine concentration and ex vivo neutrophil 
02-" production in humans (Chouker et al., 2005). This inhibition by adenosine may 
(Varani et al., 1998) or may not (Cronstein et al., 1988) be due to an increase in the 
`secondary messenger' cAMP. 
Inhibition of neutrophil oxidative burst is predominantly A2A adenosine receptor 
mediated (Gessi et al., 2002). The methylxanthine caffeine is a non-selective 
adenosine receptor antagonist with affinity in the pmol. L"' range (Ongini and 
Fredholm, 1996). In the presence of adenosine (100 nmol. L"1), caffeine increased f- 
MLP-stimulated luminol-enhanced CL but had no effect on 02-" production (Sullivan 
et al., 1995). The findings of Chapter 4 
demonstrated that caffeine ingestion alone 
does not affect the f-MLP or PMA-stimulated neutrophil oxidative burst response in 
humans at rest (i. e. where adenosine concentrations would be very low). 
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Neutrophils are also known to respond to adrenergic agonists in vitro, with increased 
cAMP synthesis and decreased immunological responses (Dulis and Wilson, 1980). 
Caffeine ingestion increases adrenaline release and an increase in cAMP 
concentration has been shown to reduce f-MLP-induced 02-" generation (Yu et at., 
1995). Moreover, adrenaline can decrease neutrophil luminol-enhanced CL 
measurements (Weiss et al., 1996) and 02-" generation (Wenisch et at., 1996) in a 
dose-dependent manner. Although this effect of adrenaline is most pronounced at 
clinically-high doses, in the presence of low concentrations of adenosine, 
physiological concentrations of adrenaline strongly inhibited neutrophil function 
(Bazzoni et al., 1991). 
Little information is known about the combined effects of adenosine, caffeine and 
adrenaline on the neutrophil oxidative burst response. It has been previously stated in 
this thesis that the net effect of caffeine on f-MLP stimulated neutrophil oxidative 
burst responses may be the result of a number of stimulatory (via adenosine receptor 
antagonism) and suppressive (via elevated adrenaline concentration) influences. The 
findings of Chapter 6 demonstrated that caffeine ingestion attenuated the exercise- 
induced decline in f-MLP stimulated neutrophil oxidative burst response following 90 
min cycling at 70% 
VOZ max, even in the presence of an elevated adrenaline 
concentration (CAF: 2.7 nmol. L', PLA: 1.5 nmol. L'1). When adrenaline 
concentration was increased further 
however, following maximal effort TT cycling 
(CAF: 5.2 nmol. L't, PLA: 3.7 nmol. L''), no attenuating effects of caffeine ingestion 
were observed (Chapter 7). 
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The aim of this study therefore was to investigate the potential mechanisms that may 
account for the effects observed in the previous exercise studies, by first determining 
the effect of physiological concentrations of adenosine on f-MLP-stimulated oxidative 
burst responses of isolated human neutrophils and secondly to compare the response 
following the addition of caffeine at a concentration detected in serum after caffeine 
ingestion (6 mg. kg t body mass). Finally, the study aimed to determine the effects of 
adrenaline (at 2 different concentrations previously observed following submaximal 
and high-intensity exercise) on f-MLP-stimulated neutrophil oxidative burst responses 
in the presence of both adenosine and caffeine. 
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8.3. Methods 
Chemicals and stimuli 
Both adenosine and adrenaline (Sigma-Aldrich Co, Gillingham, UK) were dissolved 
in phosphate buffered saline (PBS) at stock concentrations of 0.8 mmol. L4 and 40 
mmol. L'' respectively. Caffeine (BDH Laboratory Supplies, Poole, UK) was 
dissolved in PBS at a stock concentration of 4 mmo1. L'1. All stock solutions were 
made immediately before use and were protected from light. Further dilutions in PBS 
to working concentrations were made immediately prior to use. Reconstitution and 
assay buffer was used as a medium to re-suspend the neutrophils in following 
separation from whole blood. 
This consisted of Hank's Balanced Salt Solution 
(HBSS) with 20 mM Hepes at pH 7.4 (Knight Scientific Limited, Plymouth, UK). f- 
MLP was reconstituted according to manufacturer's instructions at a working 
concentration of 5 pg. ml-' (Knight 
Scientific Limited, Plymouth, UK). 
Cell Isolation Procedure 
Six healthy males (age 27 ±1 years) volunteered to participate in the study. 
Participants arrived at the laboratory at 08: 00 am following an overnight fast and 60 h 
abstention from caffeine containing products. 
Following a 10 min seated rest period, a 
blood sample (7.5 ml) was collected into a K3EDTA monovette from an antecubital 
forearm vein. Neutrophils were isolated from whole blood by adding, into a centrifuge 
tube and in the following order, 2 ml of Histopaque 1.119 separating medium (Sigma- 
Aldrich Co, Gillingham, UK), 2 ml of Histopaque 1.077 separating medium (Sigma- 
Aldrich Co, Gillingham, UK) and 3 ml of whole blood. The tubes were then 
centrifuged at 400 g for 30 min at 
24°C. After centrifugation, the halo of neutrophils 
was carefully removed using a 
Pasteur pipette and transferred to separately labelled 
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tubes containing 5 ml of PBS. The cells were re-suspended and then centrifuged at 
200 g for 10 min at 24°C. The supernatant was removed and the cells were re- 
suspended in a further 5 ml of PBS and centrifuged again at 200 g for 10 min at 24°C. 
Following this, the supernatant was discarded and the cells were re-suspended in 1 ml 
of reconstitution and assay buffer. Neutrophils were counted in a Neubauer 
haemocytometer under a light microscope and the suspension was adjusted using 
reconstitution and assay buffer to a final concentration of 1x 106 neutrophils/ml. 
Chemiluminescence assay 
The neutrophils were exposed to five separate experimental conditions that were 
performed in duplicate. In the control condition (Con), 250 µl of neutrophil 
suspension was added to an eppendorf containing 150 µl reconstitution and assay 
buffer. The solution was mixed by vortex for 5s then incubated for 2 min at 37°C in a 
dry block heater. Immediately following the incubation, 20 µ1 of suspension was 
removed and added to a well of a 96 well microplate containing 90 µl reconstitution 
and assay buffer, 20 µ1 Adjuvant K and 50 pl Pholasin (as previously described in 
Chapter 3). Upon the addition of 20 µl f-MLP, pholasin-enhanced CL was recorded 
every 1s for 100 s and peak CL (oxidative burst response) was determined. 
To determine the effect of physiological concentrations of adenosine (Aden) on the 
oxidative burst response, 50 pl adenosine (100 nmo1. L'1 final concentration) was 
added to 250 pl neutrophil suspension and 100 µl reconstitution and assay buffer, 
prior to incubation and f-MLP stimulation described above. The third condition (Aden 
+ Caf) was designed to evaluate the effect of physiological concentrations of caffeine 
on the adenosine-mediated oxidative burst response and consisted of 250 µI 
151 
Chapter 8 
neutrophil suspension, 50 µl reconstitution and assay buffer, 50 µ1 caffeine (50 
p. mol. L' final concentration) and 50 µ1 adenosine (100 nmol. Ul). In an attempt to 
replicate the conditions of the exercise studies described in Chapters 5,6 and 7, the 
final two conditions consisted of the addition of 50 µ1 adrenaline at either 2 nmol. L'' 
(final concentration) or 5 nmo1. L' (final concentration) to 250 pl neutrophil 
suspension and 50 µl caffeine (50 pmol. U') followed by the addition of 50 µl 
adenosine (100 nmol. L"1). The results of an initial pilot study are shown in Appendix 
F. 
Statistical Analysis 
Differences between conditions were assessed using Student's paired t-tests with 
Bonferronni adjustment for multiple comparisons. Data in Figure 8.1 is presented as 
of control condition (Mean ± SEM). 
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8.4. Results 
The incubation of human neutrophils with physiological concentrations of adenosine 
(100 nmol. L"') resulted in a significant inhibition (40%) of the CL response compared 
to the control condition (P = 0.001). Following the addition of 50 µmol. l. -' caffeine 
(Aden + Cat), the response was 9% lower than control but was not statistically 
different from control. Although the response on Aden + Caf was higher than Aden 
alone, this difference was not statistically significant (P = 0.12). The Cl, response of 
neutrophils incubated with adenosine (100 nmol. L''), caffeine (50 µmol. l. -') and 
adrenaline at 2 nmol. L-1 and at 5 nmol. L"1 were both significantly lower than control 
(Adren 2 nM: 37% (P = 0.002); Adren 5 nM: 40% (P = 0.001). There was no 
significant difference between the concentration of adrenaline added to the suspension 
and neutrophil response (P = 0.78). 
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Figure 8.1. Peak CL values of isolated neutrophils (stimulated with f-MLP) 
expressed as % of control condition (Con) in the five experimental conditions. 
Significantly lower than Con (**P<0.01). 
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8.5. Discussion 
The major findings of the present study were that physiological concentrations of 
adenosine significantly inhibited the f-MLP-stimulated oxidative burst response of 
isolated human neutrophils in vitro. In the presence of caffeine however, adenosine 
did not significantly reduce the oxidative burst response. The addition of adrenaline at 
both 2 nmol. L4 and at 5 nmol. L; 1 significantly reduced the neutrophil oxidative burst 
response in the presence of caffeine and adenosine, but there was no significant 
difference between the adrenaline concentrations administered. 
Resting plasma adenosine concentration in humans at rest is approximately 40 - 50 
nmol. L"' (Vizi et at., 2002; Chouker et al., 2005), however a large inter-individual 
variation of between 20 - 200 nmol. L"1 (mean 82 nmol. L") has been reported (Moser 
et at., 1989). Adenosine concentration is known to increase with exercise or metabolic 
stress. It is reported that plasma adenosine concentration increased from 40 to 60 
nmol. L'' following 6 min exercise at 90% heart rate maximum (Vizi et at., (2002) and 
was 80 nmol. L"' following a hike at low altitude (Chouker et al., 2005). In the present 
study, isolated neutrophils were incubated with 100 nmol. L'' adenosine to attempt to 
reflect the increase following high-intensity exercise. Adenosine significantly reduced 
the f-MLP-stimulated oxidative burst response of isolated human neutrophils by 40% 
compared to the control condition. The inhibition reported here is of the same 
magnitude as that reported when neutrophils were incubated with 100 nmol. L'' 
adenosine for 3 min (38% inhibition) and 5 min (40% inhibition) prior to f-MLP- 
stimulation (Cronstein et at., 1985; Swain et at., 2003). Furthermore, Chouker et at., 
(2005) observed a significant inverse relationship between in vivo plasma adenosine 
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concentration and ex vivo neutrophil 02-0 generation, reporting an IC50 of 80 nmol. L" 
i 
Adenosine produced intracellularly or formed extracellularly, diffuses to cell 
membranes of surrounding cells where it binds to adenosine receptors (Hasko and 
Cronstein, 2004). Inhibition of the f-MLP-stimulated neutrophil oxidative burst 
response, as observed here, is reported to occur via A2A adenosine receptors expressed 
on neutrophils (Gessi et at., 2002). Adenosine has been reported to inhibit neutrophil 
oxidative burst response by suppressing PL-D activity (Thibault et al., 2000). PL-D 
catalyzes the hydrolysis of phophatidylcholine to yield phosphatic acid, which is 
further metabolised. These PL-D second messengers may regulate the oxidative burst 
and other neutrophil functions. Suppression of f-MLP-induced PL-D activity has been 
correlated with an increased cAMP concentration, that may activate protein kinase A 
(PKA) to mediate this suppression (Thibault et al., 2002). In addition to this, 
adenosine is reported to increase the trafficking of flavocytochrome b (Swain et al., 
2003). This key component of NADPH oxidase may be translocated from plasma 
membrane to a higher density membrane by adenosine, coinciding with an accelerated 
shut down of the oxidative burst response by neutrophils (Swain et al., 2003). 
In the present study, the suppressive effects of adenosine on the f-MLP stimulated 
neutrophil oxidative burst response were attenuated following the addition of caffeine 
(50 µmol. L'1). Although the f-MLP stimulated neutrophil oxidative burst response 
was not significantly higher with caffeine and adenosine than adenosine alone 
(P=0.12) the response was only 9% lower than in the control condition, compared to a 
40% decrease following incubation with adenosine alone. The concentration of 
caffeine used in the present study corresponded to that previously measured in serum 
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following 90 min cycling at 70% VO2 max after the ingestion of 6 mg. kg" body mass 
caffeine. Serum caffeine concentration at post-exercise in Chapter 5,6 and 7 was 55 
µmol. Ul, 46 µmol. L 
1 and 42 µmol. L" respectively. The potency of caffeine to 
antagonise A2A adenosine receptors occurs at a K; of 40-44 pmo1. L't (Daly, 1993) 
suggesting that in the present study, caffeine may have inhibited the occupancy and/or 
activation of A2A adenosine receptors thus attenuating the suppressive effects that 
adenosine exerts. 
The addition of adrenaline at both 2 nmol. L"L and at 5 nmo1. Lt significantly reduced 
the magnitude of the f-MLP stimulated neutrophil oxidative burst response in the 
presence of caffeine and adenosine. The concentration of adrenaline used in the 
present study reflected the measured concentration in plasma following 90 min 
cycling at 70% 
V02 max (Chapter 5& 6) and high-intensity TT cycling (Chapter 7). 
Adrenaline is known to stimulate ß-2 adrenoreceptors expressed by neutrophils, 
activating adenyl cyclase and inducing cAMP synthesis (Tintinger et al., 2000). An 
increase in cAMP has been shown to specifically inhibit neutrophils stimulated with f. 
MLP (Yu et al., 1995). It has been suggested that adrenaline causes an inhibition of f- 
MLP mediated oxidative burst via production of cAMP and activation of PKA which 
subsequently suppresses PLA2-dependent arachidonic acid production (O'Dowd et al., 
2004). Arachidonic acid is another pathway by which NADPH oxidase may be 
activated; however, a concentration of 5 nmol. L"l adrenaline was required for this 
effect to be observed (O'Dowd et al., 2004). Nevertheless, in the present study, there 
was no significant difference between 2 nmol. L"1 and 5 nmo1, L'' adrenaline on the f- 
MLP stimulated neutrophil oxidative burst response in the presence of adenosine and 
caffeine. It has frequently been reported that adrenaline alone can dose-dependently 
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inhibit neutrophil oxidative burst responses (Weiss et at., 1996; Tintinger et at., 2001; 
O'Dowd et al., 2004). A study by Bazzoni et at., (1991) reported that adrenaline 
inhibited the f-MLP-stimulated neutrophil oxidative burst response with an IC50 of 69 
nmol. L't. In the presence of low concentrations of adenosine however, a strong 
inhibitory effect of adrenaline was exhibited even at physiological concentrations in 
the subnanomolar range. Given that human neutrophils in suspension spontaneously 
generate adenosine (Iannone et at., 1989), it may be that in this in vitro environment, 
adenosine markedly potentiates the potency of adrenaline to inhibit the oxidative burst 
response. 
In summary, this study supported previous findings that adenosine markedly reduces 
the oxidative burst response of isolated human neutrophils. In the presence of caffeine 
however, the response was not significantly lower than control, in accordance with the 
known antagonistic actions of caffeine on adenosine. The addition of adrenaline in the 
presence of caffeine and adenosine significantly reduced the oxidative burst response 
below control but there was no concentration-dependent effect. Unfortunately this 
study was not able to clarify the contributing mechanisms by which caffeine 
attenuates the post-exercise decrease in f-MLP-stimulated neutrophil oxidative burst 
responses in the presence of elevated adrenaline concentrations (Chapter 6). This 
reinforces the point that in vitro experimentation can not always truly reflect the in 
vivo situation. 
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Chapter 9 
The effect of caffeine co-ingested with 
carbohydrate on immunoendocrine responses 
following prolonged submaximal cycling. 
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9.1. Abstract 
The purpose of the present study was to determine the effect of caffeine consumed 
with and without CHO on f-MLP-stimulated neutrophil oxidative burst responses 
following exercise. Twelve recreationally active male cyclists (mean ± SEM: age 22 
f1 years; body mass 69.9 ± 1.9 kg; V02 max 59.8 ± 2.0 ml. kg''. min') participated 
in 4 exercise trials consisting of cycling for 2h at 65% VO2 max. Sixty min prior to 
exercise, participants ingested 6 mg. kg" body mass of caffeine (CAF) or placebo 
(PLA), then during exercise they consumed a 6% CHO or placebo (PLA) drink, 
providing 4 experimental conditions: CAF/CHO, PLA/CHO, CAF/PLA and 
PLA/PLA. The f-MLP-stimulated neutrophil oxidative burst response was 
significantly higher at post-exercise on CAF/CHO and PLA/CHO (both P<0.05) than 
PLA/PLA when expressed as % of baseline value. Oxidative burst response on 
CAF/PLA tended to be higher than PLA/PLA at this point (P=0.056). There were no 
significant differences between CAF/CHO, PLA/CHO and CAF/PLA at post- 
exercise; however, only PLA/CHO showed no significant post-exercise decline. The 
co-ingestion of CAF/CHO significantly attenuated the adrenaline (P<0.05) and IL-6 
(P<0.05) responses that occurred following the ingestion of CAF alone (CAF/PLA) 
and significantly attenuated the transient alterations in circulating total leukocyte 
(P<0.05) and neutrophil (P<0.01) count. Plasma cortisol was significantly lower on 
PLA/CHO than both CAF/PLA and PLA/PLA at post-exercise (P<0.05). Perceived 
exertion during the exercise was significantly lower on the CAF/CH0 condition than 
the other 3 trials (P<0.05). These results suggest that the co-ingestion of CAF/CHO 
provides no additional effects on the f-MLP-stimulated neutrophil oxidative burst 
response following exercise compared with that observed in response to either 
supplement alone. It may be however, that the effects of CHO on neutrophil oxidative 
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burst responses are of greater magnitude than the previously reported effects of CAF, 
therefore effectively masking any influence of CAF on the response. 
160 
Chapter 9 
9.2. Introduction 
The findings reported in Chapter 6 of this thesis showed that caffeine ingestion 
attenuated the decline of the f-MLP-stimulated neutrophil oxidative burst response 
following submaximal intensity cycling of fixed duration. As caffeine and its 
derivatives are potent adenosine receptor antagonists (Ongini & Fredholm, 1996) the 
attenuated decline was hypothesised to have been due to caffeine acting to inhibit the 
occupancy and/or activation of A2A adenosine receptors expressed on neutrophils. 
This is plausible since inhibition of the neutrophil oxidative burst response is 
predominantly A2A mediated (Gessi et al., 2002) and adenosine has been shown to 
specifically inhibit 02-' generation by f-MLP-stimulated neutrophils in vitro 
(Cronstein et al., 1985; Swain et at., 2003). Caffeine, however, also increases plasma 
levels of catecholamines (Graham, 2001a). The decline in the neutrophil oxidative 
burst response following exercise is attributed to elevated concentrations of adrenaline 
(Hack et al., 1994) and adrenaline acting via neutrophil ß-2 adrenoreceptors has been 
reported to inhibit neutrophil ROS production (Chilcoat et at., 2002; O'Dowd et at., 
2004). 
The ingestion of CHO before and during exercise is associated with a higher plasma 
glucose concentration and an attenuation of the stress hormone response. Both 
adrenaline (Nieman et al., 2005) and cortisol (Nehlsen-Cannarella et al., 1997) 
concentrations are significantly lower following prolonged submaximal exercise when 
CHO is consumed. CHO ingestion is also associated with fewer perturbations to 
immune cell counts, particularly an attenuation of the neutrophilia seen following 
prolonged exercise (Bishop et al., 2003; Nieman et al., 2005). The effect of CHO 
ingestion on neutrophil oxidative burst responses has produced equivocal findings. It 
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is reported that the post-exercise decline of the f-MLP-stimulated neutrophil oxidative 
burst response is attenuated by CHO beverage ingestion (Scharhag et al., 2002) 
whereas no effect has been observed on the PMA-stimulated neutrophil response 
following moderate exercise (Smith et al., 1996). 
CHO ingestion prior to and during exercise (Nehlsen-Cannarella et al., 1997; Starkie 
et al., 2001; Nieman et al., 2003) is also shown to attenuate the increases in plasma 
IL-6 concentration but not muscle mRNA expression (Starkie et al., 2001; Nieman et 
al., 2005) following prolonged exercise. Low muscle glycogen levels are associated 
with elevated IL-6 responses (Bishop et al., 2001b; Steensberg et al., 2001) and it is 
suggested that IL-6 may be involved in the regulation of glucose homeostasis by 
affecting hepatic glucose production to prevent hypoglycaemia (Gleeson, 2000; 
Febbraio and Pedersen, 2002). 
Many commercially available drinks contain both caffeine and CHO. Given that the 
co-ingestion of CHO and caffeine increases TT performance (Cox et at., 2002) and 
that its use is commonly reported by professional cyclists during competition (Martin, 
1997), the aim of the study was to investigate the influence of caffeine co-ingested 
with CHO upon the f-MLP-stimulated neutrophil oxidative burst and plasma IL-6 
response following 2h prolonged cycling at 65% 
VO2 max . 
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9.3. Methods 
Twelve recreational male cyclists (mean ± SEM: age 22 ±1 years; height 1.78 ± 0.03 
m; body mass 69.9 = 1.9 kg; 
VO2 max 59.8 ± 2.0 ml. kg''. min'l; Peak Power Output 
336 f 14 W) volunteered to participate in the study. Participants were informed of the 
rationale and experimental procedures involved in the study, before providing written 
consent to participate. The study protocol had earlier received approval by the local 
University Ethical Advisory Committee. Average daily caffeine intake was 140 ± 37 
mg. day''. Four participants were characterised as light users (< 50 mg. day''), 6 as 
moderate users (50-250 mg. day"') and 2 as having a high caffeine intake (> 250 
mg. day'). 
Preliminary experimental measurements were conducted within a 2-week period prior 
to the beginning of the main trials. Preliminary measurements and pre-trial 
standardisation procedures are detailed in Chapter 3. Participants performed 4 main 
experimental trials separated by a minimum of 5 days. The participants acted as their 
own controls in a double-blind, cross-over design and were randomly assigned to one 
of four experimental conditions; caffeine/carbohydrate (CAF/C110), 
placebo/carbohydrate (PLA/CHO), caffeine/placebo (CAF/PLA) or placebo/placebo 
(PLA/PLA). The order of treatments was randomised using a basic Latin squares 
design so that no participant completed the trials in the same order as another. 
Participants arrived at the laboratory at 08: 00 am following an overnight fast of 
between 10 and 12 h. Following a void, body mass was recorded and participants 
ingested 6 mg. kg'1 body mass of either caffeine or placebo (dextrose powder), taken 
in the form of a cellulose capsule (Blackfirs Health, Cheshire, UK) with 2 ml. kg" 
body mass of water before resting quietly for 60 min. Caffeine was consumed in two 
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of the trials and placebo in the remaining two trials. At the end of the 60 min period, 
participants consumed 5 ml. kg" of a6% CHO solution (in the CAF/CHO and 
PLA/CHO trials) or a similar tasting artificially sweetened solution (in the CAF/PLA 
and PLA/PLA trials). The composition of the CHO drink consisted of 150 ml of low 
calorie lemon cordial, 850 ml water and dextrose monohydrate (6.6% w/v) per litre of 
solution. The PLA drink contained 20 calorie-free sweeteners as a substitute for 
dextrose monohydrate. Participants were instructed to consume this drink as quickly 
as possible, after which they immediately began cycling for 120 min at 
65%'O2 max . Heart rate and 
RPE were measured every 15 min throughout exercise 
and 2 ml. kg"1 body mass of CHO or PLA was administered at these time points 
according to the experimental condition. At 15,45 and 75 and 105 min of exercise, 1- 
min expired gas samples were collected. Following the cessation of exercise, body 
mass was recorded and participants consumed 5 ml. kg" body mass of CHO or PLA 
before resting for a further 60 min. Venous blood samples were obtained at rest, post- 
exercise and at 1h post-exercise. Laboratory conditions were 22.8 ± 0.4°C and 37 f 
2% relative humidity. 
Blood analytical methods 
Blood sampling and analyses methods are detailed in Chapter 3.5. 
Statistical analysis 
Statistical analysis methods are detailed in Chapter 3.6. 
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9.4. Results 
Physiological variables and RPE 
There were no significant differences in overall exercise intensity between trials; 
mean %' TO max was 67.1 ± 0.7%, 65.7 ± 0.5%, 67.3 ± 0.5% and 66.3 ± 0.5% on 
CAF/CHO, PLA/CHO, CAF/PLA and PLA/PLA trials, respectively. Following 
exercise, body mass change (corrected for fluid intake) fell similarly on all trials 
(CAF/CHO: -1.9 ± 0.1 kg, PLA/CHO: -1.8 ± 0.1 kg, CAF/PLA: -1.8 ± 0.2 kg, 
PLA/PLA: -1.9 ± 0.1 kg) as did plasma volume (CAF/CHO: -8.0 ± 2.4%, PLA/CHO: 
-8.0 ± 1.3%, CAF/PLA: -8.5 ± 
1.4%, PLA/PLA: -9.5 ± 1.4%). Heart rate during 
exercise was similar between the four experimental conditions (150 ±2 beats. miri-4, 
152 ±2 beats. min 1,150 ±3 beats. min 1 and 151 ±2 beats. min 1 on CAF/CHO, 
PLA/CHO, CAF/PLA and PLA/PLA trials respectively, mean of all recordings) and 
heart rate values increased with exercise duration (main effect of time; P<0.01). Mean 
RPE was significantly lower on CAF/CHO trial (11.2 ± 0.3, P<0.05) than PLA/CHO 
(11.8 ± 0.2), CAF/PLA (11.5 ± 0.3) and PLA/PLA (11.6 ± 0.4). A significant main 
effect of time (P<0.01) was found 
for RPE with values increasing as a function of 
exercise duration. 
165 
Chapter 9 
Substrate Oxidation and Energy Expenditure 
Mean RER was significantly lower during the 120 min exercise period on CAF/PLA 
compared with PLA/CHO (P<0.05; Table 9.1). No other differences between trials 
were observed. There were no significant differences for CHO oxidation rate between 
trials, however CHO oxidation decreased with exercise duration (P<0.0 1; Table 9.1). 
Mean fat oxidation rate was significantly higher on CAF/PLA than PLA/CHO 
(P<0.05; Table 9.1). Fat oxidation increased with exercise duration on CAF/CHO, 
CAF/PLA and PLA/PLA, yet there were no differences during the exercise on the 
PLA/CHO trial (Table 9.1). 
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Table 9.1: RER and substrate oxidation rates during the 120 min exercise period. 
Time 15 45 75 105 Mean 
RER 
CAF/CHO 0.95(0.01) 0.94 (0.01) 0.93 (0.01) 0.92 (0.02) 0.93 (0.01) 
PLA/CHO 0.93 (0.01) 0.94 (0.01) 0.94 (0.01) 0.92 (0.01) 0.93 (0.01) 
CAF/PLA 0.94 (0.01) 0.92 (0.01) 0.91 (0.01) 0.87 (0.01) 0.91(0.01) a 
PLA/PLA 0.94 (0.01) 0.93 (0.01) 0.92 (0.01) 0.90(o. 01) 0.92 (0.01) 
CHO oxidation (g. min 4) 
CAF/CHO 3.03 (0.14) 2.98 (0.17) 2.91 (0.19) 2.80 (0.18) 2.93 (0.08) 
PLA/CHO 2.77 (0.22) 2.97 (0.17) 2.93 (0.18) 2.71 (0.18) 2.84 (0.09) 
CAF/PLA 2.92 (0.20) 2.80 (0.16) 2.96 (0.25) 2.27 (0.18) 2.74 (0.10) 
PLA/PLA 3.07 (0.18) 2.75 (0.16) 2.68 (0.15) 2.58 (0.13) 2.77 (0.08) 
Fat oxidation (g. min- ) 
CAF/CHO 0.23 (0.05) 0.29 (0.05) 0.32 (0.06) 0.41 (0.07)t 0.31 (0.03) 
PLA/CHO 0.30 (0.06) 0.27 (0.04) 0.29 (0.03) 0.35 (0.04) 0.30 (0.02) 
CAF/PLA 0.25 (0.06) 0.36(0.06)t 0.36(0.06)t 0.59(0.05) $b 0.39(0.03)b 
PLA/PLA 0.22 (0.06) 0.35(0.05)t 0.39(0.05)1 0.45(0.04) 1 0.35 (0.03) 
Significantly lower than PLA/CHO (a P<0.01). Significantly higher than PLA/CHO 
(b P<0.05). Significantly higher than at 15 min within trial (t P<0.05, $ P<0.01). 
There were no significant differences for mean rates of energy expenditure between 
trials (CAF/CHO: 59 ±1 kJ. miri 
1, PLA/CHO: 58 ±1 kJ. min t, CAF/PLA: 59 ±1 
kJ. miri t, PLA/PLA: 58 ±1U. min 
1). The energy derived from the oxidation of CHO 
during the 120 min exercise period decreased with exercise duration (P<0.01; Table 
9.2). The energy derived from the oxidation of fat was significantly higher on 
CAF/PLA than PLA/CHO (mean of all calculations, P<0.05; Table 9.2). A significant 
time x trial interaction (P<0.05) showed that the energy contributed by fat 
significantly increased with exercise duration on CAF/PLA and PLA/PLA, yet there 
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were no differences on PLA/CHO trial (Table 9.2). There were no significant 
differences between trials for the mean percentage contribution of CHO or fat towards 
total energy expenditure during the exercise period, however a time x trial interaction 
(P<0.05) showed that % CHO contribution at 105 min was significantly higher on 
PLA/CHO than CAF/PLA. Accordingly, at this time point, % fat contribution was 
significantly higher on CAF/PLA than PLA/CHO (Table 9.2). 
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Table 9.2: CHO and fat contribution towards energy expenditure. 
Time 15 45 75 105 Mean 
Energy derived from CHO oxidation (kJ. min 1) 
CAF/CHO 48.5 (2.3) 47.8 (2.8) 46.5 (3.1) 44.9 (2.8) 46.9 (1.3) 
PLA/CHO 44.4 (3.6) 47.5 (2.7) 46.9 (2.9) 43.3 (2.3) 45.7 (1.4) 
CAF/PLA 46.8 (3.1) 44.8 (2.6) 47.4 (4.03) 36.4 (2.9) 43.8 (1.7) 
PLA/PLA 49.1 (2.9) 44.0 (2.5) 42.9 (2.5) 41.3 (2.0) 44.3 (1.3) 
Energy derived from fat oxidation (kJ. min 1) 
CAF/CHO 9.0 (2.0) 11.2 (2.1) 12.5 (2.5) 16.0 (3.0) t 12.2 (1.2) 
PLA/CHO 11.7 (2.2) 10.4(l. 6) 11.3(l. 3) 13.6(t. 7) 11.8 (0.8) 
CAF/PLA 9.9(2.2) 14.0(2.2)t 14.0(2.8)t 22.8(1.8) 15.2(1.3)a 
PLA/PLA 8.4(2.3) 13.6(1.8)t 15.3(2.1)$ 17.5(1.6)1 13.7(1.1) 
contribution to total energy expenditure from CHO 
CAF/CHO 85 (3) 81 (3) 79 (4) 74 (4) 80 (2) 
PLA/CHO 78 (4) 82 (3) 80 (3) 76 (3) 79 (2) 
CAF/PLA 82 (4) 76 (4) 76 (5) 61(3) $b 74(2) 
PLA/PLA 85 (4) 76 (3) t 74(4)1 70(3)$ 76 (2) 
contribution to total energy expenditure from fat 
CAF/CHO 15 (3) 19 (3) 21(4) 26 (4) 20 (2) 
PLA/CHO 22 (4) 18 (3) 20 (3) 24(3) 21(2) 
CAF/PLA 18 (4) 24(4) 24 (5) 39 (3) $a 26(2) 
PLA/PLA 15(4) 24 (3) $ 26 (3) $ 30(3)1 
_; 
4. 
_(2) 
Significantly higher than PLA/CHO (a P<0.05). Significantly lower than PLA/CHO 
(b P<0.05). Significantly different from 15 min within trial (t P<0.05, $ P<O. 01). 
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Blood metabolites and hormones 
Serum caffeine was significantly higher at post-exercise and 1h post-exercise on both 
CAF/CHO and CAF/PLA than PLA/CHO and PLA/PLA (P<0.01; Figure 9.1). 
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Figure 9.1. Serum caffeine concentration. Significantly higher than PLA/CHO and 
PLA/PLA at that time point (a P<0.01). Significantly higher serum caffeine above 
resting within trial (** P<0.01). 
Plasma adrenaline concentration significantly increased on all conditions following 
the exercise protocol (P<0.01; Figure 9.2). At post-exercise, plasma adrenaline 
concentration was significantly higher on CAF/PLA than PLA/CHO (P<0.01), 
CAF/CHO and PLA/PLA (both P<0.05). At this time, adrenaline concentration on 
CAF/CHO and PLA/PLA was significantly higher than on PLA/CHO (P<0.05). 
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Figure 9.2. Plasma adrenaline concentration at rest and post-exercise. Significantly 
higher than PLA/CHO at that time point (a P<0.01). Significantly higher than 
CAF/CHO and PLA/PLA at that time point (b P<0.05). Significantly higher than 
PLA/CHO at that time point (c P<0.05). Significantly higher than rest within trial (** 
P<0.01). 
Plasma cortisol concentration was significantly higher at post-exercise on both 
CAF/PLA and PLA/PLA than PLA/CHO but not CAF/CHO (P<0.05; Figure 9.3). 
Plasma cortisol concentration at 1h post-exercise had significantly decreased from 
post-exercise on all four conditions. At this time, cortisol concentration was 
significantly lower than resting values on CAF/CHO and PLA/CHO only (P<0.01). 
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Figure 9.3. Plasma cortisol concentration. Significantly higher than PLA/CHO at that 
time point (a P<0.05). Significantly lower than rest within trial (** P<0.01). 
Plasma glucose concentration was significantly higher than rest at post-exercise on 
CAF/CHO and PLA/CHO trials (both P<0.01; Table 9.3). At this time, glucose 
concentration was significantly higher than CAF/PLA and PLA/PLA (P<0.01). There 
were no differences between trials at 1h post-exercise yet plasma glucose 
concentration had decreased below rest on PLA/CHO (P<0.05) and PLA/PLA 
(p<0.01). Plasma FFA concentration was significantly higher than rest at post- 
exercise on all experimental trials (P<0.01; Table 9.3). At this point, plasma FFA 
concentration was significantly higher on CAF/PLA than both CAF/CHO and 
PLA/CHO (P<0.01) and FFA concentration on PLA/PLA was significantly higher 
than PLA/CHO (P<0.01). Plasma FFA concentration remained elevated at 1h post- 
exercise on CAF/PLA and PLA/PLA compared to CAF/CHO and PLA/CHO 
(P<0.01), yet it was significantly higher on CAF/PLA than PLA/PLA (P<0.01). 
Plasma lactate concentration was also significantly elevated above rest following the 
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exercise period (P<0.01; Table 9.3). At post-exercise, plasma lactate concentration 
was significantly higher on CAF/PLA than both PLA/CHO and PLA/PLA (P<0.05) 
and lactate concentration on CAF/CHO was significantly higher than PLA/CHO 
(P<0.05). 
Table 9.3. Plasma concentrations of blood-borne metabolites. 
Rest Post-Exercise Ih Post-Exercise 
Glucose (mmol. L"') 
CAF/CHO 5.04 (0.12) 5.59 (0.18) **b 4.60 (0.21) 
PLA/CHO 5.02 (0.12) 5.74 (0.22)**a 4.50 (0.23)* 
CAF/PLA 5.10 (0.11) 5.16 (0.16) 4.95 (0.13) 
PLA/PLA 5.17 (0.15) 4.77 (0.11) 4.58 (0.09)** 
FFA (mmoLL"1) 
CAF/CHO 0.23 (0.03) 0.83 (0.13)** 0.41 (0.11) 
PLA/CHO 0.24 (0.03) 0.69 (0.05)** 0.24 (0.05) 
CAF/PLA 0.18 (0.02) 1.53 (0.17)**c 1.30 (0.16)**e 
PLA/PLA 0.20 (0.02) 1.16 (0.10)**d 0.98 (0.13)**f 
Lactate (mmo1. L'1) 
CAF/CHO 1.3 (0.1) 2.5 (0.2)**g - 
PLA/CHO 1.2 (0.1) 2.0 (0.2)** - 
CAF/PLA 1.3 (0.2) 2.9 (0.3)**h - 
PLA/PLA 1.2 (0.1) 2.1 (0.1)** - 
Significantly higher than CAF/PLA and PLA/PLA (a P<0.01), Significantly higher 
than PLA/PLA (b P<0.01) and CAF/PLA (b P<0.05), Significantly higher than 
CAF/CHO and PLA/CHO (c P<0.01), Significantly higher than PLA/CHO (d 
p<0.01), Significantly higher than CAF/CHO, PLA/CHO and PLA/PLA (e P<0.01), 
Significantly higher than CAF/CHO and PLA/CHO (f P<0.01), Significantly higher 
than PLA/CHO (g P<0.05), Significantly higher than PLA/CHO and PLA/PLA (h 
P<0.05), Significantly different from rest within trial (**P<0.01, *P<0.05). 
173 
Chapter 9 
Total and differential leukocyte counts 
There was a marked leukocytosis evident at post-exercise with a further increase at I 
h post-exercise on all experimental conditions (P<0.01; Figure 9.4). At post-exercise, 
circulating leukocyte count was significantly lower on PLA/CHO (P<0.01) and 
CAF/CHO (P<0.05) than both CAF/PLA and PLA/PLA. At Ih post-exercise, 
leukocyte count remained significantly lower on PLA/CHO and CAF/CHO than 
CAF/PLA and PLA/PLA (both P<0.01). 
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Figure 9.4. Total circulating leukocyte count. Significantly lower than CAF/PLA and 
PLA/PLA at that time point (a P<0.01), Significantly lower than CAF/PLA and 
PLA/PLA at that time point (b P<0.05) . Significantly higher than rest within trial (** 
P<0.01). 
Circulating neutrophil count was significantly higher than resting counts at post- 
exercise and 1h post-exercise, irrespective of the trial followed (P<0.01; Figure 9.5). 
At post-exercise, circulating neutrophil count was significantly lower on PLA/CHO 
than CAF/PLA and PLA/PLA (P<0.01). At this point, neutrophil count was 
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significantly lower on CAF/CHO than PLA/PLA (P<0.05). Neutrophil count 
remained significantly lower on PLA/CHO and CAF/CHO than CAF/PI. A and 
PLA/PLA (both P<0.01) at 1h post-exercise. 
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Figure 9.5. Circulating neutrophil count. Significantly lower than CAF/PLA and 
PLA/PLA at that time point (a P<0.01), Significantly lower than PLA/PLA at that 
time point (b P<0.05), Significantly higher than rest within trial (** P<0.01). 
Circulating lymphocyte count at post-exercise was significantly lower on PLA/CHO 
(P<0.01) and CAF/CHO (P<0.05) than PLA/PLA. A significant lymphopenia was 
observed at 1h post-exercise on all trials and at this time, circulating lymphocyte 
count was significantly higher on PLA/CHO than CAF/PLA (P<0.05; Figure 9.6). 
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Figure 9.6. Circulating lymphocyte count. Significantly lower than PLA/PLA at that 
time point (a P<0.01), Significantly lower than PLA/PLA at that time point (b 
p<0.05), Significantly higher than CAF/PLA at that time point (c P<0.05), 
Significantly lower than rest within trial (** P<0.01, * P<0.05). 
Neutrophil oxidative burst 
There were no between trial differences for the f-MLP-stimulated oxidative burst 
response when values were expressed as peak CL response per neutrophil; however, 
at post-exercise and 1h post-exercise the f-MLP-stimulated oxidative burst response 
was lower than resting values on CAF/CHO (P<0.05; Figure 9.7 A) and PLA/PLA 
(p<0.01; Figure 9.7 A). No statistically significant decreases were observed for 
PLA/CHO and CAF/PLA. When peak CL response was expressed as a% of baseline, 
f-MLP-stimulated oxidative burst response was significantly higher at post-exercise 
on CAF/CHO (P<0.05; Figure 9.7 B) and PLA/CHO (P<0.05; Figure 9.7 B) than 
PLA/PLA. CAF/PLA also tended to be higher than PLA/PLA at this time but did not 
quite reach statistical significance (P = 0.056). There were no significant differences 
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between trials at Ih post-exercise, yet the response on CAF/CHO (P<0.05), 
CAF/PLA (P<0.05) and PLA/PLA (P<0.01) was significantly lower than baseline. No 
significant decreases from baseline response were observed for PLA/CHO. 
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Figure 9.7 A. Peak CL values expressed as relative light units (RLU) for neutrophils 
(stimulated with f-MLP). Significantly lower than rest within trial (**P<0.01, 
*P<0.05). Figure 9.7 B. Peak CL of neutrophils (stimulated with f-MLP) expressed as 
% of baseline. Significantly higher than PLA/PLA at that time point (a P<0.05). 
Significantly lower than rest within trial (**P<0.01, *P<0.05). 
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Plasma IL-6 concentration was significantly elevated above resting values at post- 
exercise, with values remaining significantly higher than rest at 1h post-exercise 
(P<0.01; Figure 9.8). Plasma IL-6 concentration was significantly higher at post- 
exercise on CAF/PLA than both CAF/CHO and PLA/CHO (P<0.05). There were no 
significant differences between trials at 1h post-exercise. 
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Figure 9.8. Plasma IL-6 concentration. Significantly higher than CAF/CHO and 
PLA/CHO (a P<0.05). Significantly higher than rest within trial (* * P<0.01). 
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9.5. Discussion 
In accordance with previous reports, the findings of the present study indicate that 
cycling for 2h at 65% ' OZ max resulted in a significant decrease in f-MLP- 
stimulated neutrophil oxidative burst responses (Scharhag et al., 2002). The ingestion 
of a 6% CHO drink (PLA/CHO trial) before and during exercise significantly 
attenuated this exercise-induced decrease. The reported decline in neutrophil 
oxidative burst response is thought to be largely mediated by elevated concentrations 
of adrenaline (Hack et al., 1994). Adrenaline is known to stimulate the ß-2 
adrenoreceptors expressed by neutrophils, activating adenyl cyclase and inducing the 
synthesis of cAMP that can act to inhibit various aspects of neutrophil function (Dulis 
and Wilson, 1980). It is reported that catecholamines decrease ROS production in a 
dose-dependant manner following in vitro incubation (Wenisch et al., 1996). In the 
present study, the plasma adrenaline concentration at post-exercise was 0.53 nmol. L" 
on PLA/CHO and 1.05 nmol. L4 on PLA/PLA. At this time, the f-MLP-stimulated 
neutrophil oxidative burst response was significantly higher on PLA/CHO. 
Furthermore, for this condition, values had only fallen 15% below baseline values at 
this time, compared with a fall of 50% on PLA/PLA. 
Following the ingestion of 6 mg-kg" caffeine only (CAF/PLA trial), the f-MLP- 
stimulated neutrophil oxidative burst response at post-exercise tended to be higher 
than when placebo (PLA/PLA) was ingested throughout the trial (70% vs. 50% of 
pre-exercise response, P=0.056). This finding is in accordance with the results 
observed in Chapter 6, in which caffeine attenuated the post-exercise decline in the f- 
MLP-stimulated neutrophil oxidative burst response following 90 min cycling at 
70% V02 max . It 
is known that caffeine at physiological concentrations, exerts its 
179 
Chapter 9 
effects via adenosine receptor antagonism (Graham, 2001a). Plasma adenosine is 
reported to increase following exercise (Vizi et at., 2002) and oxidative burst 
inhibition is mediated via A2A adenosine receptors expressed on neutrophils (Gessi et 
at., 2002). Adenosine is inversely correlated with the ability of granulocytes to 
produce 02-" and is reported to dose-dependently inhibit 02-" generation following f- 
MLP stimulation (Chouker et at., 2005). The adenosine-mediated mechanism for this 
response may involve an increase in cAMP (Thibault et at., 2002), inhibition of PL-D 
activation (O'Dowd et al., 2004) and/or a redistribution of Flavocytochrome b (Swain 
et at., 2003), factors that may result in the exercise-induced fall in neutrophil 
oxidative burst response. The potency of caffeine to antagonise A2A receptors occurs 
at a K; of 40-44 µmo1. L" (Daly, 1993). In the present study, mean serum caffeine 
concentration at post-exercise on CAF/PLA was 45 µmol. L''. Therefore, caffeine may 
attenuate the exercise-induced 
decline in the f-MLP-stimulated oxidative burst 
response by inhibiting the occupancy and/or activation of A2A adenosine receptors. In 
accordance with previous 
findings, caffeine ingestion alone (CAF/PLA) also 
increased plasma adrenaline concentration at post-exercise (Graham, 2001 a). 
However, although plasma adrenaline was 3-fold higher in this trial than on 
PLA/CHO, there were no significant differences in the f-MLP-stimulated neutrophil 
oxidative burst response 
between CAF/PLA and PLA/CHO. 
It is likely that the effects of caffeine on neutrophil oxidative burst response are multi 
factorial and the net-result of a number of stimulatory and inhibitory influences. In 
light of this, the study was designed to determine the effect of caffeine co-ingested 
with CHO (CAF/CHO). It was 
hypothesised that the co-ingestion of CAF/CHO may 
provide additional benefit over each supplement alone, by combining AlA receptor 
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antagonism with an attenuation of the stress hormone response to exercise. Although 
the adrenaline response on CAF/CHO (0.99 nmol. L"1) was significantly lower than on 
CAF/PLA (1.64 nmol. 1"1), it was significantly higher than PLA/CHO (0.53 nmol. L'1) 
at post-exercise and was comparable to the response on PLA/PLA (1.05 nmol. L'l). At 
this time, the f-MLP-stimulated neutrophil oxidative burst response was significantly 
higher on CAF/CHO than PLA/PLA and had fallen by 26% below baseline values on 
CAF/CHO, compared with a 50% fall below baseline on PLA/PLA. Mean serum 
caffeine concentration at post-exercise on CAF/CHO was 47 µmol. L"l, yet there was 
no significant difference in the f-MLP-stimulated neutrophil oxidative burst response 
between trials for CAF/CHO compared to either PLA/CHO or CAF/PLA. When post- 
exercise neutrophil oxidative burst responses were compared to resting values within 
trial, only PLA/CHO trial did not exhibit a significant decrease from rest. Taken 
together, these findings may suggest that the effects of CHO are of greater magnitude 
than the effects of caffeine on neutrophil responses, but this is not to say that caffeine 
has no effect on f-MLP-stimulated neutrophil oxidative burst responses in the 
presence of CHO. When observing the % oxidative burst response at post-exercise, it 
could be argued that caffeine inhibits the actions of CHO; however, it is more likely 
that any effects of caffeine are very small in magnitude and are masked by the more 
pronounced effects of CHO when the two are co-ingested. 
CHO supplementation before and during prolonged and strenuous exercise is known 
to maintain plasma glucose concentrations, leading to an attenuation of the cortisol 
response following exercise (Nehlsen-Canarella et al., 1997; Nieman et al., 2005). In 
the present study, plasma glucose concentration was significantly higher on 
CAF/CHO and PLA/CHO than both CAF/PLA and PLA/PLA at post-exercise. 
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Accordingly, plasma cortisol concentration was significantly higher on CAF/PLA and 
PLA/PLA than PLA/CHO. This is most likely to occur via the activation of 
hypothalamic-pituitary-adrenal axis, resulting in an increased release of ACTH and 
cortisol (Nehlsen-Canarella et al., 1997). It has also been suggested that caffeine 
ingestion is associated with an elevated cortisol response following exercise. 
Following the same exercise protocol employed here, Laurent et al. (2000) reported 
that cortisol was significantly higher following caffeine ingestion, however, the 
present data do not support this finding as plasma cortisol concentration was similar 
between CAF/PLA and PLA/PLA conditions. Following cortisol release, neutrophils 
are recruited from the bone marrow into circulation (Pyne, 1994). This is likely to 
explain the larger leukocytosis and neutrophilia on CAF/PLA and PLA/PLA 
conditions and the attenuation of these responses following CHO ingestion. The 
previously reported reduction 
in f-MLP-stimulated neutrophil oxidative burst 
response following exercise has been attributed to this increased influx of less mature 
cells into circulation, since these 
have a reduced capacity to produce superoxide 
(Scharhag et al., 2002). It has also been suggested that as the oxidative burst is 
dependent on a source of glucose to provide NADPH, the oxidative burst response 
may be affected by falling plasma glucose concentration. It would appear however, 
that decreases in plasma glucose concentration exert no significant effect on oxidative 
burst responses in healthy participants (Lin et al., 1995). 
In accordance with previous findings, plasma IL-6 concentration significantly 
increased following the exercise protocol (Nehlsen-Canarella et at., 1997; Bishop et 
at., 2001b; Starkie et al., 2001). It should be noted, however, that the magnitude of the 
IL-6 response observed here was significantly lower than a study employing a 
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protocol of the same intensity and duration (Febbraio et al., 2003). Plasma IL-6 
concentration was significantly higher at post-exercise on CAF/PLA than both 
CAF/CHO and PLA/CHO. Since adrenaline concentration at post-exercise was 
significantly higher on CAF/PLA, it may be speculated that elevations in adrenaline 
lead to increased IL-6 production and therefore elevated plasma concentrations of IL- 
6 because increases in adrenaline have been previously related to increased IL-6 
production in both rats (Yu et al., 2001) and humans (Sondergaard et al., 2000; 
Papanicolaou et al., 1996). However, it is reported that following adrenaline infusion 
at physiological concentrations, the IL-6 response is of a lower magnitude than that 
observed during exercise (that elicits a similar adrenaline response) leading the 
authors to conclude that adrenaline plays only a minor role in stimulating IL-6 during 
exercise (Steensberg et al., 2001). Nevertheless, adrenaline infusion did still induce a 
six-fold increase in the plasma concentration of IL-6 (Steensberg et al., 2001). 
Furthermore, adrenaline mediated vasoconstriction of hepatosplanchic viscera may 
augment plasma levels of IL-6 through a 
decrease in cytokine clearance. In addition, 
adenosine receptors are present on smooth muscle of various organs such as the liver, 
thus a vasococonstriction by adenosine receptor-antagonism may also contribute to 
reduced clearance of IL-6 
from the systemic circulation. 
Although the co-ingestion of caffeine and CHO significantly reduced the IL-6 
response to exercise compared with caffeine 
ingestion alone, there were no 
differences between CAF/CHO (3.5 pg. Ml-') and PLA/CHO (3.5 pg. ml'') when 
compared with PLAIPLA (3.6 pg. ml"1). CHO 
ingestion before and during exercise is 
reported to attenuate the increases 
in plasma IL-6 concentration following prolonged 
exercise (Nehlsen-Canarella et at., 
1997; Starkie et al., 2001; Nieman et at., 2005) and 
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it is suggested that IL-6 may be involved in the regulation of glucose homeostasis by 
affecting hepatic glucose production to prevent hypoglycaemia (Gleeson, 2000; 
Febbraio and Pedersen, 2002). In the present study, there were no significant 
differences between CAF/CHO, PLA/CHO or PLA/PLA for carbohydrate oxidation 
rate. Furthermore, although blood glucose at post-exercise on PLA/PLA (-4.8 
mmo1. L"I) was significantly lower than CAF/CHO and PLA/CHO, it was not 
significantly lower than rest and could not be considered as hypoglycaemic. It is well 
known that low muscle glycogen levels are associated with elevated IL-6 responses 
(Steensberg et al., 2001) and that carbohydrate ingestion does not attenuate the rate of 
muscle glycogenolysis during cycling (Coyle et al., 1986; Jeukendrup et al., 1999; 
Febbraio et al., 2003). This coupled with the relatively small magnitude of the 
response may explain why CHO did not affect the IL-6 response following exercise 
compared to placebo. 
In summary, there was no additional benefit of co-ingesting caffeine and CHO 
compared with ingesting either supplement alone when the f-MLP-stimulated 
oxidative burst was expressed per neutrophil cell. When post-exercise f-MLP- 
stimulated neutrophil oxidative 
burst responses were expressed as a% of baseline 
response, only CHO ingestion alone (PLA/CHO) was associated with a maintenance 
of neutrophil function; ingestion of caffeine alone 
(CAF/PLA), co-ingestion of 
caffeine with CHO (CAF/CHO), or 
ingestion of placebo alone (PLA/PLA) all resulted 
in significant post-exercise declines in the f-MLP-stimulated neutrophil oxidative 
burst response. Caffeine and CHO (CAF/CHO) significantly attenuated the adrenaline 
and IL-6 responses that occurred following the ingestion of caffeine alone 
(CAF/PLA) and significantly attenuated the transient alterations in circulating total 
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leukocyte and neutrophil count. This may suggest that the effects of CHO on 
neutrophil oxidative burst responses are of greater magnitude than the previously 
reported effects of caffeine. There was however no detrimental effect of consuming 
caffeine (6 mg. kg" body mass) on leukocyte trafficking and f-MLP-stimulated 
neutrophil oxidative burst responses to exercise. 
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10.1. Background 
Athletes commonly consume caffeine as an ergogenic aid (Tarnopolsky, 1994). The 
effect of caffeine ingestion on the immune response in humans, and in particular 
following exercise, has received little scientific investigation. Caffeine is no longer a 
WADA prohibited substance, therefore its use is expected to increase considerably 
amongst athletes during periods of training and competition. The aim of the work 
described in this thesis was to investigate the influence of caffeine ingestion on 
immunoendocrine responses following prolonged and intensive cycle crgometry 
exercise. 
Initially, the effect of caffeine ingestion upon hormonal and immune responses was 
determined when participants were at rest. Caffeine ingestion was found to have little 
effect on immune responses at rest despite an elevated plasma adrenaline 
concentration (Chapter 4). Furthermore, following 90 min cycling at 70% 
V02 max, 
caffeine ingestion was also associated with elevated plasma adrenaline concentration 
compared with placebo, yet had little effect on neutrophil oxidative burst responses to 
PMA (Chapter 5). However, when neutrophils were stimulated with f-MLP, caffeine 
attenuated the post-exercise decline in the neutrophil oxidative burst response 
(Chapter 6). As caffeine is consumed as an ergogenic aid, its effect on 
immunoendocrine responses was investigated following a pre-loaded TT performance 
test (Chapter 7). In contrast to the response observed following submaximal intensity 
exercise of a fixed duration, there were no significant differences observed for f- 
MLP-stimulated neutrophil oxidative burst responses following exercise. At post-TT, 
plasma adrenaline and IL-6 concentrations were both significantly elevated following 
caffeine ingestion (Chapter 7). An in vitro study confirmed that caffeine antagonises 
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the suppressive effects of adenosine on f-MLP-stimulated neutrophil oxidative burst 
responses, but was not able to clarify the contributing mechanisms by which caffeine 
attenuated the post-exercise decrease in f-MLP-stimulated neutrophil oxidative burst 
responses in the presence of elevated adrenaline concentrations (Chapter 8). Caffeine 
is commonly consumed with CHO in commercially available soft drinks and energy 
drinks. The co-ingestion of caffeine with CHO significantly attenuated the adrenaline 
and IL-6 responses that occurred following the ingestion of caffeine alone and 
significantly attenuated the transient alterations in circulating total leukocyte and 
neutrophil count, but there was no benefit of co-ingesting caffeine with CI: HO on the f- 
MLP-stimulated neutrophil oxidative burst response compared with either supplement 
alone (Chapter 9). 
10.2. Neutrophil function 
There was no effect of caffeine ingestion (6 mg. kg'1 body mass) on neutrophil 
functional responses, assessed by the oxidative burst response to PMA and f-MLP- 
stimulation and by the degranulation response following bacterial-stimulation when 
participants were at rest (Chapter 4). Caffeine ingestion also did not affect bacterially- 
stimulated neutrophil elastase release or PMA-stimulated oxidative burst responses 
following 90 min cycling at 70% 'O2 max (Chapter 5). The effects of cAMP 
elevating agonists (such as adenosine and adrenaline) on neutrophil 
degranulation 
responses have produced equivocal 
findings. At gmol. L'l concentrations, both 
adenosine (Bouma et al., 1997) and adrenaline (Tintinger et al., 2000) are reported to 
decrease neutrophil degranulation responses following bacterial-stimulation, however, 
it is likely that in Chapter 4 and 5, the relatively small increases in adrenaline and 
adenosine concentration (at nmol. 
L"' concentrations) are not of sufficient magnitude 
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to affect the response. PMA directly activates PKC in blood neutrophils in a reccptor- 
independent mechanism, producing a prolonged and maximum response (Lopez et al., 
1995; Hazan et al., 1997). The PMA-stimulated neutrophil oxidative burst response 
has previously been reported to be insensitive to cAMP elevating agents, therefore, in 
hindsight PMA may not be a suitable stimulant for investigating the influence of 
caffeine ingestion on neutrophil oxidative burst responses (Yu et al., 1995; Chilcoat et 
al., 2002). In rats, however, 5 nmol. L" adrenaline significantly reduced the PMA- 
stimulated neutrophil oxidative burst response (Garcia et al., 1999). The plasma 
adrenaline concentration at post-exercise in Chapter 5 was 1.8 nmol. L'' following 
caffeine ingestion in which no effect on PMA-stimulated neutrophil oxidative burst 
was observed. 
Caffeine ingestion attenuated the exercise-induced decline in f-MLP-stimulated 
neutrophil oxidative burst responses when ingested 1h prior to cycling 
for 90 min at 
70% VO2 max (Chapter 6). However, following a pre-loaded TT, no attenuating 
effect of caffeine on the f-MLP-stimulated neutrophil oxidative burst response was 
observed (Chapter 7). It is suggested that caffeine antagonises A2A adenosine 
receptors with a Ki of 40 - 44 pmol. L'1 (Daly, 1993). In Chapters 6 and 9, post- 
exercise serum caffeine concentration was 46 pmol. I: 
' and 45 pmol. L4, respectively 
and f-MLP-stimulated oxidative burst responses were 62% of the 
baseline condition 
compared to 42% on PLA (Chapter 6) and 70% compared with 50% 
in Chapter 9. 
Similarly at post-exercise in Chapter 7, serum caffeine concentration was 42 pmol. I: 
and f-MLP-stimulated oxidative burst response was only 9% lower than resting values 
compared with a 26% decrease on PLA trial. At post-TT, however, serum caffeine 
concentration was 37 pmol. L'1 and 
f-MLP stimulated ncutrophil oxidative burst 
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response was similar between the 2 experimental conditions. The findings of Chapters 
5,6,7 and 8 suggest that the effect of caffeine on the f-MLP-stimulated neutrophil 
oxidative burst response is multi-factorial, but is predominantly the net result of 
stimulatory (via AZA adenosine receptor antagonism) and inhibitory (via adrenaline- 
mediated inhibition) factors. 
In Chapter 6, caffeine ingestion attenuated the exercise-induced decline in the f"MLP- 
stimulated neutrophil oxidative burst response in the presence of a significantly 
elevated plasma adrenaline concentration (2.8 nmol. L' and 1.3 nmol. L'' on CA1 and 
PLA, respectively). In this situation, it is likely that caffeine inhibits the 
occupancy/activation of A2A receptors and dominates the response. Adenosine is a 
indicator of metabolic distress (Klinger et al., 2002). It is well known that adenosine 
is produced during exercise by the increased dephosphorylation of ATP. Although 
adenosine is rapidly cleared by erythrocytes (Heptinstall et al., 2005), plasma 
adenosine concentration is reported to increase significantly following exercise (Vizi 
et at., 2002; Chouker et at,, 2005). 
In vitro, adenosine (100 nmol. L") reduced the f- 
MLP-stimulated oxidative burst of isolated neutrophils by 40% from a control 
condition (Chapter 8). This is in support of previous findings (Cronstein et a!., 
1985; 
Swain et al., 2003; Chouker et at., 2005) and was attributed to the A2A adenosine 
receptor subtype expressed on neutrophils (Gessi et al., 2000). Following the addition 
of caffeine (50 pmo1. L'') to the neutrophil suspension 
before incubation with 
adenosine, the response was only 
9% lower than control, which did not represent a 
statistically significant decrease (Chapter 
8). As caffeine did not affect the f-MLP- 
stimulated neutrophil oxidative 
burst response at rest when adenosine concentration is 
expected to be low (Chapter 4), yet attenuated the response at post-exercise (Chapter 
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6) and following incubation with 100 nmo1. L'1 adenosine (Chapter 8), this supports 
the notion that adenosine is necessary for the actions of caffeine to occur (Sullivan et 
al., 1995). A limitation of this work, however, is that adenosine concentration was not 
measured in the series of studies presented in this thesis. 
Incubation of human neutrophils with 5 nmo1. L'l adrenaline is reported to 
significantly inhibit the f-MLP-stimulated neutrophil oxidative burst response 
(O'Dowd et al., 2004). Following a maximal effort TT performed after 90 min 
prolonged cycling (Chapter 7), plasma adrenaline concentration was 5.2 nmol. L'l and 
3.7 nmol. L'l on CAF and PLA conditions, respectively. At this time-point, there was 
no attenuating effect of caffeine on the f-MLP-stimulated ncutrophil oxidative burst 
response as observed in Chapter 6. It may be speculated that there is a threshold, 
above which adrenaline exerts a greater negative influence on ncutrophil oxidative 
burst responses. An attempt was made to determine the relative influence of 
physiological concentrations of adrenaline, observed at post-exercise in Chapters 5 
and 6 (-2 nmol. L-1) and at post-TT in Chapter 7 (5 nmol. L') on the f-MLP-stimulated 
oxidative burst of isolated neutrophils in the presence of physiological concentrations 
of both caffeine and adenosine. The findings of Chapter 8 do not support a threshold 
theory, since the f-MLP-stimulated oxidative burst response of isolated neutrophils 
was similar following incubation with both 2 nmol. L" and 5 nmol. L*' adrenaline. This 
study was therefore not able to clarify the contributing mechanisms by which caffeine 
attenuated the post-exercise decline in the f-MLP-stimulated neutrophil oxidative 
burst response in the presence of an elevated adrenaline concentration, as reported in 
Chapter 6. 
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10.3. Circulating leukocyte counts 
There were no significant effects of caffeine ingestion on total blood leukocyte count 
or circulating neutrophil count at rest (Chapter 4) or following a number of different 
exercise protocols (Chapters 5-9). Adrenaline has been reported to dose-dependently 
inhibit neutrophil adherence to endothelial cell monolayers (Bazzoni et al., 1991). 
Furthermore, neutrophil count has been reported to increase and neutrophil adherence 
to vascular endothelium is reported to decrease following adrenaline infusion (Boxer 
et al., 1980). As caffeine ingestion was consistently associated with a significantly 
elevated adrenaline concentration (Chapters 4-9), it would appear that this is not a 
major mechanism for neutrophil mobilisation following exercise. Caffeine ingestion 
did not significantly affect plasma noradrenaline concentration. This may therefore 
support the findings of Benschop et at. (1996) that a-adrenoreceptors are 
predominantly involved in the effects of catecholamines on granulocyte trafficking. 
Caffeine ingestion was however, consistently associated with an increase in 
circulating lymphocyte count at pre-exercise (i. e. 1h following caffeine ingestion). 
This was observed following caffeine ingestion in Chapters 5,6 and 7. The circulating 
lymphocyte count was elevated following caffeine ingestion in Chapter 4, but this did 
not reach statistical significance. 
These findings are in accordance with Bishop et at. 
(2005) who reported similar findings using the same dose and timing of caffeine 
administration as that employed 
in the studies of the present thesis. An increased 
circulating lymphocyte count 
is most likely due to the elevated plasma adrenaline 
concentrations at the corresponding time-points altering endothelial adhesion via 
activation of ß-adrenoreceptors present on 
lymphocytes. A greater density of ß- 
adrenoreceptors are present on 
lymphocytes than neutrophils (Mackinnon, 1999). In 
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contrast, however, there was a significantly elevated circulating lymphocyte count at 
post-TT on PLA compared with the CAF trial. As discussed in Chapter 7, the reasons 
for this are unclear. 
10.4. Stress hormones and cytokines 
Caffeine ingestion consistently increased plasma adrenaline concentration at pre- 
exercise (i. e. 1h following caffeine ingestion) by approximately 2.5 to 3-fold 
(Chapters 4,5 and 6). Plasma adrenaline concentration was also significantly higher 
following caffeine ingestion at post-exercise following 90 min cycling at 70% 
VO2 max (Chapter 5,6 and 7), a maximal effort TT (Chapter 7) and 2h cycling at 
65% VO2 max (Chapter 9). This is in accordance with the considerable research 
demonstrating an increased plasma adrenaline concentration at both rest and 
following exercise with caffeine ingestion (Graham and Spriet, 1991; Graham et al., 
1991,2000; Spriet et al., 1992; Graham and Spriet, 1995; Jackman et al., 1996; 
Bishop et al., 2005 amongst numerous others). In line with the majority of this 
research evidence, caffeine 
ingestion did not affect plasma noradrenaline 
concentration at either rest 
(Chapter 4) or following prolonged and intensive 
submaximal exercise 
(Chapter 5 and 6). Collectively this suggests that caffeine acts 
on the sympathetic nervous control of the adrenal medulla rather than 
increasing the 
activity of the sympathetic nervous system 
in general (Graham and Spriet, 1991). 
However it is reported that circulating noradrenaline results from the release or 
'washout' of tissues, therefore tissue exchange measurements must be directly 
measured to determine whether or not the sympathetic nervous system 
is enhanced 
(Graham, 2001a). 
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Caffeine ingestion did not significantly increase plasma cortisol concentration at rest 
(Chapter 4), following prolonged and intensive submaximal cycling (Chapter 5,7 and 
9) or following a maximal intensity effort TT (Chapter 7). In Chapter 6, there was a 
significant main effect of trial for plasma cortisol concentration, with significantly 
higher values on CAF than PLA. This is the only study of the present thesis that 
demonstrated such an effect and is in support of the work of Bishop et al. (2005) who 
also reported a main effect of trial following the same caffeine dose and exercise 
protocol. Furthermore, Laurent et al. (2000) reported a significantly higher plasma 
cortisol concentration following 2h cycling at 65% 
'°2 max . The reason for a 
discrepancy between Chapter 6 and the other studies presented in this thesis is 
unclear, however the mean plasma cortisol concentration was 30 nmol. L"i higher on 
CAF than PLA when participants were in a rested state, prior to caffeine 
administration. From the studies of the present thesis, it is concluded that caffeine 
ingestion does not significantly increase plasma cortisol concentration compared to 
PLA condition. 
Caffeine ingestion significantly increased plasma IL-6 concentration following 90 
min cycling at 70% ' O2 max (Chapter 6) and following a pre-loaded cycling TT 
(Chapter 7). Plasma IL-6 concentration also tended to be higher on CAF/PLA than 
PLA/PLA (P = 0.062) following 2h cycle at 65% VO2 max (Chapter 9). Plasma IL- 
6 concentration increased by approximately 4-fold at post-exercise on CAF compared 
with a 2.5-fold increase on PLA (Chapter 6) and by 22-fold and 17-fold at post-TT on 
CAF and PLA, respectively in Chapter 7. As plasma adrenaline concentration was 
significantly higher on CAF than PLA at both of these time-points, it may be 
speculated that adrenaline lead to an increased IL-6 production. Increases in plasma 
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adrenaline concentration have previously been linked to an increased IL-6 release into 
circulation in both rats (Yu et al., 2001; Frost et at., 2004) and humans (Papanicolaou 
et at., 1996). Furthermore, an increase in cAMP production from 0-2 adrenoreceptor 
stimulation has been shown to enhance IL-6 production (Dendorfer et at., 1994). The 
ingestion of caffeine did not increase plasma IL-6 concentration at pre-exercise (1 h 
following ingestion). This suggests that the magnitude of the adrenaline response is 
not sufficient to affect IL-6 production when participants are at rest. During exercise 
however, adrenaline may affect IL-6 clearance from the circulation in humans. It is 
known that hepatosplanchnic viscera remove IL-6 from the circulation (Febbraio et 
at., 2003) thus adrenaline-mediated vasoconstriction of hepatosplanchic viscera may 
augment the level of IL-6 through a decreased clearance. Furthermore, a 
vasoconstriction due to adenosine-receptor antagonism by caffeine may also 
contribute to reduced clearance of IL-6 from the systemic circulation. 
IL-6 has previously been reported to mediate the delayed-onset neutrophilia following 
exercise (Suzuki et al., 1996b; Peake, 2002). An increased plasma IL-6 concentration 
at post-exercise (Chapter 6) or post-TT (Chapter 7) following caffeine ingestion was 
not associated with a significant neutrophilia or leukocytosis after aIh recovery 
period. Furthermore, IL-6 is also reported to be immunopotentiating (Smith, 1997) 
and has been associated with enhanced neutrophil CL responses and G protein activity 
(Suzuki et al., 1999; Peake, 2002). It may be speculated therefore, that the attenuated 
decline of the f-MLP-stimulated neutrophil oxidative burst response at post-exercise 
in Chapter 6 following caffeine ingestion was associated with an increased plasma IL- 
6 concentration at that time-point, effectively priming the neutrophils for an enhanced 
oxidative burst response. In contrast however, plasma IL-6 concentration was 
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significantly higher on CAF at post-TT (Chapter 7) and post-exercise (Chapter 9) 
without an enhancement of the f-MLP-stimulated neutrophil oxidative burst response. 
IL-6 is reported to produce a number of anti-inflammatory effects, one of these being 
to stimulate the appearance of IL-ira into circulation (Steensberg et al., 2003). There 
were no significant effects of caffeine ingestion on plasma IL-Ira concentration 
following exercise (Chapter 7). Plasma IL-ira concentration increased by 12-fold on 
CAF compared with a 7-fold increase on PLA at 1h post-TT, however a large inter- 
individual variation of the IL-ira response may have prevented statistical significance 
from being achieved. 
10.5. Blood-borne metabolites 
Serum caffeine concentration was < 0.1 pmo1. L"' in all studies of the present thesis 
when participants initially arrived at the laboratory. This indicates a full compliance 
and adherence to the caffeine abstinence procedure and suggests that a 60 h caffeine 
withdrawal was a sufficient time-period for clearance of previously ingested caffeine. 
Serum caffeine concentration reached a peak at 1h following ingestion, with 
decreases at post-exercise and 1h post-exercise. This is in support of the notion that 
caffeine absorption from the gastro-intestinal tract is rapid, with a half life of between 
2.5 and 4.5 h (Debry, 1994). Furthermore, the rate of caffeine clearance did not 
appear to be affected by exercise since similar reductions were observed at 
corresponding time-points at rest (Chapter 4) and following exercise (Chapter 6). 
Caffeine ingestion significantly increased plasma FFA concentration at rest (Chapter 
4), at pre-exercise and 1h post-exercise (Chapter 5) and with a main effect of trial in 
Chapter 6. In contrast, there was no effect observed in the studies presented in 
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Chapters 7 and 9. Caffeine ingestion has previously been reported to stimulate 
lipolysis in vitro and in vivo (Hetzler et al., 1990). It is likely that caffeine ingestion 
increases FFA concentration via the antagonism of Al receptors of adipocytes that 
stimulates lipolysis, or via increased sympathetic activity, - resulting in ß-adrenergic 
lipolytic stimulation (Graham, 2001a; Acheson et al., 2004). An increased FFA 
concentration, however, did not affect the net uptake by the exercising leg during 
exercise following caffeine ingestion (Graham et al., 2000). There were no significant 
effects of caffeine ingestion on plasma glucose concentration at rest (Chapter 4) or 
following exercise (Chapter 5,6,7,9). This finding has frequently been reported 
(Tarnopolsky et al., 1989; Graham et al., 1991; Cole et al., 1996; Mohr et al., 1996; 
Graham et al., 1998; Van Soeren et al., 1998); however, a few studies have reported 
an increased plasma glucose concentration during and following exercise with 
caffeine ingestion (Spriet et al., 1992; Graham and Spriet, 1995; Graham et at., 2000). 
Plasma lactate concentration was significantly higher at pre and post-90 min exercise 
(Chapter 5), post 2h exercise (Chapter 9) and tended to be higher at post-TT (Chapter 
7) following caffeine ingestion. In contrast, no effect of caffeine on plasma lactate 
concentration was observed at post-90 min exercise in Chapters 6 and 7. An increased 
blood lactate concentration has frequently been reported with caffeine ingestion and 
appears paradoxical, considering that glycogen sparing is proposed as a mechanism 
for caffeine's ergogenic effects (Graham, 2001a). An increase in blood lactate 
concentration may be the result of increased muscle glycogenolysis, without an 
increase in CHO oxidation (Raguso et al., 1996). However, Graham et at. (2000) 
observed an increased blood lactate concentration, without a difference in the release 
or clearance of lactate by the exercising muscle. The authors concluded that the 
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clearance of lactate by the liver or resting muscle must be reduced or the release from 
other tissues is increased to account for this increase in blood lactate concentration. 
10.6. RER and indirect calorimetry 
Although plasma FFA concentration was significantly elevated on CAF than PLA 
(Chapters 5 and 6), there were no significant differences for RER between CAF and 
PLA trials in either of these experimental chapters. Furthermore, mean RER ranged 
from 0.91 to 0.93 on both CAF and PLA during all submaximal exercise protocols 
(Chapter 5,6,7 and 9). The early proposed mechanism for caffeine as an ergogenic 
aid was that it increased FFA oxidation and spared muscle glycogen for use later 
during exercise (Essig et al., 1980; Spriet et at., 1992). A number of studies have 
reported a decreased RER value during exercise following caffeine ingestion (Costill 
et at., 1978; Ivy et at., 1979; Essig et at., 1980; Bangsbo et at., 1992; Nishijima et at., 
2002; Bishop et at., 2005). The findings of Chapter 5,6,7 and 9 of the present thesis 
showed that caffeine ingestion did not affect CHO or fat oxidation rates during 
exercise, as determined by indirect calorimetry. These findings are in accordance with 
a number of studies that failed to show a decreased RER when caffeine is ingested 
prior to exercise (Tarnopolsky et al., 1989; Graham and Spriet, 1991,1995; Graham 
et at., 1991; Van Soeren et al., 1996; Mohr et at., 1998; Graham et at., 2000; Greer et 
al., 2000 amongst others). Although many of these studies 
have failed to show a 
decreased RER during exercise following caffeine ingestion, many authors repeatedly 
propose glycogen sparing as the mechanism for caffeine's ergogenic effects (Graham, 
2001b). To assess this, Graham et al. (2000) obtained muscle biopsies and quantified 
the carbohydrate metabolism of the exercising leg in humans. They observed no 
difference for glucose uptake and muscle glycogen utilisation following caffeine 
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ingestion. Similarly Greer et at. (2000) and Laurent et al. (2000) reported no effect of 
caffeine ingestion on glycogen sparing supporting the theory that other actions of 
caffeine are responsible for its ergogenic effects. 
10.7. RPE and TT performance 
RPE was significantly lower following caffeine ingestion during 90 min cycling at 
70% V02 max (Chapters 5 and 6) but there were no significant differences between 
CAF and PLA during 2h cycling at 65% "02 max (Chapter 9). Furthermore, mean 
power output during a pre-loaded TT was improved by 11 W following caffeine 
ingestion, corresponding to a 4% improvement in TT performance (Chapter 7). A 
dampening of the perceptual response for a given work rate following caffeine 
ingestion has been previously reported (Costill et al., 1978; Doherty et al., 2002; 
2004). It is likely that caffeine crosses the blood-brain barrier and antagonises 
adenosine-receptor subpopulations within the brain (Davis et al., 2003). An increased 
adenosine concentration is known to inhibit the release of brain neurotransmitters 
such as dopamine and a decreased dopamine concentration is linked to the 
development of central fatigue during exercise (Davis and Bailey, 1997). 
Furthermore, caffeine ingestion is associated with an increased ß-endorphin 
concentration that is reported to increase feelings of euphoria and decrease 
perceptions of pain (Laurent et al., 2000). Leg hypoalgesia (decreased sensitivity to a 
painful stimulus) has been previously reported during cycling exercise following 
caffeine ingestion (O'Connor et al., 2004). Positive self-rated mood states such as 
happiness and alertness during exercise are also associated with caffeine ingestion 
(Backhouse et al., 2004). The capability of caffeine to influence pain perception and 
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psychological state may be an important factor in the exercise performance of 
athletes. 
10.8. Conclusions 
The major conclusions from this thesis are: 
1) Caffeine ingestion (6 mg. kg" body mass) did not affect PMA or f-MLP- 
stimulated neutrophil oxidative burst or bacterially-stimulated degranulation 
responses when participants were at rest. 
2) Caffeine ingestion attenuated the post-exercise decline in neutrophil oxidative 
burst response when stimulated by f-MLP but not PMA. An in vitro study 
confirmed that this is most likely the result of adenosine-receptor antagonism 
by caffeine. Following a TT however, there was no attenuating effect of 
caffeine on f-MLP-stimulated neutrophil oxidative burst responses. There was 
also no benefit of co-ingesting caffeine with CHO on the oxidative burst 
response compared with either supplement alone. 
3) None of the experimental studies indicated that caffeine ingestion was more 
detrimental than placebo on the f-MLP-stimulated neutrophil oxidative burst 
response. 
4) Caffeine ingestion had no effect on total circulating leukocyte or neutrophil 
count at rest or following exercise, but generally increased circulating 
lymphocyte count following ingestion. 
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5) Caffeine ingestion was consistently associated with an increased plasma 
adrenaline concentration but not noradrenaline concentration at rest and 
following exercise. Caffeine ingestion had no effect on plasma cortisol 
concentration but was associated with increased plasma IL-6 concentration 
following exercise. 
6) Caffeine ingestion increased plasma FFA concentration but had no effect on 
plasma glucose concentration. 
7) Despite a higher plasma FFA concentration, there was no effect of caffeine 
ingestion on RER or fat oxidation rate as determined via indirect calorimetry 
during submaximal exercise. 
8) Caffeine ingestion was occasionally associated with a reduced RPE during 
submaximal exercise and an improved pre-loaded TT performance compared 
to placebo. 
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App ndi A 
HEALTH SCREEN FOR STUDY VOLUNTEERS Name or Number ................. 
It is important that volunteers participating in research studies are currently in good health and have had no 
significant medical problems in the past. This is to ensure (i) their own continuing well-being and (ii) to 
avoid the possibility of individual health issues confounding study outcomes. 
Please complete this brief questionnaire to confirm fitness to participate: 
1. At present, do you have any health problem for which you arc: 
(a) on medication, prescribed or otherwise .............................. 
Yes J No 0 
(b) attending your general practitioner ..................................... 
Yes fJ Non 
(c) on a hospital waiting list ..................................................... Yes 
[) No [] 
2. In the past two years, have you had any illness which require you to: 
(a) consult your GP ................................................................ 
Yes Q No 
(b) attend a hospital outpatient department .............................. 
Yes J No EJ 
(c) be admitted to hospital ...................................................... 
Yes EJ No 1J 
3.1lave you ever had any of the following: 
(a) Convulsions/epilepsy .......................................................... 
Yes J No 
(b) Asthma ................................................................................ Yes No 
(c) Ccuma ................................................................................ Yes 
[J No 
(d) Diabetes .............................................................................. Yes No 
(e) A blood disorder ................................................................. Yes 
J No 
(t) Head injury ......................................................................... Yes 
C] No 
(g) Digestive problems ............................................................. 
Yes J No fJ 
(h) Heart problems ................................................................... 
Yes Q No 
(i) Problems with bones or joints ......................................... Yes 
Q No 
(j) Disturbance of balance/coordination .................................. Yes 
Q No 
(k) Numbness in hands or feet .................................................. 
Yes J No Q 
(I) Disturbance of vision .......................................................... 
Yes Q No (J 
(m) Ear / hearing problems ........................................................ 
Yes 13 No 
(n) Thyroid problems ............................................................... 
Yes [J No 
(o) Kidney or liver problems .................................................... 
Yes Q No 
(p) Allergy to nuts .................................................................... 
Yes Q No 0 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon aller exercise? ............ Yes 
13 No D 
If YES to any question, please describe briefly if you wish (cg to confirm problem waslis short-lived, 
Insignificant or weil controlled. ) ........................................................................................................ 
"f... lfiifllfirifi. lfiisiiifiifiiff. iiiii. iiffiifssllfiiifiiif. iiiffif111fiffifiiffiffiiififfllfif 4 ffif if ýf i lififiififflii. ffifiiiffiifiii. iflNiiiiilfitsi iii 
5. Have you had a cold or feverish illness in the past month? Yes 0 No 
6. Are you accustomed to vigorous exercise (1-3 hours per weck)? Yes[] No [] 
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Appendix B 
Physical Activity Questionnaire 
The following questions are designed to give us an indication of your 
current level of physical activity. 
Name: Date: // 
Are you currently ENDURANCE TRAINING? YES I NO 0 
If Yes, how many days each week do you usually train? 
How may minutes does each session last? 
What is your weekly mileage? 
Are you involved in any of the following training programmes? 
Weight training [_ ] Interval training II Skills training 11. 
If Yes, how many days each week do you usually train? 
How many minutes does each session last? 
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Appendix C 
CAFFEINE CONSUMPTION QUESTIONNAIRE 
Please complete the questionnaire concerning your caffeine usage. List the 
number of times you consume the following substances during a typical day. 
Mornin Afternoon Evenin g Ni ht 
COFFEE Re ular 5 oz. Mugs 
Regular 
Brewed 
Percolated 
Espresso (2 
oz. Serving) 
Instant 
Decaffeinated 
TEA (Regular 
5 oz mus 
Hot Chocolate 
(Regular 5 oz 
mugs) 
Chocolate 
(Regular Bar) 
Chocolate 
Biscuits / 
Cakes / 
Cereals 
Chocolate / 
Coffee Dairy 
Products 
SOFT DRINKS 330m1 Can Size 
Coke 
Dr Pepper 
Energy 
Drinks (Please 
state which 
ones) 
OVER THE CO UNTER DRUGS 
Pain Killers 
e. g. Anadin 
(Please state 
which ones) 
Pro Plus 
Do you take caffeine prior to exercise? 
If Yes, How much? 
What do you take? 
Why? 
'Id 
Appendix D 
Health Questionnaire 
Please complete the following brief questions to confirm your fitness to participate: 
At present do you have any health problems for which you are: 
1) On medication, prescribed or otherwise YES II NO 
2) Attending your general practitioner YES [I NO 
Have you any symptoms of ill health, such as those associated with a cold or other 
common infection? YES= NO= 
If you have answered yes to any of the above questions please give more details 
below: 
Do you want to take part in today's experiments? YES 
II NO 0. 
Signature: Date: 
U U"USuUUeU"sUu" 
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Appendix E 
NAME: 
As you are aware, the main of this study is to investigate the effects of caffeine 
ingestion on the immune response to prolonged cycling. It is therefore vital that you 
DO NOT exercise for 24 hours, or consume ANY caffeine for 60 hours prior to each 
main test. 
Please do ensure that you DO NOT EAT ANYTHING AFTER MIDNIGHT on the 
night prior to each main trial, and only consume water during this period. 
Caffeine is found in many foods, and below is a list of some products that you should 
avoid. We will be able to detect if any caffeine has been ingested during the 60 
hours prior to each test, and if found, the test will be invalid. 
DRINKS 
Tea 
Coffee 
Coke / Pepsi / Dr Pepper 
Hot Chocolate 
Energy Drinks e. g. Red Bull, Red Card, Solstis 
NB Alcoholic energy drinks also contain caffeine! 
CHOCOLATE AND COFFEE PRODUCTS 
Biscuits / cakes 
Chocolate / coffee bars 
Chocolate / coffee ice cream 
Chocolate / coffee yoghurts 
Chocolate / coffee mousse 
Chocolate / coffee spreads 
PHARMACEUTICAL PRODUCTS 
Pain Killers e. g. Anadin 
Cough / cold remedies e. g. Lemsip, Day Nurse 
Hang Over Remedies e. g. Alka Seltza XS! 
Pro Plus 
NB These are rough guidelines only. If you are unsure of the contents of any products 
please err on the side of caution! 
After each exercise bout, you will have a period of 1 hour in which you will be able to 
shower, etc, prior to the final sample. 
MANY THANKS FOR YOUR TIME AND COOPERATION. 
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Appendix F 
Preliminary results for in vitro protocol (Chapter 8) 
160 
140 
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0 80 
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1 11 21 31 41 51 61 71 81 91 
Time (s) 
